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Summary 
Malaria, caused by the apicomplexan parasite Plasmodium falciparum (P. falciparum), is still 
one of the world’s most severe human infectious diseases and threatens the health and life 
of millions of people, mainly those living in tropical and subtropical regions, despite strong 
eradication efforts. P. falciparum depends on its complex antioxidative system based on 
thioredoxin and glutathione for survival. The intraerythrocytic parasite lives in a pro-oxidant 
environment, and the host immune response increases the oxidative burden on the parasite, 
which can cause major oxidative damage. Interfering with the parasites’ essential redox 
system is a promising target for malaria-eradicating drugs. Several antimalarial drugs are 
supposed to mediate their effects at least partially by increasing reactive oxygen species 
(ROS) in the parasite. ROS are highly reactive and damaging towards DNA, lipids and 
proteins. Hydrogen peroxide (H2O2) is one of the most important cellular ROS. Until now, 
neither molecular targets nor regulatory mechanisms and dynamic changes of H2O2-
mediated signaling in P. falciparum are known. The development of the genetically encoded 
H2O2 sensors roGFP2-Orp1 and HyPer paved the way for non-disruptive, ratiometric, real-
time, dynamic, and specific measurements of changes in H2O2 concentrations within a living 
cell. Studying the dynamics of H2O2 signaling in parasites exposed to antimalarial drugs can 
lead to a better comprehension of their molecular mode of action and give further insights 
into the development of future chemotherapeutic agents. 
In this work, the ratiometric H2O2 redox sensors roGFP2-Orp1 and HyPer-3 and the pH-
insensitive version of HyPer (SypHer) were successfully transiently expressed in the cytosol 
of blood stage P. falciparum parasites and their functionality was systematically 
characterized in vitro and in cell culture. Both redox probes showed reproducible sensitivity 
towards H2O2 in the lower micromolar range in vitro and in cell culture. Due to the pH 
sensitivity of HyPer-3, parasites expressing roGFP2-Orp1 were used for evaluating the short, 
medium, and long-term effects of antimalarial drugs on H2O2 levels and detoxification in 
Plasmodium in combination with confocal live-cell imaging. None of the quinolines or 
artemisinins tested had significant effects on H2O2 homeostasis at pharmacologically 
relevant concentrations. However, pre-treatment of the cells with antimalarial drugs or heat 
shock led to a higher tolerance towards exogenous H2O2. Based on the data, both roGFP2-
Orp1 and HyPer-3 probes are reliable and valuable tools for studying H2O2 metabolism in 
living malaria parasites. However, the necessity to use a pH probe in parallel makes utilizing 
HyPer-3 more challenging and time consuming.  
Determination of the effects of oxidative and pharmacological stress on the H2O2 
homeostasis was optimized by stably integrating the redox sensor roGFP2-Orp1 into the 
genome of P. falciparum using the attB/attP integration method. Stable genomic integration 
overcomes limitations of transient transfection of the probes, allowing more detailed in-cell 
studies. For the first time H2O2 dynamics in the mitochondrial subcellular compartment could 
be determined using the stably integrated Mito-roGFP2-Orp1 redox probe. In both cytosol 
and mitochondrion, the sensors showed reproducible sensitivity towards H2O2 in the low 
micromolar range and towards antimalarial compounds at pharmacologically relevant 
concentrations. Upon short-term exposure (4 h), artemisinin derivatives, quinine and 
mefloquine impacted H2O2 levels in mitochondria, whereas chloroquine and G6PD inhibitors 
affected the cytosol; 24 h exposure to an arylmethylamino steroid and G6PD inhibitors 
revealed oxidation of mitochondria and cytosol, respectively. Furthermore, the redox sensors 
hGrx1-roGFP2 (glutathione sensor) and sfroGFP2 were expressed in the cytosol of NF54-
attB blood-stage P. falciparum parasites. Prior to stable integration, studies with the episomal 
transfected hGrx1-roGFP2 strain were performed. Both sensors were evaluated with regard 
to their sensitivity towards oxidative stress in cell culture. The results showed that G6PD 
inhibitors and the arylmethylamino steroid disturb GSH (reduced glutathione) redox ratio in 
either 4 h or 24 h incubations. The redox sensors hGrx1-roGFP2 and sfroGFP2 are both 
reliable tools for studying redox metabolism in malaria parasites with comparable 
oxidation/reduction sensitivities, at which sfroGFP2 appeared to exhibit a more pronounced 
fluorescence intensity. Microscopic and plate reader-based detection methods were directly 
compared in order to evaluate plate reader-based measurement of bulk cell cultures as an 
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alternative for single live-cell imaging. It is now possible to investigate quickly and efficiently 
with high reproducibility direct responses and long-term effects of compounds on H2O2/GSH 
homeostasis in cell populations.  
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Zusammenfassung 
Tropische Malaria, verursacht durch den einzelligen Parasiten Plasmodium falciparum (P. 
falciparum), stellt noch immer eine der weltweit schwerwiegendsten Infektionskrankheiten 
dar. Trotz intensiver Bemühungen die Malaria auszurotten, bedroht sie hauptsächlich in 
tropischen und subtropischen Regionen der Erde die Gesundheit und das Leben von 
Millionen von Menschen.  
P. falciparum ist in hohem Maße von seinen komplexen antioxidativen Systemen, 
insbesondere dem Thioredoxin- und dem Glutathionsystem, abhängig. Der intraerythrozytäre 
Parasit lebt in einer pro-oxidativen Umgebung und die Immunantwort des Wirtes erhöht 
zusätzlich den oxidativen Stress auf den Erreger. Das Eingreifen in den Redoxstoffwechsel 
des Parasiten stellt daher ein vielversprechendes Ziel für neue Wirkstoffe gegen Malaria dar. 
Mehrere Malariamedikamente vermitteln bereits jetzt ihre Wirkungen zumindest teilweise 
durch das Erhöhen der Konzentrationen von reaktiven Sauerstoffspezies (ROS) im 
Parasiten, wodurch DNA, Lipide und Proteine geschädigt werden können. 
Wasserstoffperoxid (H2O2) ist eine der wichtigsten zellulären ROS. Bislang waren molekulare 
Targets von H2O2, H2O2-vermittelte Signaltransduktion sowie dynamische Veränderungen 
der H2O2-Konzentration in P. falciparum wenig untersucht. Die Entwicklung der genetisch 
kodierten H2O2-Sensoren roGFP2-Orp1 und HyPer haben den Weg für ratiometrische, 
dynamische und hochspezifische Echtzeitmessungen der H2O2-Konzentrationen in lebenden 
Zellen geebnet. Das Erforschen der H2O2-Dynamik in Parasiten, die Malariamedikamenten 
ausgesetzt sind, kann zu einem besseren Verständnis ihrer molekularen Wirkungsweise und 
zu weiteren Erkenntnissen für die Entwicklung von zukünftigen Chemotherapeutika 
beitragen.  
In der vorliegenden Arbeit wurden die ratiometrischen H2O2-Redoxsensoren roGFP2-Orp1 
und das pH-sensitive HyPer-3 sowie die pH-insensitive Version von HyPer (SypHer) im 
Zytosol von P. falciparum Blutstadien erfolgreich transient exprimiert und ihre Funktionalität 
systematisch in vitro und in Zellkultur charakterisiert. Beide Redoxsonden haben eine 
reproduzierbare Sensitivität in Bezug auf H2O2 im unteren mikromolaren Bereich in vitro und 
in Zellkultur. Aufgrund der pH-Sensitivität von HyPer-3, wurden nur in roGFP2-Orp1 
exprimierenden Parasiten mittels konfokalem live-cell imaging Kurz-, Mittel- und 
Langzeiteffekte von Malariamedikamenten auf H2O2-Konzentrationen und Entgiftung 
analysiert. Keines der getesteten Quinoline oder Artemisinine zeigte in pharmakologisch 
relevanten Konzentrationen eine signifikante Wirkung auf die H2O2-Homöostase. Allerdings 
führte die Vorbehandlung der Zellen mit Malariamedikamenten oder Hitzeschock zu einer 
höheren Toleranz gegenüber exogenem H2O2. Auf diesen Daten basierend, sind beide 
Sonden, roGFP2-Orp1 und HyPer-3, zuverlässige und wertvolle Instrumente, um den H2O2-
Metabolismus in lebenden Malariaparasiten zu erforschen. Die Notwendigkeit, zeitgleich mit 
HyPer-3 eine pH-Sonde als Kontrolle einsetzen zu müssen, macht die Verwendung von 
roGFP2-Orp1 allerdings deutlich leichter.  
In einem zweiten Schritt wurde die Bestimmung der Effekte von oxidativem und 
pharmakologischem Stress auf die H2O2-Homöostase weiter optimiert. Dies gelang durch die 
stabile Integration des Redoxsensors roGFP2-Orp1 in das Genom von P. falciparum mittels 
der attB/attP-Methode. Stabile genomische Integration hebt die multiplen Einschränkungen 
einer transienten Transfektion der Sonden auf, was deutlich detailliertere Zellstudien erlaubt. 
Mittels des stabil integrierten Mito-roGFP2-Orp1 Redoxsensors konnten somit zum ersten 
Mal H2O2-Dynamiken in einem subzellulären Kompartiment, hier dem Mitochondrium, 
bestimmt werden. Sowohl im Zytosol als auch im Mitochondrion zeigten die Sensoren 
reproduzierbare Sensitivität gegenüber H2O2 im unteren mikromolaren Bereich und 
gegenüber Malariamedikamenten in pharmakologisch relevanten Konzentrationen. Bei der 
Kurzzeit-Inkubation (4 h) zeigten Artemisinin-Derivate, Chinin und Mefloquin deutliche 
Effekte auf H2O2-Konzentrationen in Mitochondrien, wogegen Chloroquin und Glucose-6-
Phosphat-Dehydrogenase Inhibitoren besonders das Zytosol beeinflussten. Eine 24 h 
Inkubation mit einem Arylmethylaminosteroid und mit G6PD Inhibitoren zeigten eine 
deutliche Oxidation von Mitochondrien und Zytosol.  
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Parallel zu den H2O2-Sonden wurden die Redoxsensoren hGrx1-roGFP2 (Glutathionsensor) 
und sfroGFP2 stabil in das Genom von P. falciparum integriert und im Zytosol von NF54-attB 
Blutstadienparasiten exprimiert. Vorausgegangen waren auch hier Untersuchungen mit 
episomal transfizierten Zellen. Beide Sensoren messen das intrazelluläre 
glutathionabhängige Redoxpotenzial und wurden hinsichtlich ihrer Sensitivität auf oxidativen 
Stress in der Zellkultur evaluiert. In 4 h und 24 h Inkubationen wurden deutliche Effekte von 
G6PD Inhibitoren und dem Arylmethylaminosteroid auf das Redoxpotenzial gemessen. 
Dabei erwiesen sich beide stabil integrierten Sensoren, hGrx1-roGFP2 und sfroGFP2, als 
zuverlässige Instrumente mit vergleichbaren Oxidation-/Reduktion-Sensitivitäten, wobei sich 
sfroGFP2 durch eine stärkere Fluoreszenzintensität auszeichnete. Mikroskopische und 
Plattenleser-basierte Detektionsmethoden wurden für die Sonden direkt miteinander 
verglichen, um Plattenleser-basierte Messungen von Zellpopulationen als Alternative zur 
Einzelzell-Visualisierung zu evaluieren. Auf Basis dieser Arbeiten ist es nun möglich, die 
H2O2/GSH-Homöostase von Zellpopulationen schnell und effizient mit einer hohen 
Reproduzierbarkeit zu untersuchen. 
Introduction 
 
1 
1 Introduction 
1.1 Malaria 
Malaria (Italian mal and aria “bad air”) is a mosquito-borne disease and one of the most 
threatening human infectious diseases in the world. The eradication of malaria along with 
HIV/AIDS and other diseases is one of eight Millennium Development Goals of the United 
Nations. Malaria has been known to mankind for thousands of years. In 1880, Alphonse 
Laveran, who was an army doctor in Algeria at that time, discovered in the blood of patients 
suffering from malaria that the disease is caused by parasites (Cox, 2010). For his discovery, 
he was awarded the Nobel Prize in 1907 (Guillemin, 2002). At the end of the 19th century, the 
British physician Dr. Ronald Ross showed that mosquitoes transmit the parasites responsible 
for malaria. Furthermore, he proved the complete life cycle of the malaria parasites in 
mosquitoes. For his research he also received a Nobel Prize in 1902 in Medicine (Chernin, 
1988; Guillemin, 2002). The Italian malarialogist Giovanni Battista Grassi discovered that 
human malaria is transmitted by Anopheles mosquitoes (Tuteja, 2007). In 2015, the World 
Health Organization (WHO) estimated 214 million new cases of malaria and 438,000 deaths, 
of which 70% were children under five years of age, taking the life of a child every 2 minutes. 
Most deaths occurred in the WHO African Region (90%), followed by the WHO South-East 
Asia Region (7%) and the WHO Eastern Mediterranean Region (2%) (WHO, 2015a). 
Figure 1.1 shows a map of the percentage population at risk of infection in different countries 
globally in 2013 (WHO, 2015b). High risk countries include Brazil, Mexico, India, China, 
Nigeria, Ethiopia, and Egypt. Nevertheless, substantial progress has been made towards the 
World Health Assembly goal of reducing the malaria burden by 75% by 2015. Between 2000 
and 2015, the malaria mortality rates, which take into account population growth, have fallen 
by 60% globally. The number of malaria deaths worldwide fell from an estimated 839,000 in 
2000 to 438,000 in 2015, a decline of 48%. Pregnant women and children under 5 years are 
the groups most affected by malaria due to weak or lacking immunity against the disease 
(WHO, 2015a). Malaria imposes substantial costs to the economy; it includes prevention 
expenses, drug treatment, travel costs to clinics, expenses for burials, and a loss of work 
force and school education. The Center for Disease Control and Prevention indicates that 
malaria costs the African continent at least $12 billion a year in economic loss (CDC, 2016). 
Global financing for malaria control increased from an estimated 960 million USD in 2005 to 
2.5 billion USD in 2014 (WHO, 2015a). 
 
 
Figure 1.1 Population at risk of malaria infection in 2013. Based on national annual data from the 
World Malaria Report, generated by the Global Malaria Mapper. (WHO 2015b) 
 
Malaria infections are caused by the protozoan parasite Plasmodium. Five species of 
Plasmodium are human pathogenic: Plasmodium falciparum (P. falciparum), P. vivax, P. 
ovale, P. malariae, and P. knowlesi, of which P. falciparum causes the most severe form of 
malaria, known as malaria tropica (Lee et al., 2011). Typical symptoms of malaria infections 
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include headache, fever, shivering, respiratory diseases, joint ache, nausea, and delirium 
and appear seven to thirty days after the bite of an infected female Anopheles mosquito 
(Taylor, 2009; CDC, 2015a). P. falciparum is the only human pathogenic species to cause 
cerebral malaria, one of the most common fatal neurological complications of severe malaria. 
Infected red blood cells (iRBCs) expose parasite-derived molecules on the surface of the 
erythrocyte and sequester in the brain microvasculature, which leads to reduced levels of 
consciousness, coma, and if untreated death (MacPherson et al., 1985; Idro et al., 2010). P. 
falciparum sequestration in pregnant women can lead to placental malaria, which might lead 
to anemia, abortion, stillbirth, and low birth weight (Uneke, 2007). In most cases malaria 
infections are not fatal, and reasons for transition from mild to serious infections are not well 
understood. Severe malaria is a complex process, including infection of a high number of 
RBCs, which results in destruction of RBCs and anemia, and a combination of inflammatory 
processes. Uncomplicated P. falciparum infections are usually treated with artemisinin-based 
combination therapies (ACTs) (WHO, 2015). Although a number of antimalarial drugs are 
available from seven drug classes e.g. 4-aminoquinolines, arylaminoalcohols, 8-
aminoquinolines, artemisinins, antifolates, inhibitors of the respiratory chain, and antibiotics 
(Schlitzer, 2008), malaria eradication has not yet been achieved. One of the main problems 
is the emerging resistance of Plasmodium parasites to most antimalarial drugs (Dondorp et 
al., 2009; Egan and Kaschula, 2007; Trape, 2001; Ginsburg, 2005). This results in an 
ongoing need for novel antimalarial drugs and the intense search for new parasitic drug 
targets. The Global Technical Strategy for Malaria sets ambitious but achievable goals for 
2030 in reducing malaria case incidence and mortality rates globally by at least 90%, 
eliminating malaria in at least 35 countries, and preventing a resurgence of malaria in all 
countries that are malaria free (WHO, 2015c). 
 
1.1.1 Anopheles spp. 
The female Anopheles mosquito transmits the malaria parasite among humans. Of the 
approximately 430 Anopheles species found worldwide except in Antarctica, about 30 to 40 
transmit malaria. In South America A. darlingi and A. marajoara are the main vectors of 
malaria, in Africa mainly A. gambiae and A. arabiensis, and in India mainly A. stephensi and 
A. culicifacies, transmit the parasite. A. gambiae, the principal vector in sub-Saharan Africa, 
is a particularly effective malaria vector because of its preference for feeding on humans and 
its long life compared to some other anopheline species. The adult male feeds on nectar, 
while the female adult feeds primarily upon blood. Mosquitoes undergo four stages in their 
life cycle: egg, larva, pupa, and adult; the first three stages are aquatic. Different species 
show different patterns of feeding and resting. They are active at dusk or dawn (crepuscular) 
or active at night (nocturnal); some feed indoors (endophagic) while others feed outdoors 
(exophagic). After blood feeding, some Anopheles mosquitoes rest indoors (endophilic), 
while others prefer to rest outdoors (exophilic). Furthermore, Anopheles mosquitoes have 
preferences for different hosts. Therefore, appropriate strategies for vector control take 
biology, behavior, host preference, susceptibility to Plasmodium and insecticides into 
consideration (CDC, 2015b). 
 
1.1.2 Plasmodium 
Plasmodium is a parasitic protozoan and belongs to the phylum Apicomplexa. Plasmodium 
merozoites and other apicomplexan parasites possess an elongated lemon-shape and a 
specialized complex in the apical region (Bannister et al., 2000) with which the merozoites 
are able to penetrate erythrocytes. In the host red blood cell (RBC), they develop by using 
the host metabolites for proliferation and digestion of hemoglobin, and they undergo 
schizogony. P. falciparum causes malaria tropica, the most dangerous form of the disease, 
and is mainly present in Africa (Snow et al., 2005). Unlike P. vivax, P. falciparum invades 
both reticulocytes and mature red blood cells (Triglia et al., 2001). In contrast to P. vivax and 
P. ovale, P. falciparum has no persistent liver forms, and relapses do not occur (CDC, 
2015a). The compartmentation of Plasmodium differs considerably from other cells in 
structure and function (Figure 1.2). Trophozoite-stage parasites (≈ 30 h) possess only one 
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mitochondrion, a plastid, called the apicoplast (Lim and McFadden, 2010), which is attached 
to the mitochondrion, as well as a digestive vacuole (DV, also referred to as pigment vacuole 
or food vacuole), where hemoglobin degradation takes place (Moura et al., 2009). The 
parasite forms a parasitophorous vacuolar membrane, which differs substantially from other 
known biological membranes (Lingelbach and Joiner, 1998). 
 
 
 
 
Figure 1.2 Mid-trophozoite stage of Plasmodium. Mid-trophozoite stage of P. falciparum, 
characterized by its irregular outline, the increase in protein synthesizing apparatus, increased feeding 
through multiple cytostomes, growth of the pigment vacuole, and structures associated with export of 
parasite proteins (Golgi body, exocytic vesicles). Inset: relative sizes of the trophozoite and red blood 
cell (RBC) as seen by light microscopy. ER, endoplasmic reticulum. (Bannister et al., 2000) 
 
1.1.2.1 The P. falciparum life cycle 
The life cycle of P. falciparum is complex, involving vertebrate and invertebrate hosts, and 
starts with the bite of an infected female Anopheles mosquito. Motile forms of the parasite 
(sporozoites) are transmitted during the blood meal from the salivary gland of the mosquito 
into the human host blood stream, initiating the pre-erythrocytic (asexual) stage of malaria 
infection. The sporozoites infect liver cells and develop into schizonts which rupture and 
release thousands of merozoites into the blood stream (Hafalla et al., 2011; Marks et al., 
2014). In contrast to P. falciparum, P. vivax and P. ovale can additionally become dormant in 
liver cells, resting as hypnozoites, and awake weeks or months later causing the relapses 
that characterize infections with these two species (Trampuz et al., 2003). After the invasion 
of erythrocytes, merozoites evolve into ring-stage parasites. The parasites start to grow, and 
approximately at the age of 20 h post invasion, the DV with hemozoin crystals appears 
resulting in trophozoites. During enlargement, the parasites need high amounts of energy, 
which they obtain from metabolization of imported glucose, ingestion of host cytoplasm, and 
digestion of hemoglobin (Tuteja, 2007). The trophozoites develop into schizonts (≈ 38 to 
48 h), which rupture and release up to approximately 20 merozoites into the blood stream to 
invade further erythrocytes, starting a new cycle of schizogony. The release of merozoites 
causes the malaria-typical symptom of fever. The length of the erythrocytic stage depends on 
the infecting Plasmodium species. P. falciparum for instance presents a 48 h cycle (Kappe et 
al., 2010; Tuteja, 2007). Under special circumstances such as stress, ring-stage parasites 
can also develop into sexual stage gametocytes, which are harmless for the host but can be 
taken up by the next mosquito bite. In the mosquito midgut, the sporogenic cycle takes place 
within the course of 10 to 14 days. Gametocytes form gametes, which fuse and built a 
zygote. The zygote transforms into an ookinete, which is able to cross the midgut epithelium 
and develop further into an oocyst. Sporozoites are released by rupture of the oocysts that 
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enter the salivary gland of the mosquito and are transmitted to the human host through an 
infectious mosquito’s bite (Marks et al., 2014; Kappe et al., 2010; Tuteja, 2007) (Figure 1.3).   
 
 
 
Figure 1.3 P. falciparum life cycle. P. falciparum undergoes a complex developmental cycle in man 
(sexual stage) and mosquito (asexual stage) that requires rapid adaptation to various environments. 
(Cowmen et al., 2012) 
 
1.1.2.2 P. falciparum subcellular compartments 
Plasmodium harbors a non-photosynthetic plastid derived from the endobiosis of 
Cyanobacteria called the apicoplast, which is essential for the parasite’s survival (Yeh and 
DeRisi, 2011). The apicoplast has four membranes and harbors biochemical pathways such 
as fatty acid synthesis, lipoate synthesis, isoprenoid synthesis, iron-sulfur cluster (FeS) 
synthesis, tRNA modification, and in part heme biosynthesis (Ralph et al., 2004) (Figure 1.4); 
it also has a small circular genome ≈ 35 kb in size (Wilson et al., 1996). Fatty acids are 
essential for the formation of membrane lipids and can be obtained by scavenging from the 
host or via the type two fatty acid synthesis (FAS-II) pathway (Tarun et al., 2009). For P. 
falciparum’s asexual blood stage replication, the FAS-II pathway is not essential (Vaughan et 
al., 2009). Isoprenoids are synthesized by the mevalonate-independent methylerythritol 
phosphate (MEP) pathway in P. falciparum, also known as the 1-deoxy-D-xylulose 5-
phosphate (DOXP) pathway. The pathway leads to the production of isopentenyl 
diphosphate (IPP) and dimethylallyl diphosphate, the precursors of ubiquinones and 
dolichols and the prenylation of proteins. The MEP isoprenoid pathway was recently shown 
to be essential for the survival of erythrocytic stage malaria parasites (Yeh and DeRisi, 2011; 
Jomaa et al., 1999). Isoprenoids are the only metabolites produced in the apicoplast that are 
needed outside the organelle (Yeh and DeRisi, 2011). FeS clusters are protein cofactors 
found in most organisms and have multifunctional roles: they transfer single electrons, 
donate sulfur atoms, initiate free radical chemistry, sense oxygen, and have structural roles 
(Beinert, 2000; Brzoska et al., 2006). FeS cluster proteins are likely required for the 
production of essential isoprenoids. In P. falciparum, two of three known FeS cluster 
biosynthesis pathways are present: the mitochondrial Isc pathway and the Suf pathway 
located in the apicoplast. Both FeS cluster synthesis pathways follow the same basic steps 
to mobilize sulfur: cluster assembly and cluster transfer. The Suf pathway is not found in 
humans but is essential for maintaining the apicoplast organelle (Gisselberg et al., 2013). 
Heme biosynthesis is initiated in the mitochondrion and is therefore explained in more detail 
in the following paragraph. 
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Figure 1.4 P. falciparum apicoplast pathways and metabolism. The apicoplast imports trioses that 
are converted to fatty acids or isoprenoid precursors through the DOXP IPP synthesis pathway. These 
acyl products are exported for use elsewhere in the parasitic cell. Various nuclear-encoded proteins 
are imported to join the endogenously produced proteins. (Ralph et al., 2004) 
 
The functions of the single mitochondrion of P. falciparum differ from mitochondria of other 
organisms. The P. falciparum one contains a linear 6-kb mtDNA genome, which is the 
smallest known among eukaryotes (Torrentino-Madamet et al., 2010). The mtDNA genome 
encodes three protein-encoding genes (namely cytochrome c oxidase subunits I and III, and 
cytochrome b) and fragmented rRNA genes but not tRNA (Vaidya et al., 2009). Heme 
biosynthesis starts in this mitochondrion by synthesizing δ-aminolaevulinic acid (three 
enzymes) (Varadharajan et al., 2002). P. falciparum blood stages have a canonical oxidative 
tricarboxylic acid (TCA) cycle, where the central carbon metabolism is derived from glucose 
and glutamine (MacRae et al., 2013). Mitochondria play an important role in several 
biosynthetic processes, producing compounds necessary to support the electron transport 
chain (ETC). These include the biosynthesis of coenzyme Q (ubiquinone), an important 
electron carrier in the ETC, heme, a prosthetic group in cytochromes, and iron-sulfur 
clusters, which also function as prosthetic groups in several proteins of the ETC (van Dooren 
et al., 2006). After glycolysis, the pyruvate product is further oxidized in the TCA cycle of the 
mitochondrion. This cycle deposits energy into the reduced coenzymes, which transfer that 
energy through the ETC (Figure 1.5). The transfer of electrons from NADH to molecular 
oxygen (O2) yields a lot of energy that is transferred in small steps in the inner membrane of 
the mitochondrion through a chain of five protein complexes to O2. As electrons are passed 
down the chain, they move from a higher to a lower energy level, releasing energy. The 
energy is used to pump protons, moving them across the inner mitochondrial membrane 
from the inner matrix to the intermembrane space, producing a strong electrochemical 
gradient across the membranes. At the end of the ETC, electrons are passed to O2, which 
takes up protons to form H2O. As protons flow down their gradient and back into the matrix, 
they pass through the protein’s complex adenosine triphosphate (ATP) synthase, which 
makes use of this membrane potential (Δψm) to accomplish the conversion of ADP to ATP 
(Torrentino-Madamet et al., 2010) (oxidative phosphorylation). The important functions of the 
mitochondrial electron transport chain (mtETC) seem to be to serve as an electron disposal 
system for dihydroorotate dehydrogenase, an essential mitochondrial enzyme in pyrimidine 
biosynthesis (Painter et al., 2007), and to generate the Δψm. Numerous metabolic pathways 
within mitochondria require maintenance of Δψm to support the transport of molecules 
necessary for protein synthesis, iron-sulfur cluster and heme biogenesis, and the 
biosynthesis of ubiquinone (Vaidya and Mather, 2009). Furthermore, during the reduction of 
O2, superoxide anions (O2
•-) are produced, which represent the major source of intracellular 
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reactive oxygen species (ROS) in cells. Torrentino-Madamet et al. (2010) suggested that the 
mitochondrion of P. falciparum has a low respiratory metabolism during the asexual life cycle 
in order to prevent the generation of toxic ROS. Blocking the ETC with rotenone (Rot) 
(inhibition of complex I) (Figure 1.6), for example, increases mitochondrial production of 
ROS, e.g. O2
•- and H2O2 (Boveris, 1977; Li et al., 2003). Rot is a plant toxin and blocks NAD
+ 
linked oxidation in complex I of the ETC.  
 
Figure 1.5 P. falciparum mitochondrial respiratory chain. Electrons are transferred from NADH to 
O2 through a chain of five protein complexes. Electron flow within these transmembrane complexes 
via coenzyme Q (CoQ) leads to the transport of protons across the inner mitochondrial membrane and 
establishment of the transmembrane potential gradient used to produce ATP. The three 
characteristics of P. falciparum ETC are an alternative NADH dehydrogenase (CI), a hypothetical 
alternative oxidase (AOX), and a putative uncoupled protein (UCP). Electron flow (e -) is shown in 
dotted lines. NAD
+
: nicotinamide adenine dinucleotide, NADH: nicotinamide adenine dinucleotide 
hydride, L-DHO: L-dihydroorotate, TCA: tricarboxylic acid, Cyt c: Cytochrome c, complex I (CI, NADH 
dehydrogenase), complex II (CII, succinate-ubiquinone reductase/quinol fumaratereductase), complex 
III (CIII, ubiquinol-cytochrome c oxidoreductase), complex IV (CIV, cytochrome c oxidase), complex V 
(CV, ATP synthase). (Torrentino-Madamet et al., 2010) 
 
 
Figure 1.6 Structure of the electron transport chain blocker (ETCB) rotenone. The structure was 
created using ChemSketch 2.0. 
 
Hemoglobin degradation is essential for the growth of the intraerythrocytic stages of malarial 
parasites. Hemoglobin digestion takes place in an acidic compartment, the DV. This 
degradative process provides a source of amino acids for P. falciparum. The degradation of 
hemoglobin leads to the release of toxic α-hematin (heme precursor ferriprotoporphyrin IX, 
PIX) that is taken up by the acidic (pH 5.2) DV (Kuhn et al., 2007). Oxidation (Fe2+ to Fe3+) of 
PIX promotes the generation of ROS (Fitch, 2004). P. falciparum detoxifies Fe3+-PIX by 
polymerizing it into β-hematin crystals, also called hemozoin (Francis et al., 1997). 
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Plasmepsins and falcipains, aspartic and cysteine proteases, respectively, are mainly 
responsible for the degradation (Goldberg et al., 1990; Loria et al., 1999). The survival of P. 
falciparum within human erythrocytes is dependent upon export of parasite proteins that 
remodel the host cell in order to permit the exchange of nutrients, especially hemoglobin, and 
metabolites. Most exported proteins require signal sequences, called the Plasmodium export 
element (PEXEL) or cell vacuolar targeting sequence (VTS), for transport across the 
parasitophorous vacuole membrane and into the host, both short peptide sequences 
(Boddey et al., 2009). 
 
Glycolysis takes place in the cytoplasm of P. falciparum; it is the main pathway for ATP 
production and essential for its survival. Glucose consumption in erythrocytes as non-
proliferative cells with modest energetic needs is relatively low (Jensen, 1983). Upon 
invasion the glucose consumption rate increases up to 100-fold at the most metabolically 
active trophozoite and schizont stages (Roth, 1990). The parasite increases hexose 
permeability of the erythrocyte membrane (Kirk, 1996) by expressing at least one essential 
hexose transporter to the surface of the infected cell (Slavic et al., 2010). Free glucose is 
quickly phosphorylated to glucose-6-phosphate by the host cell hexokinase upon invasion 
into RBC cytosol in order to make it impermeable, thus effectively trapping it within the host 
compartment. An acid phosphatase that is trafficked to the erythrocyte and cleaves 
phosphate from a diversity of small molecules might dephosphorylate glucose-6-phosphate 
for import into the parasite (Müller et al., 2010). Inhibitors of glycolysis have shown potent 
antimalarial activity, including 2-deoxyglucose (2-DG) (Figure 1.7), which significantly 
reduced parasite survival in P. falciparum (Van Schalkwyk et al., 2008; Udeinya and Van 
Dyke, 1981).  
 
Figure 1.7 Structure of the glycolysis inhibitor 2-deoxy-D-glucose. The structure were created 
using ChemSketch 2.0. 
 
1.1.3 Malaria treatment  
Drug targets of interest are the DV (hemoglobin degradation), the apicoplast (plastid that 
originated from a green algal symbiont), an acrystate mitochondrion (limited electron 
transport system), and the cytosol. Currently used antimalarial drugs are from seven drug 
classes: 4-aminoquinolines (chloroquine, amodiaquine), arylaminoalcohols (quinine, 
mefloquine, halofantrine, lumefantrine), 8-aminoquinolines (primaquine), artemisinins 
(artemisinin, dihydroartemisinin, artesunate, and artemether), antifolates (pyrimethamine, 
sulfadoxine, proguanil, chlorproguanil), inhibitors of the respiratory chain (atovaquone), and 
antibiotics (doxycycline, clindamycin) (Schlitzer, 2008). Factors involved when deciding on 
the best treatment for malaria include the parasite species, the severity of disease, the 
patient’s age and immune status, the parasite’s susceptibility to drugs (i.e. drug resistance), 
and the cost and availability of drugs.  
 
1.1.3.1 4-aminoquinolines, 8-aminoquinolines, arylaminoalcohols 
Chloroquine (CQ), mefloquine (MQ), and quinine (QN) are members of the quinoline 
antimalarials. QN is the active ingredient of the Cinchona tree bark (South America), while 
CQ and MQ are synthetically produced (Gorka et al., 2013; Krafts et al., 2012; Wainwright 
and Amaral, 2005). CQ and amodiaquine (AQ) are 4-aminoquinolines. Quinolines are 
supposed to act as FP detoxification inhibitors within the DV of the parasite, thus inhibiting 
hemoglobin degradation. Quinoline antimalarials kill malaria parasites by binding to α-
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hematin and preventing the sequestration of toxic heme into the nontoxic crystalline 
hemozoin stored in the DV (Becker et al., 2004; Gorka et al., 2013; Bray et al., 1999). This 
leads to membrane and protein damages caused by toxic, free FP and enhanced toxicity of 
ROS, which are produced during hemoglobin degradation. Quinoline might also influence 
cellular GSH levels and inhibit potassium channels (Sullivan, 2013; Becker et al., 2004). CQ 
accumulates in iRBCs, particularly in the acidic DV, to reach levels hundreds of times higher 
than those in plasma. CQ has been for a long time the drug of choice in antimalarial therapy 
(Krafts et al., 2012; Wainwright and Amaral, 2005); however, resistance to CQ has rapidly 
developed. Related drugs became cross-resistant, e.g. AQ, QN, and MQ (Platel et al., 1998), 
or have serious side effects, such as QN (Sullivan, 2013). It is even argued that CQ is no 
longer an appropriate partner drug (Buchholz et al., 2008), but the use of MQ in ACT is very 
promising (Gorka et al., 2013). Furthermore, GSH detoxifies α-hematin into hemozoin in the 
DV. CQ and AQ inhibit this degradation, leading to the accumulation of α-hematin, 
permeabilization of membranes, enzyme inhibition, and parasite death. Primaquine (PQ) 
belongs to the 8-aminoquinolines and it is the only available antimalarial drug that is active 
against both liver (Dembele et al., 2011) and sexual blood stages (Bousema et al., 2010; 
Shekalaghe et al., 2007; Delves et al., 2012). Therefore, PQ is the only drug that can prevent 
relapses after P. vivax and P. ovale infection. It is suggested that ROS-labile FeS groups are 
the primary targets of PQ (Lalève et al., 2016). Its mechanism of action is nonetheless still 
poorly understood, but disruption of mitochondria (Hill et al., 2006) and increase of oxidative 
stress (Ganesan et al., 2012) seem to be involved. Furthermore, PQ administration can lead 
to severe side effects (e.g. hemolytic toxicity) against glucose-6-phosphate dehydrogenase-
deficient (G6PD) human erythrocytes (Ganesan et al., 2012). Lumefantrine (LUM) is an 
antimalarial agent used to treat acute, uncomplicated malaria. It is administered in 
combination with ATM for improved efficacy (White et al., 1999). This combination therapy 
exerts its effects against the erythrocytic stages of Plasmodium spp. and is effective even 
against multidrug-resistant malaria parasites. The structures of the aforementioned drugs 
are depicted in Figure 1.8.  
 
 
Figure 1.8 Structures of 4-aminoquinolines, 8-aminoquinolines, and arylaminoalcohols. The 
structures were created using ChemSketch 2.0. 
 
1.1.3.2 Artemisinins 
Artemisinin (ART) is the oldest and most effective antimalarial drug in use. It is the active 
ingredient in extracts of the herb qinghaosu (Artemisia annua; sweet wormwood), which has 
been used in traditional medical practice in China for over thousands of years with a 
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sesquiterpene lactone endoperoxide structure (1,2,4-trioxane ring) (Tu, 2011). Its derivatives 
such as the lipophilic ester artemether (ATM) and the hydrophilic artesunate (ATS) are semi-
synthetically derived from ART to improve its poor solubility and relatively short half-life 
(Becker et al., 2004; Mohring et al., 2014). Artemisinins are the most important part of 
malaria therapy because of their activity against multi-drug resistant parasites (Mohring et al., 
2014). They act more rapidly on parasites than other known antimalarial drugs (100 to 1,000-
fold reduction in parasite numbers per asexual cycle). ART and its derivatives are used in 
combination with other antimalarial drugs as part of the 7-day long ACTs for treatment of 
uncomplicated malaria as the first choice (WHO, 2015a). However, P. falciparum resistance 
to ART and ACTs has been recently described (Dondorp et al., 2009; WHO, 2015a). For 
severe P. falciparum and P. vivax malaria ART is the drug of choice. Relapses of 
uncomplicated P. vivax malaria can be prevented by a 14-day treatment with PQ. Because 
ART is naturally derived, which results in high costs in comparison to synthetic drugs, there 
is an urgent need to discover novel antimalarial drugs (Mohring et al., 2014). The antimalarial 
effect of ART is mediated by cleavage of the endoperoxide bridge that interacts with reduced 
heme generated from hemoglobin degradation. This leads to the generation of free toxic 
radicals that trigger oxidative stress and damage cellular macromolecules including proteins, 
lipids, or enzymes in either the DV or cytosol of the parasite (Becker et al., 2004; Sullivan, 
2013; Mohring et al., 2014; Hartwig et al., 2009; Klonis et al., 2011). Other researchers 
showed that ART interferes with Δψm, which leads to an increase in ROS formation (Wang et 
al., 2010; Antoine et al., 2014). ART is also supposed to oxidize FADH2 that has been 
reduced by NADPH (Nicotinamide adenine dinucleotide phosphate).This process depletes 
NADPH, thus perturbing redox homeostasis in P. falciparum (Haynes et al., 2011). ART 
targets DNA synthesis, glycolysis and hemoglobin digestion pathways within the 
intraerythrocytic life stage of the parasite (Ismail et al., 2016). Today, no equally efficient and 
tolerable alternative to ACTs is available. Due to emerging resistance of parasites to 
antimalarial drugs, the WHO recommends replacing ART monotherapy with ACTs as the 
main treatment of P. falciparum infections (Dondorp et al., 2009). The structures of the 
aforementioned drugs are depicted in Figure 1.9.  
 
 
Figure 1.9 Artemisinin structures. The structures were created using ChemSketch 2.0. 
 
1.1.3.3 Other antimalarial drugs and compounds 
Ellagic acid (EA) is a polyphenolic lactone found in various plants (Sturm et al., 2009), e.g. in 
Alchornea cordifolia (Banzouzi et al., 2002). FEA (flavellagic acid) and CEA (coruleoellagic 
acid) were created for higher hydrophilicity by introducing one or two additional hydroxyl 
groups into the antimalarial compound EA. This leads to improved inhibition of GST, 
glutathione reductase (GR), and thioredoxin reductase (TrxR) as well as heme aggregation 
due to higher hydrophilicity compared to EA (Sturm et al., 2009). FEA and CEA possess 
enhanced antiplasmodial activity in the lower nanomolar range, while EA has antiplasmodial 
activities in the upper nanomolar range (Banzouzi et al., 2002). CQ-resistant P. falciparum 
strains are also particularly affected by CEA and FEA (Sturm et al., 2009). 
Methylene blue (MB) (3,7-bis(dimethylamino)-phenothiazin-5-ium chloride) was the first 
known synthetic antimalarial drug that can stain tissues or other substances (Wainwright and 
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Amaral, 2005; Mohring et al., 2014). In 1891, Ehrlich and Guttmann discovered MB as a 
potential antimalarial drug. The heterocyclic aromatic compound is a reversible redox-type 
agent due to its central thiazine ring, which enables it to undergo oxidation-reduction 
reactions (redox cycler) (Wainwright and Amaral, 2005). MB is still of great interest due to 
increasing resistance to other antimalarials (Wainwright and Amaral, 2005). Combination 
therapy with CQ was a possible antimalarial treatment due to the GSH depletion capacity of 
MB in the cytosol, enhancing the activity of CQ (Becker et al., 2004; Mohring et al., 2014). 
However, antagonistic effects of MB and CQ were detected (Rengelshausen et al., 2004; 
Akoachere et al., 2005). MB-based combination therapy showed pronounced 
gametocytocidal activity, which appeared to act against both existing and developing P. 
falciparum gametocytes (Coulibaly et al., 2009). MB has multifactorial activity comprising 
enhanced production of H2O2, loss of NAD(P)H, interference with disulfide reductases, DV 
basification, and inhibition of heme crystallization (Becker et al., 2004; Wainwright and 
Amaral, 2005; Buchholz et al., 2008; Sullivan, 2013). However, the antimalarial mode of 
action of MB is not yet fully understood (Sullivan, 2013; Wainwright and Amaral, 2005; 
Becker et al., 2004).  
Antifolate antimalarial drugs interfere with folate metabolism, which is essential to malaria 
parasite survival. Antifolates target the two enzymes of the biosynthesis of tetrahydrofolate, 
dihydropteroate synthase (class I antifolates) and dihydrofolate reductase (DHFR, class II 
antifolates) (Gregson and Plowe, 2005). Proguanil inhibits DHFR, and the combination of 
proguanil and atovaquone (ATQ) (Malarone®) is used for prophylaxis and therapy of 
uncomplicated malaria tropica (Looareesuwan et al., 1999; Baggish and Hill, 2002). 
Proguanil increases the drug effect of ATQ and minimizes the generation of resistance. ATQ, 
a coenzyme Q analogue, has been indicated to specifically target the cytochrome bc1 
complex of the mitochondrial respiratory chain in the malarial parasite (Fry et al., 1992), but 
resistance due to mutations at position 268 (Tyr) occurs rapidly (Akhoon et al., 2014). The 
consequence of this inhibition is the collapse of the Δψm (Srivastava et al., 1997). WR99210 
also inhibits DHFR; however, due to its low bioavailability it is not used as an antimalarial 
drug but as a selection agent for transfections of plasmids harboring the DHFR inhibition 
resistance gene (Nzila, 2006). Young trophozoite-stage parasites seem to have the highest 
susceptibility, as reported in parasite growth studies (Painter et al., 2010). The apicoplast 
and the mitochondrion are drug targets of antibiotics, including doxycycline and clindamycin 
due to its algal and bacterial ancestry (Lell and Kremsner, 2002; Tan et al., 2011). Up to now, 
no clinically relevant resistance of malaria parasites against antibiotics has been reported. 
The lead steroid compound 1o, out of more than 60 derivatives, was found to be fast acting 
and highly active against P. falciparum blood stages (EC50 1-5 nM) and gametocytes (Krieg 
et al., 2017). Oral administration of compound 1o drastically reduced parasitemia in P. 
berghei-infected mice and cured the animals. Furthermore, parasite transmission from mice 
to mosquitoes was efficiently blocked by compound 1o (Krieg et al., 2017). The steroid 
compounds showed low cytotoxicity in mammalian cells and did not induce acute toxicity 
symptoms in mice (Krieg et al., 2017). The steroid and the hydroxyarylmethylamino moieties 
were found to be essential for antimalarial activity, which indicated a chelate-based quinone 
methide mechanism involving metal or heme bioactivation (Krieg et al., 2017). The 
antiparasitic effect of compound 1o was reinforced by studies employing the cytosolic 
glutathione redox sensor hGrx1-roGFP2. The results demonstrated that incubation with 
nanomolalar concentrations of compound 1o led to a dose-dependent increase in the redox 
ratio, indicating oxidation and alterations in the intracellular redox potential (Krieg et al., 
2017). 
Glucose-6-phosphate dehydrogenase (G6PD) is a novel target for antimalarial drug design 
based on observations that G6PD deficiency in humans protects the carrier from malaria 
infections (Cappellini and Fiorelli, 2008). G6PD catalyzes the initial and rate-limiting step in 
the pentose phosphate pathway (PPP), a key metabolic pathway yielding NADPH, an 
essential reducing equivalent in the antioxidative defense of cells (Ruwende and Hill, 1998). 
The malaria parasite is susceptible to oxidative stress in the intraerythrocytic stage. G6PD 
deficiency leads to a lack of reducing equivalents, an increase in oxidative stress, and thus to 
protection against malaria. NADPH in parasite-infected RBCs is generated by human G6PD, 
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but also by P. falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase 
(PfGluPho) with G6PD activity. PfGluPho is essential for Plasmodium proliferation and 
propagation and differs structurally and mechanistically from the human ortholog (Jortzik et 
al., 2011). Therefore, developing PfGluPho inhibitors is a promising way to kill the parasite 
and treat malaria. ML304 is a ring-expanded chemical scaffold and selectively inhibits 
PfGluPho (EC50 < 1 µM) but not human G6PD (> 420-fold selectivity). It is the second 
reported PfG6PDH inhibitor after the previously reported ML276 (Maloney et al., 2012). The 
structures of selected aforementioned antimalarial compounds are depicted in Figure 1.10. 
 
 
Figure 1.10 Structures of other antimalarial compounds. The structures were created using 
ChemSketch 2.0. 
 
New targets of antimalarial drugs are seen in the redox system of P. falciparum. In this 
thesis, investigations focus on the effects of ART, ATM, ATS, CQ, QN, MQ, MB, CEA, FEA, 
ATQ, AQ, LUM, compound 1o, ML304, and a new synthesized derivative of ML304, here 
referred to as compound S. The structure of compound S cannot be shown in this 
dissertation due to publication restrictions. 
  
1.2 Redox and antioxidant systems of P. falciparum 
P. falciparum has to face oxidative stress during its intraerythrocytic life cycle. In order to 
maintain redox balance, the parasites’ antioxidant system includes a GSH and Trx system 
closely interacting (Jones and Go, 2006), as well as iron (Fe)-superoxide dismutase (SOD) 
and manganese (Mn)-SOD (Jortzik and Becker, 2012; Mohring et al., 2014). Furthermore, P. 
falciparum possesses four unique selenoproteins, which may also represent components of 
the redox-regulatory network (Röseler et al., 2012). GSH is the major low molecular mass 
antioxidant in the parasite (Becker et al., 2003a); classic glutathione peroxidases (Gpx) and 
catalase are absent. Intracellular redox changes are either short- or long-lived and unique to 
different subcellular compartments. The compartmentation of the redox system has been 
characterized in detail (Kehr et al., 2010) and is depicted in Figure 1.11. P. falciparum is 
exposed exogenously and endogenously to oxidative and nitrosative stress (Müller, 2003; 
Becker et al., 2004). P. falciparum-infected RBCs produce about twice as many hydroxyl 
radicals (HO•) as normal RBCs (Atamna et al., 1993). Oxidative stress is triggered by ROS 
including H2O2, superoxide radicals, HO
•, and reactive nitrogen species (RNS) comprising 
nitric oxide (NO) and peroxynitrite. Spontaneous oxidation and degradation of ingested 
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hemoglobin by the parasite contributes to oxidative stress, resulting in the liberation of pro-
oxidative heme. Two-thirds of the oxyhemoglobin is converted into methemoglobin in the DV 
upon generation of O2
•- that dismutate to H2O2 due to the low pH of the vacuole (Atamna and 
Ginsburg, 1993; Müller, 2004; Loria et al., 1999). 
 
 
Figure 1.11 Compartmentation of redox metabolism in malaria parasites. Schematic 
representation of an intraerythrocytic trophozoite. AOP, antioxidant protein; 1-Cys Prx, 1-cysteine 
peroxiredoxin; ER, endoplasmic reticulum; GILP, glyoxalase-1-like protein; Glo, glyoxalase; GLP, 
glutaredoxin-like protein; GR, glutathione reductase; Grx, glutaredoxin; GST, glutathione-S-
transferase; LipDH, lipoamide dehydrogenase-like protein; Plrx, plasmoredoxin; SOD, superoxide 
dismutase; Tlp, thioredoxin-like protein; TPx, thioredoxin-dependent peroxidase; Trx, thioredoxin; 
TrxR, thioredoxin reductase. *, tGloII was found to localize to the cytosol and the apicoplast; 
#
, Trx2 
was targeted to the parasitophorous vacuole and a yet unidentified organelle of the parasite; 
+
, TPxGl 
was localized both to the cytosol and the apicoplast. Endogenous glutathione peroxidases and a 
catalase are not present in Plasmodium. (Kehr et al., 2010) 
  
Free α-hematin is released from the vacuole into the cytoplasm, causing membrane damage 
and producing O2
•- (Müller, 2004). Heme degradation causes the release of iron, which 
reacts with H2O2, generating highly toxic HO
• (Fenton reaction) (Ginsburg et al., 1998; Becker 
et al., 2004). Heme can be degraded by GSH in a radical-mediated reaction and can be 
inhibited by the antimalarial drugs CQ and AQ (Ginsburg and Golenser, 2003). Moreover, the 
parasite has to face oxidative and nitrosative stress from the immune system of the host. 
During the mtETC, O2
•- is also generated (Turrens, 2003). Immune cells such as 
macrophages and neutrophils generate ROS and RNS. The parasite seems to protect itself 
from the host immune system by depleting the host arginine pool in order to decrease the 
activity of nitric oxide synthase, since arginine is the substrate for NO radical synthesis 
(Olszewski et al., 2009). Interfering with the essential parasites’ redox system is a promising 
target for malaria-eradicating drugs. The positive effects of antimalarial drugs with antioxidant 
properties and the role of oxygen and nitrogen stress in the parasites’ pathology were 
recently discussed in detail (Percario et al., 2012). Generally in eukaryotic cells, the cytosol, 
mitochondria, and nucleus have a reducing milieu in contrast to the oxidizing one of the 
endoplasmic reticulum (ER). The cytosol is a reducing compartment surrounding organelles 
with high oxidative activity, and it is a milieu for redox regulation. In Plasmodium, specific 
cysteine residues in proteins are often crucial for redox reactions, cell signaling, and 
transcription factor activity. They bind metal ions and affect protein structures by forming 
Introduction 
 
13 
disulfide bonds (Jortzik et al., 2012). Thiols are organosulfur compounds with a cysteine 
sulfhydryl group (SH) serving as a proton donor. Many proteins can be (de)activated by 
oxidation of specific cysteinyl thiols (Cys-SH) to sulfenic acids (Cys-SOH) (highly reactive), 
sulfinic acids (Cys-SO2H), sulfonic acids (Cys-SO3H), and disulfides (Reddie et al., 2008). 
Figure 1.12 gives an overview of different oxidation states of cysteine residues.  
 
 
Figure 1.12 Different oxidation states of cysteine residues. Cysteines can be oxidized by different 
ROS to sulfenic acids, which can be reduced by several reductants such as glutathione and 
thioredoxin. Further oxidation leads to sulfinic acid, which can be reduced by sulfiredoxin, and to 
irreversibly oxidized sulfonic acid that cannot be reduced. (Jortzik et al., 2012) 
 
1.2.1 The glutathione redox system 
GSH (γ-L-glutamyl-L-cysteinylglycine) is the most abundant low-molecular-weight thiol in 
most cells, with estimated intracellular levels in the millimolar range in P. falciparum, where 
the glutathione system has been investigated in detail (Becker et al., 2003a). GSH prevents 
ROS-induced cell membrane damage and degradation of protein-bound, free, or membrane-
associated heme, and it is involved in the invasion process of merozoites and further 
development of the parasite (Stocker et al., 1985; Atamna and Ginsburg, 1995). GSH is de 
novo synthesized by two enzymes: γ-glutamylcysteine synthetase (γGCS), which catalyzes 
the ATP-dependent condensation of L-cysteine and L-glutamate, and glutathione synthetase 
(GS), which fuses the dipeptide L-γ-glutamylcysteine with glycine under consumption of ATP 
(Müller, 2004). The generation of γGCS and GS null mutants of P. falciparum blood stages 
has failed so far, supporting the assumption of the central role of GSH in the parasite 
(Patzewitz et al., 2012). The glutathione metabolism of P. falciparum includes GR, GST, 
glyoxalases, glutaredoxin (Grx) and glutaredoxin-like proteins. GSH is oxidized to glutathione 
disulfide (GSSG) and is either regenerated back to GSH by GR (Färber et al., 1996) or 
exported to maintain the redox state of the cell. The GSH:GSSG thiol switch is a central 
redox regulator (Becker et al., 1994; Atamna and Ginsburg, 1997). Physiological ratios of 
reduced (GSH) and oxidized (GSSG) glutathione when employing genetically encoded redox 
probes are more than 10,000:1. GSH plays a major role in redox regulation by directly 
reacting with hydroperoxides and modulating enzyme activity by forming a mixed disulfide 
with specific cysteine residues (glutathionylation). Furthermore, S-glutathionylation protects 
redox-sensitive cysteine residues from irreversible overoxidation (Pastore and Piemonte, 
2012). GSH is a coenzyme in GST-based reactions. GSTs are involved in the conversion of 
lipophilic, non-polar xenobiotics into less toxic, hydrophilic metabolites that can be eliminated 
more easily from the cell. Recently, 493 targets of protein S-glutathionylation were identified 
in Plasmodium blood stage parasites (Kehr et al., 2011). S-glutathionylation can be reversed 
enzymatically by Trx, Grx, Plrx, sulfiredoxin, and GST or spontaneously by GSH, a process 
called deglutathionylation (Kehr et al., 2011; Jortzik et al., 2012). Grxs, also known as 
thioltransferases, use GSH for downstream reactions, including the reduction of proteins, and 
are electron donors for ribonucleotide reductase (Jortzik and Becker, 2012; Holmgren, 2000). 
NADPH is the major electron donor for the glutathione system derived from the PPP. The 
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dimeric flavoenzyme GR catalyzes the NADPH-dependent regeneration of GSH from GSSG 
(Figure 1.13).  
 
 
Figure 1.13 The glutathione system of P. falciparum. Glutathione is synthesized by the enzymes γ-
glutamyl-L-cysteine synthetase (γGCS) and glutathione synthetase (GS). Glutathione reductase (GR) 
reduces oxidized glutathione disulfide (GSSG) to reduced glutathione (GSH) upon consumption of 
NADPH. GSSG can also be reduced by thioredoxin (Trx) and be exported from the parasite cell into 
the host erythrocyte. Reduced (GSH) is a co-factor for glyoxalase, which detoxifies methylglyoxal and 
glutathione S-transferase (GST) for the detoxification of electrophilic compounds. GSH and GSSG can 
covalently modify proteins referred to as protein S-glutathionylation (protein-SSG). GSH is the major 
reductant of oxidoreductase glutaredoxin (Grx), which reduces a number of target proteins. (Jortzik 
and Becker, 2012) 
 
1.2.2 The thioredoxin redox system 
The thioredoxin system (TrxS) of P. falciparum (Figure 1.14) supports the antioxidative 
defense mechanisms of the glutathione system. It comprises the NADPH-dependent TrxR 
(Becker et al., 2000), three thioredoxins (Trx), two thioredoxin-like proteins, five 
peroxiredoxins (Prx) and plasmoredoxin (Plrx), a 22 kDa redox-active protein exclusively 
found in Plasmodium.. In return, it can be reduced by GSH, Trx, and Grx and harbors a 
typical Cys-xx-Cys active site motif. Trxs directly detoxify hydroperoxides or reduce GSSG, 
S-nitrosoglutathione (GSNO), H2O2, tert-butylhydroperoxide, and cumene hydroperoxide 
(Powis and Montfort, 2001; Kanzok et al., 2002). Trx1 is suggested to act as an electron 
shuttle between reduced TrxR and GSSG because it does not itself reduce GSSG (Kanzok 
et al., 2002). Furthermore, Trx1 interacts with a range of proteins involved in, e.g. signal 
transduction, protein folding, transcription and translation, glycolysis, and hemoglobin 
catabolism (Sturm et al., 2009). Plrx is involved in DNA synthesis by reducing ribonucleotide 
reductase, it catalyzes the reduction of GSSG and Prx1a, can undergo protein S-
glutathionylation, and is able to deglutathionylate S-glutathionylated proteins (Becker et al., 
2003b). Hydroperoxides can be detoxified by five Prxs (Gretes et al., 2012) localized in 
different cellular compartments (Kehr et al., 2010), as well as by a glutathione peroxidase-
like thioredoxin peroxidase (Sztajer et al., 2001). Knocking out TrxR in P. falciparum was 
lethal for intraerythrocytic parasites (Krnajski et al., 2002). 
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Figure 1.14 The thioredoxin system of P. falciparum. Thioredoxin (Trx) reduces disulfides in 
various target proteins and low molecular weight molecules such as glutathione disulfide; the oxidants 
hydrogen peroxide (H2O2), cumene hydroperoxide (CHP), tert-butylhydroperoxide (tBuOOH), S-
nitrosoglutathione; and the antioxidants dehydroascorbate, lipoic acid, and lipoamide. Trx is reduced 
by thioredoxin reductase (TrxR) upon consumption of NADPH + H
+
. P. falciparum employs five 
peroxiredoxins (Prx), which detoxify peroxides by using Trx as a reducing substrate. P. falciparum Trx 
has around 20 target proteins, with the most intensely studied proteins shown in the figure. Moreover, 
PfTrx can deglutathionylate S-glutathionylated proteins (protein-SSG). (Jortzik and Becker, 2012) 
 
1.3 ROS and H2O2 
ROS are products of incomplete O2 reduction. For a long time, ROS were regarded as 
destructive molecules and were associated with nonspecific damage to DNA, lipids, and 
proteins, supported by the discovery of antioxidant enzymes decomposing ROS and by the 
fact that phagocytes produce ROS when killing pathogens. Now ROS such as O2
•- and H2O2 
are known as signaling molecules with a regulatory function (Neill et al., 2002; Veal et al., 
2007). H2O2 is one of the most important cellular ROS. Diffusing through biological 
membranes, H2O2 can act as a long-range, fast-acting signaling molecule by regulating 
growth factors and cytokines to control cell division, differentiation, and migration (Rhee et 
al., 2010; Veal et al., 2007). Within cells H2O2 can be produced by the mitochondrial 
respiratory chain, via NADPH oxidases, through the enzymatic detoxification of superoxide 
radicals via SOD, or during hemoglobin degradation in P. falciparum (Becker et al., 2004). 
Erythrocytes infected with P. falciparum produce significantly higher amounts of OH• radicals 
and H2O2 when compared to uninfected erythrocytes (Atamna and Ginsburg, 1993). Immune 
cells such as macrophages and neutrophils generate large amounts of ROS and RNS in 
response to Plasmodium infection. During their intraerythrocytic life stages malaria parasites 
are exposed to oxidative stress generated by increased ROS formation through the Fenton 
reaction (Becker et al., 2004; Müller, 2003; Simoes et al., 1992). Furthermore, H2O2 controls 
protein functions of redox-sensitive proteins by selectively oxidizing cysteine-reactive 
residues (Meyer and Dick, 2010; Winterbourn, 2008). An overview of the antioxidant defense 
system of P. falciparum is shown in Figure 1.15. 
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Figure 1.15 Antioxidant defense system of P. falciparum-infected red blood cells. (Becker et al., 
2004) 
  
1.4 Genetically encoded fluorescent probes 
The extraction of green fluorescent protein (GFP) from the jellyfish Aequorea victoria in the 
early 1960s (Shimomura et al., 1962) is the basis for many biological applications. GFP 
consists of 238 amino acids, including a fluorophore in the protein sequence (Prasher et al., 
1992). The GFP cDNA can be inserted into a cell or organism without decreasing cell viability 
or growth (Dooley et al., 2004). The chromophore is formed by intramolecular cyclization of 
three amino acids (S65/Y66/G67). Fusing GFP to proteins enables visualization of their 
intracellular distribution and real-time dynamics in living cells that can be detected via 
fluorescence microscopy, flow cytometry, and other fluorescence-based methods.  Wild type 
GFP (wtGFP) chromophore is fluorescent in both deprotonated and protonated states. In 
recent years, novel imaging tools including genetically encoded fluorescent probes were 
developed, which paved the way for visualization and quantification of redox reactions in 
living cells. Conventional redox measurements as recently reviewed (Rahbari et al., 2015), 
for example with redox-sensitive fluorescent dyes, are limited in live-cell imaging due to cell 
disruption, which might lead to the generation of artificial ROS and interaction with multiple 
oxidants (Meyer and Dick, 2010; Bonini et al., 2006). They also lack specificity for certain 
ROS species (Tarpey et al., 2004), they are irreversible, which hinders dynamic 
measurements, they lack compartment specificity, and they are prone to artifacts (Rahbari et 
al., 2015). Genetically encoded biosensors overcome most of these limitations. These 
probes can be expressed in a wide variety of cells and organisms (Dooley et al., 2004). They 
can be targeted to specific proteins or organelles of interest, e.g. mitochondria, nucleus, 
cytoplasm, ER and others, making it possible to track redox processes. They enable non-
disruptive, real-time, and subcellular compartment-specific measurements of redox changes. 
Measurements at the single-cell level are based on microscopy, whereas population 
behavior can be studied with flow cytometry or microplate readers. These redox probes are 
fusion proteins consisting of a reduction-oxidation (redox-active) GFP2 (roGFP2) genetically 
fused to redox enzymes such as human glutaredoxin-1 (hGrx1), which is used to measure 
the GSH/GSSG redox state, or Orp1 from Saccharomyces cerevisiae (S. cerevisiae) for 
measuring H2O2 as previously described (Gutscher et al., 2008; Gutscher et al., 2009). 
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HyPer (hydrogen peroxide) is also a redox probe used for measuring changes in H2O2 
concentration but consists of a circularly permuted yellow fluorescent protein (YFP) 
(Belousov et al., 2006). YFP is generated via point mutation (T203Y) of GFP, resulting in a 
shift in emission from green to yellow fluorescence (Rhee et al., 2010). These probes allow 
real-time monitoring of the thiol redox state and ROS in living cells and tissues. RoGFP was 
constructed by introducing two redox-active cysteines (S147C, Q204C) into wtGFP 
molecules close to the chromophore, where disulfides can be formed (Hanson et al., 2004). 
GFP is pH stable under physiological conditions (pH 5.5-8.0) and is not degraded by 
proteases. A key advantage of roGFPs, in comparison to other fluorescent probes, is that 
ratiometric studies independent of intracellular protein concentrations can be performed 
since it has two excitation peaks and one emission peak (Meyer and Dick, 2010). These 
minimize measurement errors that can occur due to different expression levels, cell 
thickness, or photo bleaching (Morgan et al., 2011; Hanson et al., 2004). 
Different mutants of GFPs led to the development of roGFP variants with differences in pH 
sensitivity, in the dynamic range, and mid-point redox potential (Dooley et al., 2004). 
RoGFP1 has low pH sensitivity, which is useful for measurements in highly acidic 
environments. Its low mid-point redox potential makes it suitable for analyses in highly 
reducing milieus. RoGFP2 was developed by adding the mutation S65T. The amino acid 
exchange leads to a shift in the excitation spectrum, brighter fluorescence, and an extended 
dynamic range for ratiometric fluorescence measurements (Lukyanov and Belousov, 2014). 
The consensus average values of the midpoint redox potential of roGFP1 and roGFP2 at 
pH 7 are -291 mV and -280 mV, respectively (Dooley et al., 2004). In order to engineer 
roGFP variants better suited for analysis within more oxidizing compartments such as the 
ER, roGFP1-iX and roGFP2-iX (insertion of amino acid X, (E or L)) with midpoint potentials of 
-220 mV to -240 mV have been developed (Lohman and Remington, 2008).  
Current genetically encoded fluorescent indicators (GEFIs) emit light in the green part of the 
visible spectrum and cannot be used for dual-compartment or dual-redox-couple imaging 
within the same cell. This would enable the study of the interplay between different redox 
couples or redox interactions between organelles on an individual cell basis. Therefore, red 
fluorescent sensors for H2O2, GSH/GSSG, and other redox couples are in high demand 
because they improve the brightness and photostability of existing probes. GEFIs for O2
•, 
NO•, and other important redox-related molecules still have to be developed.  
 
1.4.1 H2O2 redox sensor roGFP2-Orp1 
The genetically encoded fluorescent redox probe roGFP2-Orp1 detects changes in H2O2 
concentration. It has the spectral properties of roGFP2: a ratiometric pH-stable readout 
reporting submicromolar H2O2 (Gutscher et al., 2009). The sensor consists of roGFP2 fused 
to Orp1 (oxidant receptor peroxidase 1), a highly sensitive thiol peroxidase (Delaunay et al., 
2002; Hanson et al., 2004). Orp1 is classified as a Prx due to its Trx dependency. It is also 
known as GPx3, a seleno-independent member of the GPx family (Gutscher et al., 2009). In 
yeast (S. cerevisiae), Orp1 oxidizes the basic leucine zipper transcription factor Yap1 that 
regulates H2O2 homeostasis by indirectly sensing cellular H2O2 levels (Gutscher et al., 2009; 
D’Autréaux and Toledano, 2007; Delaunay et al., 2002). Orp1 acts as a primary oxidant 
receptor that transfers oxidation to Yap1, a secondary oxidant target protein. Initially, H2O2 
oxidizes one of the three cysteines in Orp1, resulting in the sulfenic acid Cys36-SOH. Cys36-
SOH forms an intermolecular disulfide bond with Yap1 by reacting with the target thiol 
Cys598. The intermolecular disulfide linkage of Orp1-Yap1 is transposed to an intramolecular 
disulfide bond of activated Yap1 (Cys303-S-S-Cys598) (Delaunay et al., 2002). Then, a 
second disulfide bond (Cys310-SS-Cys629) can be formed via a similar pathway with 
another oxidized Orp1 molecule (D’Autréaux and Toledano, 2007). The yeast transcription 
factor Yap1 activates expression of antioxidant genes in response to oxidative stress. To 
oxidize Yap1 with Orp1, a complex of Yap1 must be formed with a second protein (Ybp1). 
However, the exact function of Ybp1 is still unknown (Veal et al., 2007). The protein oxidation 
relay is not restricted to Yap1 but can also oxidize other proteins, for example roGFP 
(Gutscher et al., 2009). Gutscher et al. (2009) engineered covalent fusions of the yeast thiol 
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peroxidase Orp1 and roGFP2, which is selectively oxidized by H2O2. Figure 1.16 shows this 
oxidation transfer from H2O2 via Orp1 to roGFP2. 
 
Figure 1.16 Oxidant transfer in roGFP2-Orp1. (Adapted from Morgan et al., 2011)  
 
RoGFP2-Orp1 has two excitation peaks with maxima at 390 nm and 480 nm and one 
emission peak at 510 nm. When roGFP2 is oxidized, the excitation peak at 390 nm 
increases, while the 480 nm peak decreases (Gutscher et al., 2009). RoGFP2 has been 
fused to Orp1 by using a 32-amino acid linker peptide that enables proximity and flexible 
interactions and facilitates oxidizing equivalents being passed from H2O2 via Orp1 to 
roGFP2, resulting in an almost stoichiometric oxidation of the probe (Gutscher et al., 2009). 
The probe roGFP2-Orp1 responds to H2O2 in the same highly specific way as wtOrp1 and is 
not oxidized by other oxidants such as GSSG, cystine, hydroxyethyl disulfide, and 
dehydroascorbic acid (Gutscher et al., 2009; Delaunay et al., 2002). The oxidation of 
roGFP2-Orp1 is fully reversible; it can be expressed in various systems and targeted to 
subcellular compartments (Morgan et al., 2011). RoGFP2-Orp1 responds rapidly in a highly 
sensitive manner to H2O2 (submicromolar range) and specifically to H2O2, enabling sensitive 
fluorescent real-time measurements of changes in H2O2 concentrations. However, roGFP2-
Orp1 cannot be used to measure absolute H2O2 concentrations and determine absolute rates 
of H2O2 production (Morgan et al., 2011; Gutscher et al., 2009). In yeast cells, Orp1 is 
reduced by Trx (Chu et al., 2009); therefore, the TrxS is the most favored system for 
reducing the probe roGFP2-Orp1 (Gutscher et al., 2009; Delaunay et al., 2002), although a 
reduction by endogenous Grxs cannot be excluded (Belousov et al., 2006; Zhao et al., 2011).  
 
Table 1.1 Mutations in roGFP1 and roGFP2. 
 
Classification Mutations 
roGFP1 
roGFP2 mutations (Dooley et al., 2004) 
C48S, S147C, Q204C 
S65T 
 
1.4.2 H2O2 redox sensor HyPer-3 
HyPer is a genetically encoded biosensor for H2O2 (Belousov et al., 2006). It is composed of 
a circularly permuted YFP (cpYFP) inserted between amino acids 205 and 206 of the 
conformation-changing region in the regulatory domain (RD) of the H2O2 sensing protein 
OxyR (Belousuv et al., 2006). Circularly permuted fluorescent proteins (cpFP) are generated 
by fusing the original N- and C-termini of the YFP protein with a short polypeptide linker (6-10 
amino acids), which introduces new termini at the site of the β-barrel near the chromophore 
(Topell et al., 1999; Abad et al., 2004). CpFPs have the advantage of being highly sensitive 
to protein conformation via changes in structure or interactions of the sensing domains fused 
to their termini. These cause changes in the FP chromophore environment and spectral 
properties of the sensor and lead to their ability to sense H2O2 concentrations due to their 
fluorescence dependency, when they are combined with H2O2-sensitive proteins such as 
OxyR (Lukyanov and Belousov, 2014). The E. coli transcription regulator OxyR is a member 
of the LysR family of bacterial transcription factors and can selectively sense small amounts 
of H2O2 (Zheng et al., 1998; Belousov et al., 2006; Christman et al., 1989). The dimeric OxyR 
consists of a DNA-binding domain (amino acids 1-79) and an OxyR-RD (amino acids 
80-310). OxyR is oxidized by H2O2 and changes its conformation to the DNA-binding form 
(Belousov et al., 2006) forming a disulfide bond between the key cysteine residues Cys199 
and Cys208 (Zheng et al., 1998) (Figure 1.17). H2O2 oxidizes Cys199 located in a 
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hydrophobic pocket, which restricts penetration of charged oxidants such as O2
•- (Choi et al., 
2001). Thus, Cys199 is transformed into a charged sulfenic acid intermediate (SOH) and is 
repelled by the hydrophobic pocket due to its charge. Cys199 gets close to Cys208, and they 
form the intramolecular transient disulfide bond (Choi et al., 2001). This leads to a reversible 
conformational change, primarily between residues 205-222 (flexible region of OxyR), which 
lets OxyR bind to DNA and regulate transcription (Zheng, 1998; Choi et al., 2001). OxyR is 
reduced by Grx (D’Autréaux and Toledano, 2007). 
 
 
Figure 1.17 Composition and conformational change in HyPer after exposition to H2O2. (Adapted 
from Lukyanov and Belousov, 2014) 
 
HyPer has two excitation peaks with maxima at 420 nm and 500 nm and one emission peak 
at 530 nm. When H2O2 oxidizes HyPer, the 420 nm excitation peak decreases, and the 500 
nm excitation peak increases proportionally, making the sensor ratiometric (Belousov et al., 
2006). Short amino acid linkers (Ser-Ala-Gly and Gly-Thr) are introduced between OxyR and 
cpYFP for ratiometric characteristics. The 420 nm and 500 nm excitation peaks correspond 
to protonated and anionic forms of the chromophore, respectively. An acidified environment 
leads to an increase in the protonated form (ex 420 nm) and a decrease in the deprotonated 
form (ex 500 nm), thus mimicking reduction of HyPer (Belousov et al., 2006; Poburko et al., 
2011). In contrast, an alkalized environment mimics oxidation of the probe. HyPer has 
several considerable advantages for monitoring real-time dynamics of H2O2 in the living cell: 
it is reversible (can be reduced via cellular thiol-reducing systems), highly sensitive to H2O2 in 
the submicromolar range (Belousov et al., 2006), specific (does not interact with other 
oxidants), and it has a fast reaction rate constant (Bilan et al., 2013). HyPer can also be 
targeted to a specific compartment of the cell. Its prokaryotic origin may prevent undesirable 
specific interactions within eukaryotic cells. HyPer’s redox-active Cys pair has a midpoint 
potential of −185 mV (Zheng et al., 1998). Therefore, HyPer can be used only in the relatively 
reducing nucleocytoplasmatic compartment (Belousov et al., 2006; Malinouski et al., 2011; 
Mishinia et al., 2011), mitochondria (Belousov et al., 2006; Malinouski et al., 2011), and 
peroxisomes (Malinouski et al., 2011; Costa et al., 2010; Elsner et al., 2011), but not outside 
the cell or in the lumen of endosomes and the ER. Attempts to express ER-targeted HyPer 
resulted in a completely oxidized sensor (Malinouski et al., 2011; Enyedi et al., 2010), even 
though one study reported reduced HyPer in the ER lumen (Wu et al., 2010). 
HyPer is a monomer or weak dimer depending on its concentration (Markvicheva et al., 
2011). Recently, two enhanced versions of HyPer have been developed, HyPer-2 
(Markvicheva et al., 2011) and HyPer-3 (Bilan et al., 2013). HyPer-2 was developed by 
inserting a point mutation into HyPer (A406V, corresponding to A233V in wtOxyR). HyPer-2 
forms a strong dimer and has an extended dynamic range upon oxidation (6-7 compared to 3 
in HyPer), but two times slower oxidation and reduction rates in vitro. HyPer-2 is able to 
detect lower concentrations of endogenous H2O2 than HyPer (Markvicheva et al., 2011). To 
improve oxidation-reduction rates, Bilan et al. (2013) generated HyPer-3 (weak dimer) by 
inserting the mutation H34Y (corresponding to H114Y in wtOxyR), while keeping its dynamic 
range high. This resulted in a probe with a high signal-to-noise ratio. The reduction half-time 
of HyPer-3 was the shortest in comparison to HyPer and HyPer-2, whereas oxidation was 
1.4-fold faster than HyPer-2 but slower than HyPer (Bilan et al., 2013). HyPer can be 
reduced by the antioxidant proteins Grx, Prx, or Trx. While oxidation of the probe takes 
seconds, reduction takes minutes (Belousov et al., 2006; Bilan et al., 2013; Markvicheva et 
al., 2011). The major drawback of HyPer is its pH sensitivity. This issue can be addressed by 
using pH-specific probes as a control. A control for HyPer is its H2O2-insensitive but pH-
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sensitive form HyPer-C199S (Belousov et al., 2006). Later, the name HyPer-C199S was 
changed to SypHer (Poburko et al., 2011). SypHer’s pH dependency has been characterized 
in detail and was successfully used to track pH changes in the cytoplasm and mitochondria 
(Poburko et al., 2011). SypHer and HyPer are supposed to have exactly the same pH 
sensitivity.  
 
Table 1.2 Mutations in HyPer. 
 
Classification Mutations 
HyPer mutations 
HyPer-2 mutations 
HyPer-3 mutation 
F46L, Q69K, V163A, S175G, H148D, F64L, Y203F  
A406V 
H34Y 
 
1.4.3 Glutathione redox sensor hGrx1-roGFP2 
The reaction of thiol-disulfide exchange between glutathione and roGFPs is catalyzed by 
hGrx1. HGrx1-roGFP2 senses redox potential changes between −240 mV and −320 mV. 
This range corresponds to very minor concentrations of GSSG. The probe is insensitive to 
H2O2, but adding GSH leads to H2O2-induced oxidation of the sensor, indicating that H2O2 
affects the sensor only by oxidizing GSH (Gutscher et al., 2008). HGrx1 was fused to the N- 
or C-terminus of roGFP in order to increase the sensitivity of roGFP to the redox state of 
glutathione. HGrx1 catalyzes rapid redox equilibration between glutathione and roGFP2 so 
that the sensor is able to detect nanomolar changes in GSSG against a backdrop of 
millimolar GSH within seconds (Gutscher et al., 2008). In the oxidative response (monothiol 
mechanism), the nucleophilic cysteine C23 of hGrx1 specifically reacts with GSSG to form a 
mixed hGrx1-glutathione disulfide intermediate. This intermediate reacts with one of the two 
thiols on roGFP2, which becomes S-glutathionylated. In the last step, glutathionylated 
roGFP2 rearranges to form the intramolecular disulfide bridge (C147–C204) (Figure 1.18).  
 
 
Figure 1.18 Oxidation mechanism of the glutathione redox sensor hGrx1-roGFP2. (Adapted from 
Meyer and Dick, 2010) 
 
The redox sensor has two excitation maxima at 405 nm and 488 nm and one emission peak 
at 520 nm, as roGFP2-Orp1. An increase in the 405 nm peak reflects protonation/oxidation of 
the chromophore; an increase in the 488 nm peak reflects deprotonation/reduction of the 
chromophore. The hGrx1-roGFP2 redox sensor has already been applied in the cytosol of P. 
falciparum in order to determine the basal glutathione redox potential (Kasozi et al., 2013). 
The glutathione redox potential of CQ-sensitive (Pf3D7) and resistant (PfDd2) parasites was 
estimated to be around -314 mV. Pedelacq et al. (2006) fused different GFP mutants N-
terminally to poorly folding polypeptides and investigated their folding and refolding 
capacities in order to engineer a superfolder GFP mutant. The lab of Myles Akabas, Albert 
Einstein College of Medicine (New York, USA) developed a superfolder roGFP2 (sfroGFP2), 
combining the roGFP2 mutations with the superfolding mutations (Table 1.3). 
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Table 1.3 Mutations in sfroGFP2. 
 
Classification Mutations 
roGFP2 mutations (Dooley et al., 2004) C48S, S65T, S147C, Q204C 
“superfolding” mutations, including folding-
enhancing, enhanced-GFP, and cycle-3 GFP 
mutations  (Pedelacq et al., 2006) 
S30R, Y39N, F64L, S65T (note: same as 
roGFP2-specific S65T mutation listed 
above), F99S, N105T, Y145F, M153T, 
V163A, I171V, A206V 
GFP-specific mutations (present among 
various existing GFP forms)  
L68V, A72S, Q80R, F223R (blocks 
dimerization) 
 
1.5 Objectives of the study 
The goal of this work was to elucidate the impact of antimalarial drugs and new compounds 
on H2O2-mediated signaling of P. falciparum under physiological and pharmacological 
conditions. The antiplasmodial mechanisms and oxidative capacities of antimalarial drugs 
and newly synthetized compounds are not fully known; further research is therefore 
necessary. Establishing genetically encoded H2O2 probes within the parasite enables non-
disruptive, real-time, and subcellular compartment-specific monitoring of changes in H2O2 
levels.  Cellular and subcellular effects of oxidants on the H2O2 level can be determined by 
employing this new tool. In order to implement these goals, the following steps were taken: 
 
 Cloning and transfection of the redox-sensitive H2O2 sensors roGFP2-Orp1, HyPer-3, 
and the pH control SypHer into P. falciparum blood stage parasites 
 Cloning and transfection of the sensors targeting the compartments apicoplast, 
mitochondrion, DV, and ER of P. falciparum  
 Live-cell imaging of P. falciparum H2O2 signaling and the effects of antimalarial drugs 
and new compounds on its cytosol and organelles via fluorescence microscopy 
 Determination of the cytosolic pH using SypHer and the pH-sensitive protein pHluorin  
 Optimization of real-time imaging of parasites expressing genetically encoded redox 
and pH sensors via stable integration 
 Real-time 3D visualization of P. falciparum parasites expressing the probe roGFP2-
Orp1 exposed to different concentrations of H2O2 
 Establishing a method to measure redox changes with a microtiter plate reader 
 
As part of this work, the impact of new compounds on the glutathione redox system of P. 
falciparum was also investigated using the already established glutathione redox probe 
hGrx1-roGFP2 and the alternative redox-sensitive roGFP2 version, namely sfroGFP2, 
leading to the following steps: 
 
 Live-cell imaging of the effects of new compounds on the glutathione redox system of 
P. falciparum using hGrx1-roGFP2 and sfroGFP2 
 Optimization of real-time imaging of parasites expressing the redox sensors hGrx1-
roGFP2 and sfroGFP2 
 Real-time 3D visualization of P. falciparum parasites expressing the probe hGrx1-
roGFP2 exposed to different concentrations of H2O2 
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2 Materials 
2.1 Equipment, consumables, and software 
 
Table 2.1 Nomenclature and manufacturer of equipment used in alphabetical order. 
 
Equipment Manufacturer 
Autoclave VX-95 Systec, Wettenberg 
Biophotometer Beckmann, Munich 
Beckman SW41-Ti ultracentrifuge 
Centrifuge 5415R 
Clariostar plate reader 
Confocal microscope TCS SP5 
Duomax 1030 
Electrophoresis system OwI EasyCast 
Flake ice maker F80C 
GelDoc 2000 
Gene pulser X cell electroporator 
Heating block neoBlock II 
Beckmann, Munich 
Eppendorf, Hamburg 
BMG Labtech, Ortenberg 
Leica, Wetzlar 
Heidolph Instruments, Schwabach 
Thermo Scientific, Dreieich 
Icematic, Meerbusch 
Bio-Rad, München 
Bio-Rad, Munich 
NeoLab, Heidelberg 
Heating block Thermomixer comfort 
Incubator orbital shaker Thermo Forma 430 
Incubator Heraeus cytoperm 2 
Infinite M200 microplate reader 
Eppendorf, Hamburg 
Thermo Scientific, Dreieich 
Thermo Scientific, Dreieich 
Tecan, Männedorf 
Megafuge 1.0R Heraeus Instruments, Hanau 
MACS seperator Miltenyi Biotech, Bergisch Gladbach 
Magnetic uniStirrer 1 LLG Labware, Meckenheim 
Mastercycler gradient Eppendorf, Hamburg 
Microscope axiostar Zeiss, Jena 
Minishaker IKA MS2 Sigma-Aldrich, Steinheim 
Minispin table centrifuge Eppendorf, Hamburg 
Neubauer hemocytometer 
PH meter 
Brand GmbH, Germany 
Knick, Berlin 
Power Pac 300 and 1000 Bio-Rad, Munich 
Safety cabinet Herasafe 
Sonicator 
Thermo Scientific, Dreieich 
Bandelin Electronics, Berlin 
Sorval RC 6+ and rotor SS-34 Thermo Scientific, Dreieich 
Spectrophotometer DU® 650 Beckmann, Munich 
Spectrophotometer U-2001 Hitachi, Schwäbisch Gmünd 
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Table 2.2 Nomenclature and manufacturer of the consumables used in alphabetical order. 
 
Consumables Manufacturer 
Discofix 3-way stopcock 
Electroporation cuvettes 2 mm GenePulser 
Falcon tubes 15 ml, 50 ml 
Braun, Melsungen 
Bio-Rad, Munich 
Greiner Bio-One, Frickenhausen 
Filter Whatman, 0.2 µM 
Filter Millex-GP 0.22 µM 
GE Life Sciences, Dassel 
Merck, Darmstadt 
Hypordermic needles Sterican  
Ø 0.55x25 mm 
Braun, Sempach 
LoBind tubes 1.5 ml Sarstedt, Nümbrecht 
MACS separation columns 25 LS Miltenyi Biotec, Bergisch Gladbach 
Petri dishes Sarstedt, Nümbrecht 
Pipette tips Greiner Bio-One, Frickenhausen 
Poly-L-Lysine µ-Slide VI 0.4 + 18 well 
Serological pipettes: 1, 5, 10, 25 and 50 ml 
Ibidi, Martinsried 
Sarstedt, Nümbrecht 
Tubes 0.5, 1.5 and 2 ml Eppendorf, Hamburg 
UV-Cuvettes micro Brand, Wertheim 
Vivaspin columns (30 kDa) Sartorius Stedim Biotech, Göttingen 
ZebaTM Spin Desalting Columns Thermo Scientific, Schwerte 
96-well-plates LoBind Eppendorf, Hamburg 
96-well-plates half area black 
96-well-plates clear 
Greiner Bio-One, Frickenhausen 
Greiner Bio-One, Frickenhausen 
384-well plates black Greiner Bio-One, Frickenhausen 
 
Table 2.3 Nomenclature and manufacturer of the software used in alphabetical order. 
 
Software Manufacturer 
GraphPad Prism 5 GraphPad Software, Inc., La Jolla, USA 
Huygens 
 
Image J/Fiji 
Scientific Volume Imaging, Hilversum, The 
Netherlands 
NIH (National Institute of Health), Bethesda 
(MD), USA;  Schindelin et al., 2012 
LAS AF Lite Leica, Wetzlar 
 
2.2 Chemicals, buffers, media, proteins, kits 
2.2.1 Chemicals and buffers 
 
Table 2.4 Nomenclature and manufacturer of the chemicals used in alphabetical order. 
 
Chemical Manufacturer 
Acetic acid 
Acrylamide solution 
Agar-agar 
Agarose 
Albumax 
APS 
Bovine serum albumin (BSA) 
Bradford-Reagenz 
Calciumchloride 
Complete Protease inhibitor cocktail 
Coomassie brilliant blue R250 
Cumarin acid 
Cystatin 
Diamide (DIA) 
Dipotassium phosphate 
Roth, Karlsruhe 
BioRad, Munich 
Roth, Karlsruhe 
PeqLab, Erlangen 
Gibco, Karlsruhe 
Roth, Karlsruhe 
Roth, Karlsruhe 
Bio-Rad, Munich 
Roth, Karlsruhe 
Sigma-Aldrich, Steinheim  
Sigma-Aldrich, Steinheim 
Sigma-Aldrich, Steinheim 
Roth, Karlsruhe 
Sigma-Aldrich, Steinheim 
Roth, Karlsruhe 
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Dithiothreitol (DTT) 
Dimethyl sulfoxide (DMSO) 
DNA-Dye NonTox 
EDTA 
Ethylene glycol tetraacetic acid (EGTA) 
Ethanol 
Giemsa 
Glucose 
Glycerine 
Glutaraldehyde 
HEPES 
Hydrogen chloride 
Hydrogen peroxide 
Hypoxanthin 
Isopropyl-β-D-1-thiogalactopyranoside 
(IPTG) 
Isopropanol 
Luminol 
Magnesium chloride 
Methanol 
Milk powder 
Monosodium phosphate 
Nigericin 
Paraformaldehyde 
Pepstatin A 
Phenylmethylsulfonyl fluoride (PMSF) 
Phosphate buffered saline (PBS) 
Ponceau S 
Polystyrene reservoir 
Potassium chloride 
Potassium hydrogen phosphate 
Rhamnose 
RPMI 1640 medium 
Saponin 
Sodium acetate 
Sodium bicarbonate 
Sodium dodecyl sulfate 
Sodium chloride 
Sodium hydroxide 
Sorbitol 
TEMED 
Tris base 
Triton X-100 
Trypton/Pepton 
Tween 20 
Yeast extract 
Roth, Karlsruhe 
Roth, Karlsruhe 
Applichem, Darmstadt 
Roth, Karlsruhe 
Sigma-Aldrich, Steinheim 
Roth, Karlsruhe 
Merck, Darmstadt 
Roth, Karlsruhe 
Sigma-Aldrich, Steinheim 
Sigma-Aldrich, Steinheim 
Roth, Karlsruhe 
Roth, Karlsruhe 
Roth, Karlsruhe 
Sigma-Aldrich, Steinheim 
Roth, Karlsruhe 
 
Roth, Karlsruhe 
Sigma-Aldrich, Steinheim 
Roth, Karlsruhe 
Roth, Karlsruhe 
Roth, Karlsruhe 
Merck, Darmstadt 
Sigma-Aldrich, Steinheim 
Sigma-Aldrich, Steinheim 
Sigma-Aldrich, Steinheim 
Sigma-Aldrich, Steinheim 
Sigma-Aldrich, Steinheim 
Sigma-Aldrich, Steinheim 
VWR, Darmstadt 
Roth, Karlsruhe 
Roth, Karlsruhe 
Becton Dickinson, Heidelberg 
Gibco, Paisley, UK 
Roth, Karlsruhe 
Roth, Karlsruhe 
Roth, Karlsruhe 
Roth, Karlsruhe 
Roth, Karlsruhe 
Roth, Karlsruhe 
Roth, Karlsruhe 
Roth, Karlsruhe 
Roth, Karlsruhe 
Sigma-Alrich, Steinheim 
Roth, Karlsruhe 
Roth, Karlsruhe 
Oxoid LTD, UK 
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2.2.2 Buffer compositions 
 
Table 2.5 Composition of gels and gel electrophoresis buffers used.  
 
 Gel Composition 
Agarose gel 0.7% 
SDS-polyacrylamide separating 
gel, 12% (for 4 gels) 
0.7 g agarose in 100 ml TBE buffer (1 x) 
5.1 ml ddH2O, 3.75 ml separating gel buffer, 6 ml 30% 
acrylamide/bisacrylamide, 0.15 ml 10% SDS, 75 µl 
10% APS, 7.5 µl tetramethylethylene-diamine 
(TEMED) 
SDS-polyacrylamide sample gel, 
4% (for 4 gels) 
3.05 ml ddH2O, 1.25 ml separating gel buffer, 0.65 ml 
30% acrylamide/bisacrylamide, 0.05 ml 10% SDS, 25 
µl 10% APS, 5 µl TEMED 
Tris-Borat-EDTA (TBE) buffer (5 x) 89 mM Tris (tris(hydroxymethyl)-aminomethane), 89 
mM boric acid, 2 mM ethylenediaminetetraacetic acid 
(EDTA), pH 8.3 
10 x TBE 1 M Tris, 1 M boric acid, 20 mM EDTA, pH 8.0 with 
acetic acid 
 
Table 2.6 SDS-PAGE buffers and solutions used. 
 
Buffer Composition 
SDS sample buffer (1x) 40.5 ml ddH2O, 12.5 ml sample gel buffer, 25 ml 
glycerol, 20 ml SDS (10%), 2 ml bromophenol blue 
(0.5%) ad 0.01%, 771 mg DTT 
Separating gel buffer 1.5 M Tris-HCl, pH 8.8 
Sample gel buffer 0.5 M Tric-HCl, pH 6.8 
Electrophoresis buffer for SDS- 
PAGE (4 x) 
24.2 g Tris, 115.4 g glycerol, 8.0 g SDS in 2 l ddH2O 
Coomassie staining solution  
(water-based Coomassie staining 
system) 
160 mg Coomassie brillant blue R250 in 1 l ddH2O, 
3 ml HCl (conc.) 
Sample buffer (Laemmli buffer) 62.5 mM Tris-HCl, 25% glycerine, 2% SDS, 0.01 
bromophenol blue, 5 % mercapthoethanol 
Electrophoresis buffer 1.5 M Tris-HCl, pH 8.8 
Coomassie staining solution 0.5% Coomassie brilliant blue R250, 10% acetic acid, 
30% 2-propanol 
Coomassie destaining solution 10% acetic acid, 40% methanol 
 
Table 2.7 Composition oft the assay buffers used. 
 
Buffer Composition 
Standard assay buffer (potassium 
phosphate buffer) (pH buffer) 
100 mM K2HPO4/KH2PO4, 1 mM EDTA, pH 7.0 
(degassed) 
 
Table 2.8 Composition of the immunofluorescence assay buffers used. 
 
Buffer Composition 
Blocking buffer 3% BSA in 1 x PBS 
Fixation buffer 4% paraformaldehyde, 0.0075% glutaldehyde in 1 x 
PBS 
Permeabilization/quench buffer 
Hoechst 33258 
125 mM glycine, 0.1% Triton-X-100 in 1 x PBS 
1 µg/ml Hoechst 33258 in 1 x PBS 
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Table 2.9 Composition of the protein purification buffers used. 
 
Buffer Composition 
Ultrasound buffer (1 x) 6.97 mM NaH2PO4, 43.02 mM Na2HPO4, 300 mM 
NaCl, pH 8.0 
Elution buffer US buffer containing imidazole (ad 10 mM, 50 mM, 
100 mM, 200 mM and 500 mM) 
 
Table 2.10 Composition of western blot buffers and solutions used. 
 
Buffer Composition 
Anode buffer I 300 mM Tris (36.3 g/1 l ddH2O) 
Anode buffer II 25 mM Tris (3.06 g/1 l ddH2O) 
Cathode buffer 40 mM 6-aminohexanoic acid (2.6 g/500 ml ddH2O) 
Tris-buffered saline (TBS) buffer 10 mM Tris, 0.9% NaCl (155 mM), pH 7.4 with HCl 
(24.2 g Tris, 180 g NaCL in 2 l ddH2O) 
TBS with Tween 20 (TBST) buffer TBS + 0.05% Tween20 (500 µl in 1 l TBS buffer) 
Ponceau S solution 2% Ponceau S, 3% trichloroacetic acid (TCA) 
Ponceau staining solution 1% Ponceau S, 1% acetic acid 
Ponceau destaining solution 1% acetic acid 
Blocking buffer 5% milk powder in TBST buffer (1 g/20 ml TBST) 
Luminol mixture 1.25 mM Luminol, 0.0093% H2O2, 100 mM Tris-HCl, pH 
8.6 (10 mg/40 ml, in 0.1 M Tris HCL, pH 8.6, 12.4 µl of 
30% H2O2, stored in the dark at 4 °C) 
Chemiluminescence mixture (ECL 
reagent) 
1 ml Luminol, 10 µl coumarinic acid (0.11% in DMSO) 
 
Table 2.11 Composition of P. falciparum cell culture buffers used. 
 
Buffer Composition 
Ringer’s solution 
 
 
Cytomix 
 
122.5 mM NaCl, 5.4 mM KCl, 1.2 mM CaCl2, 0.8 mM 
MgCl2, 11 mM D-glucose, 25 mM HEPES, 1 mM 
NaH2PO4, pH 7.4 with NaOH 
120 mM KCl, 0.15 mM CaCl2, 5 mM MgCl2, 10 mM 
K2HPO4/KH2PO4, 25 mM HEPES/2 mM EGTA pH 7.6 
with 1 M KOH 
Calibration buffer 160 mM KCl, 1.2 mM CaCl2, 0.8 MgCl2, 11 mM 
glucose, 25 mM HEPES 
Saponin lysis buffer 7 mM K2HPO4, 1 mM NaH2PO4, 11 mM NaHCO3, 
58 mM KCl, 1 mM MgCl2, 14 mM glucose (H2O free), 
0.02% saponin, pH 7.4 with HCl 
Freezing solution 
 
Tris/EDTA buffer for absorption of 
Maxi-prep DNA 
SYBR Green-I assay lysis buffer 
3% sorbitol, 0.65% NaCl, 28% glycerol, ddH2O ad 
50 ml 
10 mM Tris/1 mM EDTA buffer, pH 7.5 with HCl 
 
20 mM Tris-HCl, 5 mM EDTA, 0.16% w/v saponin, 
and 1.6% v/v Triton X-100 
 
2.2.3 Medium for E. coli culture 
 
Table 2.12 Composition of the medium for cultivating of E. coli cells. 
 
Medium Composition 
Luria-Bertani (LB) 10 g/l Trypton, 5 g/l yeast extract, 10 g/l NaCl 
Agar plates 10 g/l Trypton, 5 g/l yeast extract, 10 g/l NaCl, 15 g/l 
agar; the respective antibiotics are added after 
autoclaving at 50-60 °C 
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2.2.4 Antibiotics and antimalarial drugs 
 
Table 2.13 Nomenclature, manufacturer, and stock/final concentrations of the antibiotics used. 
 
Antibiotic Source Stock 
concentration 
Final  
concentration 
Carbenicillin 
 
Chloramphenicol 
Roth, Karlsruhe 
 
Roth, Karlsruhe 
50 mg/ml in 50%  
ethanol 
25 mg/ml in 100% 
ethanol 
100 µg/ml 
 
25 µg/ml 
Gentamycin 
Kanamycin 
Invitrogen, Karlsruhe 
Roth, Karlsruhe 
50 mg/ml in ddH2O 
25 mg/ml in ddH2O 
22 µg/ml 
50 µg/ml 
 
Table 2.14 Nomenclature and manufacturer of the antimalarial drugs used. 
 
Drug Stock solution Source 
Amodiaquine (AQ) 
Artemisinine (ART) 
10 mM in DMSO 
10 mM in DMSO 
Sigma-Aldrich, Steinheim 
Roth, Karlsruhe 
Artemether (ATM) 10 mM in DMSO TCI Deutschland, Eschborn 
Artesunate (ATS) 10 mM in DMSO Sigma-Aldrich, Steinheim 
Atovaquone (ATQ) 
Chloroquine (CQ) 
Compound S 
 
Compound 1o 
10 mM in DMSO 
10 mM in ddH2O 
10 mM in DMSO 
 
10 mM in DMSO 
Sigma-Aldrich, Steinheim 
Sigma-Aldrich, Steinheim 
Kindly provided by Anthony Pinkerton, La 
Jolla, CA, USA 
Kindly provided by Reimar Krieg, Jena 
Coruleoellagic acid (CEA) 10 mM in DMSO Kindly provided by Herbert Zimmermann, 
Heidelberg 
2-deoxyglucose (2-DG) 
Flavoellagic acid (FEA) 
100 mM in ddH2O 
10 mM in DMSO 
Roth, Karlsruhe 
Kindly provided by Herbert Zimmermann, 
Heidelberg 
Lumenfantrine (LUM) 
 
Mefloquine (MQ) 
10 mM in DMSO 
 
10 mM in DMSO 
Kindly provided by David Fidock, New 
York, USA 
Roche, Mannheim 
Methylene blue (MB) 
ML304 
10 mM in DMSO 
20 mM in DMSO 
Roth, Karlsruhe 
Kindly provided by Anthony Pinkerton, La 
Jolla, CA, USA 
Quinine (QN) 
Rotenone (Rot) 
10 mM in DMSO 
20 mM in DMSO 
ACROS Organics, Geel (Belgium) 
Sigma-Aldrich, Steinheim 
 
Table 2.15 Nomenclature and manufacturer of P. falciparum selectable drugs used. 
 
Drug Final 
concentration 
Source 
WR99210 [2 nM/5 nM] Jacobus Pharmaceuticals, New Jersey, 
USA 
Bsd S hydrochloride 
(blasticidin S) 
[2.5 µg/µl] AppliChem, Darmstadt 
G418 (geniticin) [125 µg/µl] Roth, Karlsruhe 
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2.2.5 Kits for protein biochemistry, molecular- and cell biology 
 
Table 2.16 Nomenclature and manufacturer of the kits used. 
 
Kit Source 
Kapa Blood PCR-Mastermix B Kit, Peqlab 
QIAprep Spin Miniprep Kit 
VWR, Darmstadt 
Qiagen, Hilden 
QIAquick PCR Purification Kit Qiagen, Hilden 
QIAquick Gel Extraction Kit Qiagen, Hilden 
HiSpeed Plasmid Maxi Kit Qiagen, Hilden 
FastGeneTM Xpress (Plus) Plasmid Kit Nippon Genetics Europe GmbH, Düren 
PureYieldTM Plasmid Miniprep System Promega, Mannheim 
 
2.2.6 Enzymes, antibodies, fluorescent dyes, and other proteins 
 
Table 2.17 Nomenclature and manufacturer of restriction enzymes used in alphabetical order. 
 
Enzyme Restriction site Source 
AvrII CCTAGG New England BioLabs, Frankfurt am Main 
KpnI GGTACC New England BioLabs, Frankfurt am Main 
KpnI – Fast Digestion GGTACC Fermentas, St. Leon-Rot 
NcoI 
XhoI 
CCATGG 
CTCGAG 
Thermo Scientific, Schwerte 
Thermo Scientific, Schwerte 
XmaI CCCGGG New England BioLabs, Frankfurt am Main 
 
Table 2.18 Nomenclature and manufacturer of other enzymes used in alphabetical order. 
 
Enzyme Source 
AccuPrimeTM Taq DNA Polymerase Invitrogen, Darmstadt 
DNaseI Roche, Mannheim 
FastAP Thermosensitive Alkaline 
Phosphatase 
Fermentas, St. Leon-Rot 
T4 DNA ligase Promega, Mannheim 
Pfu Polymerase Promega, Mannheim 
Happy Taq BAG, Lich 
 
Table 2.19 Nomenclature and manufacturer of antibodies used. 
 
Antibody Source 
α-PfACP (rabbit) Przyborski lab, Marburg 
α-PfCRT (rabbit) Przyborski lab, Marburg 
Cy2 α-chicken Przyborski lab, Marburg 
Cy3 α-rabbit Przyborski lab, Marburg 
CDC48 Przyborski lab, Marburg 
α-ERC Przyborski lab, Marburg 
Mouse α-GFP Roche, Basel oder Steinheim 
Rabbit α-YFP Santa Cruz Biotechnology, San 
Francisco (USA) 
α-mouse Dianova, Hamburg 
α-rabbit Dianova, Hamburg 
 
Table 2.20 Nomenclature and manufacturer of fluorescent dyes used in alphabetical order. 
 
Fluorescent dyes Source 
Hoechst 33258 Przyborski lab, Marburg 
MitoTracker Orange 
SYBR Green 
Przyborski lab, Marburg 
Thermo Scientific, Schwerte 
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Table 2.21 Working concentrations of protease inhibitors used. 
 
Protein Working concentration [stock solution] 
Cystatin 1 µl/1 ml [40 µM in US-Buffer] 
Pepstatin 0.5 µl/1 ml [0.3 mM in DMSO] 
PMSF 
Complete protease inhibitor cocktail 
1 µl/1 ml [100 mM in ethanol] 
[100 mM in PBS], pH 7.0 
 
2.3 Plasmids and primers 
2.3.1 Plasmids 
 
Table 2.22 Nomenclature, antibiotic resistance, and source of plasmids used. 
 
Plasmid     Source 
pARL1a(+)-CRT  
 
Kindly provided by Alan Cowman, 
WEHI, Melbourne, Australia 
pARL1a(+)-CRT-STEVOR-[X-SDEL]  Kindly provided by Jude 
Przyborski, Philips University of 
Marburg 
pARL1a(+)-CRT-[hGrx1-roGFP2] 
 
pARL1a(+)-CRT-[PM-pHluorin] 
 
p[Hyper-3/pSypHer] cyto vector 
 
 
pQE60-[roGFP2-Orp1] 
 
pET28a(+) 
pQE30-[sfroGFP2] 
 
Transient transfection 
pARL1a(+)-CRT-[roGFP2-Orp1] 
pARL1a(+)-CRT-[ACP-roGFP2-Orp1] 
pARL1a(+)-CRT-[CS-roGFP2-hGrx1] 
pARL1a(+)-CRT-[PM-roGFP2-hGrx1] 
pARL1a(+)-CRT-[STEVOR-roGFP2-hGrx1-SDEL] 
pARL1a(+)-CRT-[HyPer-3/SypHer] 
pARL1a(+)-CRT-[ACP-HyPer/SypHer] 
pARL1a(+)-CRT-[CS-HyPer-3/SypHer] 
pARL1a(+)-CRT-[PM-HyPer-3/SypHer] 
pARL1a(+)-CRT-[STEVOR-HyPer-3/SypHer-SDEL] 
pARL1a(+)-CRT-[pHluorin] 
 
Stable transfection – 1600-CRT promoter 
pDC2-CRT-[FA2a-roGFP1]-attP 
 
pDC2-CRT-[roGFP2-Orp1]-attP 
pDC2-CRT-[ACP-roGFP2-Orp1]-attP 
pDC2-CRT-[CS-roGFP2-hGrx1]-attP 
pDC2-CRT-[ACP-HyPer-3/SypHer]-attP 
pDC2-CRT-[CS-HyPer-3/SypHer]-attP 
pDC2-CRT-[hGrx1-roGFP2]-attP 
pDC2-CRT-[ACP-roGFP2-hGrx1]-attP 
pDC2-CRT-[CS-roGFP2-hGrx1]-attP 
 Kindly provided by Andreas Meyer, 
Bonn Universtiy 
Kindly provided by Michael Lanzer, 
Heidelberg University Hospital 
Kindly provided by Vsevolod 
Belousov, Russian Academy of 
Sciences, Moscow, Russia 
Kindly provided by Tobias Dick, 
DKFZ, Heidelberg 
Novagen, Darmstadt 
Generated 
 
 
Generated 
Generated 
Generated 
Generated 
Generated 
Generated 
Generated 
Generated 
Generated 
Generated 
Generated 
 
 
Kindly provided by David Fidock, 
Columbia University, NY, USA  
Generated 
Generated 
Generated 
Generated 
Generated 
Generated 
Generated 
Generated 
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Stable transfection – CAM (calmodulin) promoter 
pDC2-CAM-[hGrx1-roGFP2]-attP 
 
pDC2-CAM-[sfroGFP2]-attP 
 
 
pDC2-CAM-[roGFP2-Orp1]-attP 
pDC2-CAM-[ACP-roGFP2-Orp1]-attP 
pDC2-CAM-[CS-roGFP2-hGrx1]-attP 
pDC2-CAM-[ACP-HyPer-3/SypHer]-attP 
pDC2-CAM-[CS-HyPer-3/SypHer]-attP 
pDC2-CAM-[ACP-roGFP2-hGrx1]-attP 
pDC2-CAM-[CS-roGFP2-hGrx1]-attP 
 
 
Kindly provided by David Fidock, 
Columbia University, NY, USA  
Kindly provided by Myles Akabas, 
Albert Einstein College of 
Medicine, NY, USA 
Generated  
Generated  
Generated 
Generated 
Generated 
Generated 
Generated 
 
Table 2.23 Nomenclature and antibiotic resistance of plasmids used for cloning in E. coli and P. 
falciparum cell culture. 
 
Plasmid (Pf strains)                Antibiotic resistance                    Pf cell culture 
Cloning in E. coli         Selectable marker Drug for culturing 
pARL1a(+) (3D7) Cn     hDHDR                     WR99210* 
pDC2-CRT-X-attB (NF54) 
pDC2-CAM-X-attB(NF54) 
pINT 
pHyper-3/pSypHer cyto 
pQE60 
pQE30 
Cn 
Cn 
Cn 
Kan 
Cn 
Cn 
    hDHDR + BSD          None** 
    hDHDR + BSD          None** 
    neo***                        G418 (geniticin) 
pET28a(+) Kan  
 
*Antifolate selection agent against human dihydrofolate reductase (dhfr) resistance gene provided by 
Jacobus Pharmaceuticals, Princeton, NJ. 
**Optionally 2.5 nM WR99210 + 2.5 µg/ml BSD. 
***Neomycin is a broad spectrum aminoglycoside antibiotic. 
 
Table 2.24 Nomenclature and sizes of plasmids/constructs used. 
 
Plasmid/construct Size 
pARL1a(+)  6656 bp 
pHyPer-3/pSypHer-cyto vector 5400 bp 
pQE60-roGFP2-Orp1-His 
pARL1a(+)-[PM-pHluorin] 
4700 bp 
7589 bp 
HyPer-3 1400 bp 
roGFP2-Orp1 1320 bp 
hGrx1-roGFP2 
sfroGFP2 
1136 bp 
732 bp 
pARL-1a(+)-STEVOR-X-SDEL 
pDC2-1600-CRT-X-BSD-attP 
pDC2-CAM-X-BSD-attP 
pDC2-CAM-[sfroGFP2]-BSD-attP 
pDC2-1600-CRT-[FA2-roGFP1]-BSD-attP 
6767 bp 
6870 bp 
6380 bp 
7112 bp 
7923 bp 
pDC2-CAM-[hGrx1-roGFP2]-BSD-attP 7514 bp 
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Table 2.25 Sizes of target peptides used. 
 
Organelle Signal peptide Size 
Apicoplast (Api) Acyl carrier protein (ACP) 180 bp 
Mitochondrion (Mito) Citrate synthase (CS) 354 bp 
Digestive vacuole (DV) Plasmepsin (PM) IV 210 bp 
Endoplasmic reticulum (ER) STEVOR-X-SDEL 99 bp-X-12 bp 
 
Table 2.26 Nomenclature and protein sizes of inserts used. 
 
Insert Protein size 
roGFP2-Orp1 49 kDa 
HyPer-3/SypHer 52 kDa 
hGrx1-roGFP2 
sfroGFP2 
47 kDa 
26 kDa 
 
2.3.2 Primers 
 
Table 2.27 PCR and sequencing primer nucleotide sequences for roGFP2-Orp1, HyPer-3, 
SypHer, and pHluorin. 
 
Primer Nucleotide sequence Amplification of 
PCR primers 
Cloning roGFP2-Orp1, HyPer-3, SypHer, and pHluorin into pARL1a(+) 
 
OroGFP2Kpns 5’-atatGGTACCATGAGCAAGGGCGAGGAGC-3’ roGFP2-Orp1 K 
OOrp1Kpnas 5’-atatGGTACCTTATTCCACCTCTTTCAAAAGTTC-3’ roGFP2-Orp1 K 
OHyPKpns 5’-atatGGTACCATGGAGATGGCAAGCCAGC-3’ HyPer-3 K/SypHer K 
OHyPKpnas 
OPfpHNXho 
OPfpHCXma 
5’-atatGGTACCTTAAACCGCCTGTTTTAAAACTT-3’ 
5’-atatCTCGAGATGAGTAAAGGAGAAGAAC-3’ 
5’-atatCCCGGGTTATTTGTATAGTTCATCC-3’ 
HyPer-3 K/SypHer K 
pHluorin 
pHluorin 
Targeting roGFP2-Orp1, HyPer-3, and SypHer 
 
OroGFP2Avrs 5’-atatCCTAGGAGCAAGGGCGAGGAGCTGT-3’ roGFP2-Orp1 AX 
OOrp1ERCXmaas 5’atatCCCGGGTTATAATTCGTCACTTTCCACCTCTTTC
AAAAGTTC-3’ 
roGFP2-Orp1 AX 
OroGFP2Kpn2s 5’-atatGGTACCAGCAAGGGCGAGGAGCTGTT-3’ roGFP2-Orp1 KX 
OOrp1Xmaas 5’-atatCCCGGGTTATTCCACCTCTTTCAAAAGTTC-3’ roGFP2-Orp1 KX 
OHyPAvrs 
OHyPERCXmaas 
 
OHypKpn2s 
5’-atatCCTAGGGAGATGGCAAGCCAGCAGG-3’ 
5’atatCCCGGGTTATAATTCGTCACTAACCGCCTGTTTT
AAAACTTT-3’ 
5’-atatGGTACCGAGATGGCAAGCCAGCAGG-3’ 
HyPer-3/SypHer AX 
HyPer-3/SypHer AX 
 
HyPer-3/SypHer KX 
OHypXmaas 5’-atatCCCGGGTTAAACCGCCTGTTTTAAAACTTT-3’ HyPer-3/SypHer KX 
 
Target peptides 
OPfacps 
 
 
5’-ggGGTACCATGAAGATCTTATTACTTTGTATAA-3’ 
 
 
ACP 
OPfacpas 
OPfCSs 
5’-ggGGTACCTTTTAAAGAGCTAGATGGGTTTT-3’ 
5’-ggGGTACCATGGAAGGAATAAGATACCTATC-3’ 
ACP 
CS 
OPfCSasN 5’-ggGGTACCTTTCAAAATATTCATAATAACAGATT-3’ CS 
OPfPms 5’-ggGGTACCATGGCTCTTACCGTTAAAGAAG-3’ PM IV 
OPfPmasN 5’-ggGGTACCAACTTGATACAACTTGCGATGT-3’ PM IV 
Stable integration into pDC2-1600-CRT-X-BSD-attP (AvrII + SDM XhoI   XmaI) 
 
OroGFPAvrs 5’-atatCCTAGGATGTGAGCAAGGGCGAGGAG-3’ roGFP2-Orp1  
OOrp1Xmaas 
OACPAvrs 
5’-atatCCCGGGTTATTCCACCTCTTTCAAAAGTTC-3’ 
5’-atatCCTAGGATGAAGATCTTATTACTTTGTATAAT-3’ 
roGFP2-Orp1 
ACP-roGFP2-Orp1 
OOrp1Xmaas 5’-atatCCCGGGTTATTCCACCTCTTTCAAAAGTTC-3’ ACP-roGFP2-Orp1 
OCSAvrs 5’-atatCCTAGGATGGAAGGAATAAGATACCTATC-3’ CS-roGFP2-Orp1 
OOrp1Xmaas 
OHyPAvrs 
5’-atatCCCGGGTTATTCCACCTCTTTCAAAAGTTC-3’ 
5’-atatCCTAGGATGGAGATGGCAAGCCAGC-3’ 
CS-roGFP2-Orp1 
HyPer-3/SypHer 
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OHypXmaas 5’-atatCCCGGGTTAAACCGCCTGTTTTAAAACTTT-3’ HyPer-3/SypHer 
OGrxAvrs 
OroGFPXmaas 
5’-atatCCTAGGATGGCTCAAGAGTTTGTGAACT-3’ 
5’-atatCCCGGGTTAAATCTTGTACAGCTCGTCC-3’ 
hGrx1-roGFP2 
hGrx1-roGFP2 
OACPAvrs 5’-atatCCTAGGATGAAGATCTTATTACTTTGTATAAT-3’ ACP-roGFP2-hGrx1 
OGrxXmaas 5’-atatCCCGGGTTAAATCTGCAGAGCTCCAATC-3’ ACP-roGFP2-hGrx1 
OCSAvrs 
OGrxXmaas 
5’-atatCCTAGGATGGAAGGAATAAGATACCTATC-3’ 
5’-atatCCCGGGTTAAATCTGCAGAGCTCCAATC-3’ 
CS-roGFP2-hGrx1 
CS-roGFP2-hGrx1 
Stable integration into pDC2-CAM-X-BSD-attP (AvrII + XhoI) 
 
OroGFPAvrs 5’-atatCCTAGGATGTGAGCAAGGGCGAGGAG-3’ roGFP2-Orp1  
OOrp1Xhoas  
OACPAvrs 
5’-atatCTCGAGTTATTCCACCTCTTTCAAAAGTTC-3’ 
5’-atatCCTAGGATGAAGATCTTATTACTTTGTATAAT-3’ 
roGFP2-Orp1 
ACP-roGFP2-Orp1 
OOrp1Xhoas 5’-atatCTCGAGTTATTCCACCTCTTTCAAAAGTTC-3’ ACP-roGFP2-Orp1 
OCSAvrs 5’-atatCCTAGGATGGAAGGAATAAGATACCTATC-3’ CS-roGFP2-Orp1 
OOrp1Xhoas 
OHyPAvrs 
OHypXhoas 
5’-atatCTCGAGTTATTCCACCTCTTTCAAAAGTTC-3’ 
5’-atatCCTAGGATGGAGATGGCAAGCCAGC-3’ 
5’-atatCTCGAGTTAAACCGCCTGTTTTAAAACTTT-3’ 
CS-roGFP2-Orp1 
HyPer-3/SypHer 
HyPer-3/SypHer 
Stable integration into pDC2-CAM-X-BSD-attP (AvrII + SDM XhoI  XmaI) 
 
OGrxAvrs 
OroGFPXmaas 
5’-atatCCTAGGATGGCTCAAGAGTTTGTGAACT-3’ 
5’-atatCCCGGGTTAAATCTTGTACAGCTCGTCC-3’ 
hGrx1-roGFP2 
hGrx1-roGFP2 
OACPAvrs 5’-atatCCTAGGATGAAGATCTTATTACTTTGTATAAT-3’ ACP-roGFP2-hGrx1 
OGrxXmaas 
OCSAvrs 
OGrxXmaas 
OPfpHNAvrII 
OPfpHCXma 
5’-atatCCCGGGTTAAATCTGCAGAGCTCCAATC-3’ 
5’-atatCCTAGGATGGAAGGAATAAGATACCTATC-3’ 
5’-atatCCCGGGTTAAATCTGCAGAGCTCCAATC-3’ 
5’-atatCCTAGGATGAGTAAAGGAGAAGAAC-3’ 
5’-atatCCCGGGTTATTTGTATAGTTCATCC-3’ 
ACP-roGFP2-hGrx1 
CS-roGFP2-hGrx1 
CS-roGFP2-hGrx1 
pHluorin 
pHluorin 
Determination of stable integration 
cg6 5' F 5’-GAAAATATTATTACAAAGGGTGAGG-3’ NF54-attB strain 
bsd R 5’-ACGAATTCTTAGCTAATTCGCTTGTAAGA-3’ NF54-attB strain 
 
Overexpression   
OHyPNcoIs 
OpetHyPXho 
R12 s 
R12 as 
 
 
5’-atatCCATGGAGATGGCAAGCCAGCAGG-3’ 
5’-atatCTCGAGAACCGCCTGTTTTAAAACTTTA-3’ 
5’-atatGGATCCGTTAGTAAAGGAGAAGAACTTTT-3’ 
5’-atatAAGCTTTTATTTGTATAGTTCATCCATGC-3’ 
 
 
HyPer-3/SypHer NX 
HyPer-3/SypHer NX 
sfroGFP2 
sfroGFP2 
Sequencing primers 
OpARL1s 5’-CCGTTAATAATAAATACACGCAG-3’ pARL-1a(+) 
OpARL1as 5’-ATACACATTTTTACAGTTATAAATAC-3’ pARL-1a(+) 
OHyP1s 5’-TCTGGCAGGGGAAAAACTGC-3’ HyPer-3/SypHer 
OHyP2s 5’-AGCTGTACAACGTGGATGGC-3’ HyPer-3/SypHer 
OHyP3s 5’-TGAAGTTCGAGGGCGACAC-3’ HyPer-3/SypHer 
OGFPORP1s 5’-GCACCATCTTCTTCAAGGAC-3’ roGFP2-Orp1 
OGFPORP2s 5’-ATGGTCCTGCTGGAGTTCG-3’ roGFP2-Orp1 
OGFPORP3s 
OMitos 
roGFPGRXas 
roGFP2012as 
OGFPs 
OLinkerGFPs 
pDC2 crt s 
pDC2 crt as 
OpDC2CAMs 
5’-AGAACCTGGCTCTGATGAAG-3’ 
5’-ATAGTATAGATAATGAAGAATCTG-3’ 
5’-CTTCCCAGGCTGGATTTTGC-3’ 
5’-TGAACTTGTGGCCGTTTACG-3’ 
5’-CGCCGAGGTGAAGTTCGA-3’ 
5’-GGATCAGGAGGAGAATTCGTG-3’ 
5’-ACGCAGTCATATTATTTATTATAC-3’ 
5’-ATTGGGGTGATGATAAAATGAAA-3’ 
5’-CTAATATTTTATTTATTATCATTCAAG-3’ 
roGFP2-Orp1 
CS targetpeptide 
hGrx1-roGFP2 
hGrx1-roGFP2 
hGrx1-roGFP2 
hGrx1-roGFP2 
pDC2 crt 
pDC2 crt 
pDC2 CAM 
OpDC2CAMas 5’-TCTTTATTTTTTTTTTTTTGTAGACC-3’ pDC2 CAM 
 
The AvrII (CCTAGG), KpnI (GGTACC), XmaI (CCCGGG), XhoI (CTCGAG), and NcoI (CCATGG) 
restriction sites are underlined. 
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2.4 Organisms 
2.4.1 Parasite strains 
 
Table 2.28 P. falciparum strains. 
 
P. falciparum strain Source 
3D7 Lanzer lab, Heidelberg 
NF54-attB David Fidock, Columbia University, NY 
2.4.2 Bacterial strains 
 
Table 2.29 Escherichia coli (E. coli) cells. 
 
E. coli strain Genotype Source 
BL21 
 
 
XL1-blue 
 
 
 
M15 [pREP4] 
F– ompT gal dcm lon hsdSB(rB
- mB
-) 
λ(DE3 [lacI lacUV5-T7 gene 1 ind1 
sam7 nin5] 
recA1, endA1, gyrA96, thi-1, 
hsd-r17, supE44, relA1, lac, 
[F' pro AB, laclqZ M15, 
Tn10, (Tetr)] 
nalS, StrS, rifS, KmR, lac-, ara-, gal-, 
mtl-, F-, recA+, uvr+ 
Qiagen 
 
 
Stratagene, La Jolla, 
USA 
 
 
Qiagen, Hilden 
Single step (KRX) 
competent cells 
[F’, traD36, ∆ompP, proA+B+, lacIq, 
∆(lacZ)M15] ∆ompT, endA1, recA1, 
gyrA96 (Nalr), thi-1, hsdR17 (rk
-, 
mk
+), e14- (McrA-), relA1, supE44, 
∆(lac-proAB), ∆(rhaBAD): T7 RNA 
Polymerase 
Promega, Mannheim 
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3 Methods 
3.1 Molecular biology methods 
Lab work with E. coli was carried out in accordance with German gene technology 
regulations [GenTG] and fell under safety level S1. The lab work on genetically modified P. 
falciparum was carried out at safety level S2. All solutions and containers contaminated with 
E. coli or Plasmodium cells were collected separately and sterilized in the autoclave for 
30 min at 120 °C and 2.5 bar. All materials that were used for sterile work were first 
autoclaved. 
 
3.1.1 Cloning cytosolic roGFP2-Orp1, HyPer-3, SypHer, and pHluorin into 
pARL1a(+) 
The H2O2 redox sensors roGFP2-Orp1, HyPer-3, the pH insensitive version of HyPer-3 
SypHer, and the pH probe pHluorin (Kuhn et al., 2007) were cloned into the pARL1a(+) 
vector under the CRT promoter. The pARL1a(+) vector contains three restriction sites, XhoI, 
KpnI, and XmaI. Tobias Dick kindly provided the redox sensor roGFP2-Orp1 in pQE60 
vector; Vsevolod Belousov kindly provided HyPer-3 and SypHer in pHyPer-cyto vector and 
pSypHer-Cyto vector, respectively. PM-pHluorin was obtained from the Lanzer lab and was 
modified for targeting the cytosol of P. falciparum. An overview of the plasmids obtained is 
given in Figure 3.1. The redox probes obtained in the pARL1a(+) vector were transiently 
transfected into P. falciparum.  
 
Figure 3.1 Cloned roGFP2-Orp1, 
HyPer-3, SypHer, and pHluorin 
constructs. RoGFP2-Orp1, HyPer-
3, and SypHer were cloned into the 
pARL1a(+) vector by using KpnI 
restriction sites, pHluorin by using 
XhoI and XmaI restriction sites. 
 
 
 
 
 
 
 
 
3.1.1.1 Polymerase chain reaction (PCR) 
PCR starts with denaturation of double-stranded DNA at 95 °C (Mullis and Faloona, 1987). 
24 cycles of denaturation (30 sec), annealing, and elongation were used to amplify the DNA 
sequences. The temperatures and times depended on the length of the DNA sequence, the 
length of the primer, and the optimal temperature for activity of the polymerase. Sense and 
antisense primers (oligonucleotides) hybridize onto the corresponding sequence of the 
template DNA, and the DNA polymerase (Accu Prime Taq polymerase) starts to elongate the 
new strand with single nucleotides (dNTPs) provided in the PCR buffer (AccuPrimeTM Buffer 
I). An overview of the PCR times and temperatures are given in Table 3.1. The time for the 
elongation step was 60 sec/1 kb of amplifying PCR construct. HyPer-3 and SypHer differ 
only in one amino acid (C199S). Therefore, the same primers were utilized. 
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Table 3.1 Times and temperatures for cytosolic roGFP2-Orp1, HyPer-3, SypHer, and pHluorin. 
 
 roGFP2-Orp1 HyPer-3/SypHer pHluorin 
Denaturation 2 min, 94 °C 2 min, 94 °C 1 min, 95 °C 
Cycles 24 x 24 x 24 x 
Denaturation 30 sec, 94 °C 30 sec, 94 °C 15 sec, 94 °C 
Annealing 30 sec, 58 °C 30 sec, 55 °C 15 sec, 60 °C 
Elongation 2 min, 72 °C 2 min, 72 °C 40 sec, 72 °C 
Final elongation 4 min, 72 °C 4 min, 72 °C 2 min, 72 °C 
Hold 8 °C 8 °C 4 °C 
 
Table 3.2 PCR conditions for amplifying roGFP2-Orp1, HyPer-3, SypHer, and pHluorin. 
 
 
 
 
 
 
 
 
Afterwards, the QIAquick PCR purification kit (Qiagen) was used according the 
manufacturer’s instructions to purify the amplified PCR products. Their sizes were checked 
via agarose gel electrophoresis (3.1.1.2). 
 
 
3.1.1.2 Agarose gel electrophoresis 
Agarose gel electrophoresis (Koolmann and Röhm, 2003) was used to separate and analyze 
DNA fragments. Agarose gels were prepared by solving 0.7% agarose in 1 x Tris-borate-
EDTA (TBE) buffer in a microwave and were transferred in an electrophoresis chamber 
containing 1 x TBE buffer. The DNA samples were mixed 5:1 with DNA-Dye NonTox and 
transferred into gel pockets of the solid agarose gel. For size reference, a 1 kb DNA ladder 
(GeneRuler) was used. Electrophoresis lasted approximately 45 min at 100 V. The separated 
DNA bands were visualized with UV light in the gel documentation chamber (Gel Doc 2000). 
 
3.1.1.3 Cleaving double-stranded DNA with restriction endonucleases 
Restriction endonucleases recognize specific palindromic restriction sites on the DNA and 
cut them. The purified and amplified PCR products, as well as the pARL1a(+) vector, were 
digested with FastDigest KpnI for 10 min or with XhoI/XmaI (for pHluorin) for 1.5 h at 37 °C 
and purified with the QIAquick PCR purification kit. The condition for digestion is 
demonstrated in Table 3.3. Furthermore, after digestion of pARL1a(+), the vector was 
incubated for 15 min with alkaline phosphatase (AP) at 37 °C. 
 
 
 
 
 
 
 
 
Component Volume  
AccuPrimeTM Buffer I (10 x) 5 µl  
Template (50 ng) 1 µl  
Forward primer (100 µM) 1 µl  
Reverse primer (100 µM) 1 µl  
AccuPrimeTM Taq DNA Polymerase (2 U/µl) 1 µl  
Autoclaved ddH2O 41 µl  
Final volume 50 µl  
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Table 3.3 Digestion mixture of PCR products and the pARL1a(+) vector.  
 
Component Volume 
Purified PCR product/vector 10 µl 
KpnI Buffer (10 x) or CutSmartTM Buffer 3 µl 
FastDigest KpnI or XhoI/XmaI 1 µl 
Autoclaved ddH2O 15-16 µl 
Final volume 30 µl 
 
3.1.1.4 DNA quantification 
To determine the DNA concentration of a sample, absorption at 260 nm was measured. 
According to Sambrook et al. (1989), A260nm = 1 equals the DNA concentration of 50 µg/ml. 
The ratio of A260nm/A280nm was calculated to determine the degree of purity. A sample with the 
ratio of A260nm/A280nm = 1.8-2.0 was defined as pure.  
 
3.1.1.5 Ligation 
The enzyme DNA ligase was used to connect the insert with the vector. DNA ligase 
catalyzes the formation of covalent phosphodiester linkages between the 3’ hydroxyl ends of 
one nucleotide with the 5’ phosphate end of another by consuming ATP, which permanently 
joins the nucleotides together. After ligation, the insert DNA is attached to the backbone, and 
the complete plasmid can be transformed into bacterial cells for propagation. The volume of 
the insert (HyPer-3, SypHer) was two times higher than that of the vector (2:1, insert to 
vector molar ratio), for roGFP2-Orp1 and pHluorin five times higher. The inserted DNA 
quantity can also be calculated according to the following equation: 
 
ng of insert needed for a 1:1 molar ratio =  
kb of insert
kb of vector
 × ng of vector 
 
The ligation mixture by using Quick-T4-DNA-Ligase and the 2 x rapid buffer was incubated 
for 10 min at RT, while the classic ligation with T4-DNA-Ligase and the 10 x buffer was 
incubated overnight at 4 °C. Ligations of roGFP2-Orp1, HyPer-3, SypHer, and pHluorin PCR 
products with the restricted purified pARL1a(+) vector (alkaline phosphatase digested -AP-, 
3.1.1.3) were carried out according to Tables 3.4 and 3.5 overnight at 4 °C. Due to the fact 
that the template DNA of roGFP2-Orp1 (pQE60) had the same antibiotic resistance as the 
pARL1a(+) vector (Cn) that led to colonies with empty pQE60 template vectors or empty 
pARL1a(+) vectors after transformation, agarose gel electrophoresis (3.1.1.2) with 
subsequent gel extraction (Qiagen Gel Extraction Kit) of the KpnI-amplified and restricted 
roGFP2-Orp1 construct was performed. Then, ligation with the gel-extracted roGFP2-Orp1 
and the pARL1a(+) vector was carried out for 10 min at RT (Table 3.6). All ligation partners 
with respective restriction sites are summarized in Table 3.7. 
 
Table 3.4 Ligation mixture of HyPer-3 and SypHer with the vector pARL1a(+). 
 
Component Volume 
Purified restricted PCR product HyPer-3, SypHer (≈ 50 ng) 2 µl 
Purified restricted vector pARL1a(+) -AP- (≈ 60 ng) 1 µl 
T4 DNA ligase buffer (10 x) 1 µl 
T4 DNA ligase (1-3 U/µl) 1 µl 
Autoclaved ddH2O 5 µl 
Final volume 10 µl 
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Table 3.5 Ligation mixture of pHluorin with the vector pARL1a(+). 
 
Component Volume 
Purified restricted PCR product pHluorin (≈ 100 ng) 14 µl 
Purified restricted vector pARL1a(+) -AP- (≈ 50 ng)   3 µl 
T4 DNA ligase buffer (10 x)   2 µl 
T4 DNA ligase (1-3 U/µl)   1 µl 
Final volume  20 µl 
 
Table 3.6 Ligation mixture of roGFP2-Orp1 with the vector pARL1a(+). 
 
Component Volume 
Purified restricted PCR product roGFP2-Orp1 (≈ 50 ng) 5 µl 
Purified restricted vector pARL1a(+) -AP- (≈ 60 ng) 1 µl 
T4 DNA ligase buffer (2 x) 7.5 µl 
T4 DNA ligase (1-3 U/µl) 1 µl 
Autoclaved ddH2O 5.5 µl 
Final volume 20 µl 
 
Table 3.7 Ligation partners of roGFP2-Orp1, HyPer-3, SypHer, and pHluorin. 
 
Insert Restriction enzyme Vector 
roGFP2-Orp1 
HyPer-3 
SypHer 
pHluorin 
KpnI 
KpnI 
KpnI 
XhoI, XmaI 
pARL1a(+) 
pARL1a(+) 
pARL1a(+) 
pARL1a(+) 
 
3.1.1.6 Transformation 
Transformation is the process by which exogenous DNA is incorporated into a cell. Bacterial 
cells have to be competent in order to take up DNA. This process can be performed, for 
example, with calcium chloride (CaCl2) and heat shock or via electroporation (Dagert and 
Ehrlich, 1979; Neumann et al., 1982). The method predominantly used in this study was 
transformation with CaCl2 and heat shock. In order to prepare competent cells, a 3 ml 
overnight culture of E. coli in LB medium was used to inoculate 100 ml of LB medium and 
was incubated in a shaking incubator until an optical density (OD600 nm) of 0.6 was reached. 
The cells were centrifuged for 10 min at 4,000 x g and 4 °C to harvest the cells. The cell 
pellet was resuspended in 1 ml of ice cold CaCl2 solution and incubated for 15 min on ice. 
100 µl aliquots were frozen in liquid nitrogen and stored at -80 °C. For transformation, an 
aliquot of E. coli cells was thawed on ice for 5 min. After adding 3-5 µl (100-400 ng DNA) of 
the DNA plasmid (ligation mixture), the cells were mixed carefully and placed on ice for 
30 min. During this time, plasmid DNA bound to the membranes of the bacteria. The cells 
were then heated at 42 °C for 90 sec to induce a heat shock, forcing the cells to internalize 
the DNA plasmid. Afterwards, the cells were placed on ice again for 2 min. 300 µl of LB 
medium was added to the cells; the suspension was mixed and incubated for 1 h at 37 °C 
with shaking. Finally, 50-100 µl of E. coli cells were plated on agar plates containing the 
appropriate antibiotics and incubated at 37 °C overnight. The antibiotic is essential for 
selection of transformed cells and conservation of the plasmid. The colonies were observed 
the next morning. All transformations are summarized in Table 3.8. 
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Table 3.8 Transformations of roGFP2-Orp1, HyPer-3, SypHer, and pHluorin in E. coli cells. 
 
 
 
 
 
 
 
3.1.1.7 Preparation of E. coli stocks 
A colony of transformed E. coli cells from the agar plate was used to inoculate 3 ml LB 
medium containing the appropriate antibiotic and was incubated overnight at 37 °C in a 
shaking incubator. The culture was vortexed, and 900 µl of cells were transferred into a 2 ml 
reaction tube under sterile conditions. 200 µl of glycerol was added and the mixture was 
stored at -80 °C. 
 
3.1.1.8 Preparation of plasmid DNA 
To check whether the cloning process was successful, the plasmids had to be isolated via 
plasmid preparation. Colonies from the agar plate of the transformation were separately used 
to inoculate 3 ml of LB medium containing the appropriate antibiotic. After overnight 
incubation at 37 °C under continuous shaking, the plasmids were extracted and purified by 
using the QIAprep Spin Miniprep Kit (Qiagen) according to the manufacturer’s instructions. 
Plasmids were eluted with 30 µl of elution buffer. The DNA concentration was measured as 
described above. To investigate whether the plasmids contained the insert, plasmid DNA 
was digested with the respective restriction enzymes, followed by agarose gel 
electrophoresis (see section 3.1.1.2). The sequence was confirmed via sequencing in an 
in-house sequencing facility according to Sanger et al. (1977). Stock cultures of the cells with 
a successfully integrated insert within the plasmid were prepared as described in section 
3.1.1.7. The Qiagen Plasmid Maxi Kit or the FastGeneTM Xpress (Plus) Plasmid Kit were 
used to generate high concentrations of plasmids for the transfection of P. falciparum 
according to the manufacturer’s instructions. 3 ml of LB medium with the respective antibiotic 
was inoculated with a bit of the frozen E. coli stock culture and incubated overnight at 37 °C 
under constant shaking. Then, 300 µl of the pre-culture was used to inoculate again 3 ml of 
LB medium with the respective antibiotic and incubated for 8 h at 37 °C under constant 
shaking. The culture was used to inoculate 250 ml of LB medium containing the appropriate 
antibiotic and incubated overnight at 37 °C. The cells were harvested via centrifugation for 
15 min at 8,000 rpm and 4 °C in the Sorvall centrifuge with the SLA 3000 rotor. The cell 
pellet was transferred into a 50 ml Falcon® tube. Within the Maxi Kit, the alkaline cell lysis 
was briefly used to access plasmid DNA; then cell debris was removed. Appropriate low salt 
pH conditions bound the DNA to resin and RNA; proteins and other impurities were removed 
by washing with medium salt buffer. Plasmid DNA was eluted in a high salt buffer, 
concentrated, desalted via isopropanol precipitation, and washed with 70% ethanol. The 
plasmid DNA pellet was dried under a sterile bench and resuspended for transient 
transfection in sterile 10 mM Tris/1 mM EDTA buffer (pH 7.5 with HCl) to a final 
concentration of approximately 3 µg/µl (150 µg DNA/50 µl needed for transfection). For 
stable transfection 200 µl of the 10 mM Tris/1 mM EDTA buffer was added to the plasmid 
DNA (50 µg DNA needed for transfection). 
 
3.1.2 Vector construction for Api-, Mito-, DV-, and ER-targeted roGFP2-Orp1, 
HyPer-3, and SypHer into pARL1a(+) 
The H2O2 redox probes roGFP2-Orp1 and HyPer-3, and the pH probe SypHer were modified 
for targeting to different subcellular compartments of the malaria parasite P. falciparum. 
Target sequences had to be inserted at the 3’ end of the pfcrt region. Signal sequences of 4 
to 50 amino acids (short peptides) were fused to the N-terminus or C-terminus of the redox 
probes. The apicoplast signal sequences of acyl carrier protein (ACP), the mitochondrial 
Plasmid  Resistance of plasmid E. coli cells 
pARL1a(+)-[roGFP2-Orp1] -KpnI- Cn KRX 
pARL1a(+)-[HyPer-3] -KpnI- Cn KRX 
pARL1a(+)-[SypHer] -KpnI- 
pARL1a(+)-[pHluorin] -XhoI-, -XmaI- 
Cn 
Cn 
KRX 
KRX 
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signal sequence of citrate synthase (CS), and the DV targeting sequence of plasmepsin IV 
(PM IV) were inserted at the N-terminus of the constructs roGFP2-Orp1, HyPer-3, and 
SypHer. The target sequences of Api, Mito and DV had already been successfully cloned 
into pARL1a(+) vector in the lab. These plasmids and the purified PCR product of PM served 
as templates for the present work. To target the proteins to the ER, pARL1a(+)-[STEVOR-X-
SDEL] was used. The sensors were inserted at the C-terminus of STEVOR. Additionally, the 
sequence SDEL was inserted at the C-terminus of roGFP2-Orp1, HyPer-3 and SypHer. The 
corresponding target protein sequences and their sizes are shown in Table 2.25 (2.3.1). 
First, pARL1a(+) vectors had to be constructed with new restriction sites that corresponded 
to the target sequences in order to enable the expression of the probes in P. falciparum. An 
overview of the plasmids obtained is given in Figure 3.2. Vector construction of organelle-
targeted roGFP2-Orp1, HyPer-3, and SypHer were performed by my master student Stine 
Weder (Weder, 2015). These obtained redox probes in the pARL1a(+) vector under the CRT 
promoter were transiently transfected into P. falciparum 3D7.  
 
Figure 3.2 Cloned roGFP2-
Orp1, HyPer-3 and SypHer 
constructs targeted to different 
organelles. Numerous biosensor 
constructs were cloned in order 
to target subcellular 
compartments of P. falciparum. 
Target sequences of acyl carrier 
protein (ACP) for the apicoplast 
(Api), citrate synthase (CS) for 
the mitochondrion (Mito), 
plasmepsin IV (PM) for the 
digestive vacuole (DV), and 
STEVOR/SDEL for the 
endoplasmic reticulum (ER) were 
used.  
 
 
 
 
3.1.2.1 Polymerase chain reaction 
The target sequences for the organelles Api, Mito and DV possess KpnI restriction sites, thus 
a corresponding KpnI restriction site had to be added to the coding sequences of roGFP2-
Orp1, HyPer-3 and SypHer. For this purpose, the templates pQE-60-[roGFP2-Orp1], HyPer-
3- and SypHer cyto vector were used. For the organelles Api, Mito, and DV restriction sites 
for KpnI and XmaI were added (HyPer-3 -KX-, SypHer -KX- and roGFP2-Orp1 -KX-). To 
generate the inserts targeted to the ER AvrII and XmaI restriction sites were added to the 
sequences of the probes (roGFP2-Orp1 -AX-, HyPer-3 -AX-, and SypHer -AX-). The PCR 
conditions and the PCR mixture are shown in Tables 3.9 and 3.10 (target sequences), 
whereas the used primers are shown in Table 2.27 (2.3.2). The time for the elongation step 
was 60 sec/1 kb of amplifying PCR construct. 
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Table 3.9 PCR conditions to amplify roGFP2-Orp1, HyPer-3, and SypHer for organelle targeting. 
 
 roGFP2-Orp1   HyPer-3/SypHer  
 -KX- -AX-  -KX- -AX-  
Denaturation 2 min, 94 °C 2 min, 94 °C  2 min, 94 °C 2 min, 94 °C 
Cycles 24 x 24 x  24 x 24 x 
Denaturation 30 sec, 94 °C 30 sec, 94 °C  30 sec, 94 °C 30 sec, 94 °C 
Annealing 30 sec, 59 °C 30 sec, 59 °C  30 sec, 57 °C 30 sec, 57 °C 
Elongation 2 min, 72 °C 2 min, 72 °C  2 min, 72 °C 2 min, 72 °C 
Final elongation 4 min, 72 °C 4 min, 72 °C  4 min, 72 °C 4 min, 72 °C 
Hold 8 °C 8 °C  8 °C 8 °C 
 
Table 3.10 PCR conditions to amplify the target sequences ACP, CS, and PM IV. 
 
 ACP, CS, PM IV  
Denaturation 2 min, 94 °C 
Cycles 24 x 
Denaturation 30 sec, 94 °C 
Annealing 30 sec, 57 °C 
Elongation 30 sec, 68 °C 
Final elongation 2 min, 68 °C 
Hold 8 °C 
 
The primers in Table 2.27 inserted KpnI restriction sites into ACP, CS and PM target 
sequences. Table 3.11 presents the PCR mixture. The PCR products were purified using the 
QIAquick PCR purification kit (DNA elution by 40 µl buffer EB) and were checked via agarose 
gel electrophoresis (3.1.1.2). 
Table 3.11 PCR mixture to amplify roGFP2-Orp1, HyPer-3, and SypHer for organelle targeting   
(-KX- and -AX-) and to amplify the target sequences ACP, CS, and PM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1.2.2 Initial preparation for targeting 
The cleaned and amplified PCR products as well as the pARL1a(+) and pARL1(+)-STEVOR-
[X-SDEL] vectors were digested with KpnI/XmaI (Api, Mito, DV) and AvrII/XmaI (ER), 
respectively, for 1.5 h at 37 °C (Table 3.12) and purified using the QIAquick PCR purification 
kit. To set up the ligation mixture, concentrations of the digested and purified PCR products 
(inserts) were measured at 260 nm in a photometer, and were used in an insert to vector 
molar ratio of 2:1 up to 5:1 (Table 3.13) according to 3.1.1.4 (DNA quantification) and 3.1.1.5 
(Ligation). AvrII and XmaI were used to insert roGFP2-Orp1-SDEL, HyPer-3-SDEL, and 
Component Volume  
AccuPrimeTM Buffer I (10 x) 5 µl  
Template  1 µl  
Forward primer (100 µM) 1 µl  
Reverse primer (100 µM) 1 µl  
AccuPrimeTM Taq DNA Polymerase (2 U/µl) 1 µl  
Autoclaved ddH2O 41 µl  
Final volume 50 µl  
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SypHer-SDEL into the pARL1a(+)-STEVOR vector. Ligations were carried out overnight at 
4 °C; the ligation partners are depicted in Table 3.14. Following the ligation, the plasmids 
were transformed into 50 µl competent E. coli KRX cells using 5 µl of the ligation mixtures. 
Transformations were performed as outlined in 3.1.1.6, plated out onto LB agar plates 
containing Cn (100 µl/ml), and incubated overnight at 37 °C. Subsequently, 3 ml LB medium 
containing Cn was inoculated with one colony from each transformation and grown overnight 
while constantly shaking at 37 °C. The overnight cultures were prepared as described in 
3.1.1.7 (Preparation of E. coli stocks) and 3.1.1.8 (Preparation of plasmid DNA). Afterwards, 
the plasmids were restricted with the appropriate enzymes (KpnI/XmaI or AvrII/XmaI) for 1 h 
at 37 °C and then verified using agarose gel electrophoresis (3.1.1.2). If the plasmids and 
inserts had the right sizes, the plasmids were sequenced thereafter in an in-house 
sequencing facility according to Sanger et al. (1977).  
 
Table 3.12 Digestion mixture of the PCR products and the pARL1a(+) and pARL1a(+)-STEVOR-
[X-SDEL] vectors. 
 
Component Volume 
Purified PCR product/vector 10 µl 
CutSmartTM Buffer (10 x) 3 µl 
KpnI or AvrII 1 µl 
XmaI 1 µl 
Autoclaved ddH2O 15 µl 
Final volume 30 µl 
 
Table 3.13 Ligation mixture of roGFP2-Orp1, HyPer-3, and SypHer (-KX- and -AX-) with the 
vector pARL1a(+) and pARL1a(+)-STEVOR. 
 
Component Volume 
Purified restricted PCR products roGFP2-Orp1, HyPer-3, SypHer (-KX-, -AX-) 2-5 µl 
Purified restricted vector pARL1a(+), pARL1a(+)-STEVOR 1 µl 
T4 DNA ligase buffer (10 x) 1 µl 
T4 DNA ligase (1-3 U/µl) 1 µl 
Autoclaved ddH2O 2-5 µl 
Final volume 10 µl 
 
Table 3.14 Ligation partners of cytosolic roGFP2-Orp1, HyPer-3, and SypHer for targeting to 
Api, Mito, DV, and ER. 
 
Insert Restriction enzyme Vector 
roGFP2-Orp1 
roGFP2-Orp1-SDEL 
HyPer-3/SypHer 
HyPer-3/SypHer-SDEL 
KpnI, XmaI 
AvrII, XmaI 
KpnI, XmaI 
AvrII, XmaI 
pARL1a(+) 
pARL1a(+)-STEVOR 
pARL1a(+) 
pARL1a(+)-STEVOR 
 
The sequenced cytosolic roGFP2-Orp1, HyPer-3, and SypHer vectors (KpnI and XmaI 
restriction sites) as well as the coding sequences of the target proteins for Api, Mito, and DV 
were restricted with FastDigest KpnI for 10 min at 37 °C (Table 3.15). Purification of the 
digested sequences was performed with the QIAquick PCR purification kit and 
concentrations were measured at 260 nm. The conditions for digestion are demonstrated in 
Table 3.15. 
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Table 3.15 Digestion mixture of the sequenced pARL1a(+)-[roGFP2-Orp1]/-[HyPer-3]/-[SypHer] 
vector with KpnI/XmaI restriction sites and the organelle coding sequences ACP, CS, and PM. 
 
Component Volume 
Purified PCR product/ vector 10 µl 
KpnI buffer (10 x) 3 µl 
FastDigest KpnI 1 µl 
Autoclaved ddH2O 16 µl 
Final volume 30 µl 
3.1.2.3 Dephosphorylation of vectors 
After digestion and purification of the cytosolic vectors with KpnI/XmaI restriction sites, they 
were additionally dephosphorylated in order to decrease the extent of re-ligated vectors. 
Table 3.16 shows the conditions of dephosphorylation with alkaline phosphatase for 30 min 
at RT.  
 
Table 3.16 Dephosphorylation conditions with alkaline phosphatase. 
 
Component Volume 
Digested, purified vector 10 µl 
Tango Buffer (10 x) 3 µl 
Fast thermosensitive alkaline phosphatase (1 U/µl) 2 µl 
Autoclaved ddH2O 15 µl 
Final volume 30 µl 
 
3.1.2.4 Gel extraction of ACP and CS 
Agarose gel electrophoresis (3.1.1.2) and subsequent gel extractions of the KpnI-amplified 
and digested target sequences ACP and CS were carried out with the QIAquick Gel 
Extraction Kit (Qiagen), following the manufacturer’s instructions, to prevent the insertion of 
template DNA during ligation. The concentration of the target sequences were measured at 
260 nm according to 3.1.1.4. 
 
3.1.2.5 Ligation 
To set up the ligation mixture, concentrations of the digested and purified PCR products were 
measured at 260 nm, and were used in an insert to vector molar ratio of 2:1 up to 5:1 (Table 
3.17) according to 3.1.1.4 (DNA quantification) and 3.1.1.5 (Ligation). The restriction site of 
KpnI was used to ligate the purified restricted target sequences of ACP, CS, and PM IV with 
the vector pARL1a(+)-[roGFP2-Orp1]/-[HyPer-3]/-[SypHer] (KpnI/XmaI restriction sites) 
overnight at 4 °C (Table 3.17). All ligation partners with respective restriction sites are 
summarized in Table 3.18.  
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Table 3.17 Ligation mixture of the target sequences ACP, CS, and PM IV and the pARL1a(+)-
[roGFP2-Orp1]/-[HyPer-3]/-[SypHer] vector.  
 
Component Volume 
Purified restricted PCR products ACP, CS, PM IV 2-5 µl 
Purified restricted vector pARL1a(+)-[roGFP2-Orp1]/-[HyPer-3]/-[SypHer] 1 µl 
T4 DNA Ligase Buffer (10 x) 1 µl 
T4 DNA Ligase (1-3 U/µl) 1 µl 
Autoclaved ddH2O 2-5 µl 
Final volume 10 µl 
 
Table 3.18 Ligation partners of ACP-, CS-, and PM-coding sequences with the pARL1a(+)-
[roGFP2-Orp1]/-[HyPer-3] and -[SypHer] vector. 
 
Insert Restriction enzyme Vector 
ACP 
CS 
KpnI 
KpnI 
pARL1a(+)-[roGFP2-Orp1] 
pARL1a(+)-[roGFP2-Orp1] 
PM IV KpnI pARL1a(+)-[roGFP2-Orp1] 
ACP 
CS 
KpnI  
KpnI 
pARL1a(+)-[HyPer-3] 
pARL1a(+)-[HyPer-3] 
PM IV KpnI pARL1a(+)-[HyPer-3] 
ACP 
CS 
KpnI  
KpnI 
pARL1a(+)-[SypHer] 
pARL1a(+)-[SypHer] 
PM IV KpnI pARL1a(+)-[SypHer] 
3.1.2.6 Transformation  
Following ligation, the plasmids were transformed into 50 µl competent E. coli KRX cells 
using 5 µl of the ligation mixtures. Transformations were performed as outlined in 3.1.1.6, 
plated out onto LB agar plates containing Cn (100 µl/ml), and incubated overnight at 37 °C. 
All the transformations are depicted in Table 3.19. E. coli stocks were prepared as described 
in 3.1.1.7. 
Table 3.19 Transformations. 
 
Plasmid Resistance of plasmid E. coli cells 
pARL1a(+)-[ACP-roGFP2-Orp1] (-KX-) Cn KRX 
pARL1a(+)-[CS-roGFP2-Orp1] (-KX-) Cn KRX 
pARL1a(+)-[PM-roGFP2-Orp1] (-KX-) 
pARL1a(+)-STEVOR-[roGFP2-Orp1-SDEL] (-AX-) 
Cn 
Cn 
KRX 
KRX 
pARL1a(+)-[ACP-HyPer-3] (-KX-) Cn KRX 
pARL1a(+)-[CS-HyPer-3] (-KX-) Cn KRX 
pARL1a(+)-[PM-HyPer-3] (-KX-) 
pARL1a(+)-STEVOR-[HyPer-3-SDEL] (-AX-) 
Cn 
Cn 
KRX 
KRX 
pARL1a(+)-[ACP-SypHer] (-KX-) 
pARL1a(+)-[CS-SypHer] (-KX-) 
pARL1a(+)-[PM-SypHer] (-KX-) 
pARL1a(+)-STEVOR-[ SypHer-SDEL] (-AX-) 
Cn 
Cn 
Cn 
Cn 
KRX 
KRX 
KRX 
KRX 
-KX-: restriction sites KpnI/XmaI, -AX- : restriction sites AvrII/XmaI 
 
3.1.2.7 Preparation of plasmid DNA 
3 ml LB medium containing Cn was inoculated with one colony from each transformation and 
grown overnight while constantly shaking at 37 °C. The cultures grown overnight were 
prepared as described in 3.1.1.8. Afterwards, the plasmids were restricted with the 
appropriate enzymes (AvrII and XmaI or KpnI and XmaI) for 1 h at 37 °C and then verified 
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using agarose gel electrophoresis (3.1.1.2). If the plasmids and inserts had the right sizes, 
the plasmids were sequenced in an in-house sequencing facility according to Sanger et al. 
(1977), and E. coli stock cultures were prepared (3.1.1.7). The Qiagen Plasmid Maxi Kit was 
used to generate a high concentration of the plasmids for the transfection of P. falciparum 
according to the manufacturer’s guidelines as described above in 3.1.1.8. 
 
3.1.2.8 Verification of inserts 
Due to the small sizes of the target sequences ACP and PM IV (180 bp and 210 bp, 
respectively), different methods were performed to distinguish between empty vectors and 
vectors with inserts. For ACP, PCR of the putative pARL1a(+)-[ACP-X] vector with the same 
conditions was conducted as described above (Tables 3.10 and 3.11). It was then possible 
via agarose gel electrophoresis to verify whether there was an amplified PCR product of an 
appropriate size. For PM IV, pARL1a(+)-[PM-X] with the restriction enzymes XhoI and XmaI 
was digested so that the restricted insert was bigger (approximately 1600 bp) and it was 
easier to see whether the PCR product was inserted into the vector. Plasmids with an insert 
of the appropriate size were sequenced. 
 
3.1.3 Stable integration of the biosensors into the pDC2-CRT-X-attP and pDC2-
CAM-X-attP vector  
Cytosolic roGFP2-Orp1, HyPer-3, SypHer, hGrx1-roGFP2, and organelle-targeted ACP-
roGFP2-Orp1, CS-roGFP2-Orp1, ACP-roGFP2-hGrx1 and CS-roGFP2-hGrx1 were cloned 
into the pDC2-CRT-X-BSD-attP (Figure 3.3) and pDC2-CAM-X-BSD-attP vector (Figure 3.4) 
for stable transfection into P. falciparum. The same vectors, just with different promoters, 
were used to check whether the CAM promoter, which is thought to be a strong promoter, 
has a stronger effect on the expression of the inserted constructs in comparison to the CRT 
promoter, a weak promoter. Moreover, cytosolic pHluorin probe was cloned into the pDC2-
CAM-X-BSD-attP vector. The cytosolic glutathione redox sensor hGrx1-roGFP2 in the 
pARL1a(+) vector (Kasozi et al., 2013) and the targeted constructs ACP-roGFP2-hGrx1 and 
CS-roGFP2-hGrx1 in the pARL1a(+) vector (Mohring et al., 2017) under the CRT promoter 
were already present in the lab. The sensors were modified for cloning into the pDC2-CRT-
X-BSD-attP and pDC2-CAM-X-BSD-attP vector. An overview of the plasmids obtained are 
given in Figures 3.3 and 3.4. The redox probes can be genetically integrated into P. 
falciparum NF54 via the attB/attP system of integrative recombination. The 
mycobacteriophage Bxb1 serine integrase mediates site-specific recombination between the 
phage attP site of the pDC2 expression plasmid and the attB site at the non-essential cg6 
locus in Plasmodium NF54-attB parasites (Nkrumah et al., 2006; Adjalley et al., 2010). The 
pDC2-1600-CRT-[FA2a-roGFP1]-BSD-attP plasmid (AvrII/XhoI restriction sites) and pDC2-
CAM-[hGrx1-roGFP2]-BSD-attP plasmid (AvrII/XhoI restriction sites) were used for cloning 
procedures, which were kindly provided by the laboratory of David Fidock, Columbia 
University, New York. Due to an XhoI restriction site within the hGrx1 gene of the hGrx1-
roGFP2 glutathione redox sensor, Stanislav Gabryszewski from the lab of David Fidock 
mutated the XhoI restriction site in the hGrx1 gene via site-directed mutagenesis (SDM) 
before cloning it into the pDC2-CAM-X-BSD-attP plasmid. To enable the insertion of the 
cytosolic and organelle-targeted hGrx1-roGFP2 constructs into the pDC2-CRT-X-attP and 
pDC2-CAM-X-attP plasmids, Stanislav Gabryszewski also mutated the XhoI restriction sites 
of both plasmids via SDM to XmaI restriction sites. 
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Figure 3.3 Cloning roGFP2-Orp1, HyPer-3, SypHer, and 
hGrx1-roGFP2 constructs into the pDC2-CRT-X-BSD-attP 
vector. The cytosolic H2O2 sensors roGFP2-Orp1 and HyPer-3, 
the pH insensitive version of HyPer, SypHer, and the glutathione 
redox sensor hGrx1-roGFP2 were cloned into the pDC2-CRT-X-
attP vector using AvrII and XmaI restriction sites. Moreover, Api- 
and Mito-targeted roGFP2-Orp1 and roGFP2-hGrx1 were 
cloned into the vector. Before, the XhoI restriction site of the 
pDC2-1600-CRT-[FA2a-roGFP1]-BSD-attP plasmid was 
mutated to an XmaI restriction site and served as a template for 
the insertion of various constructs. 
 
 
 
 
 
 
 
 
 
 
For cloning into the pDC2-CAM-[X]-BSD-attP vector (AvrII/XhoI restriction sites), a second 
vector with AvrII/XmaI restriction sites was created to insert the constructs ACP-/CS-roGFP2- 
hGrx1 and pHluorin. 
 
Figure 3.4 Cloning roGFP2-
Orp1, HyPer-3, SypHer, 
hGrx1-roGFP2, and pHluorin 
constructs into the pDC2-
CAM-X-attP vector. The 
cytosolic H2O2 sensors roGFP2-
Orp1 and HyPer-3, the pH 
insensitive version of HyPer, 
SypHer, and the Api- and Mito-
targeted roGFP2-Orp1 were 
cloned into the template pDC2-
CAM-X-attP vector using AvrII 
and XhoI restriction sites. To 
insert Api- and Mito-targeted 
roGFP2-hGrx1, the XhoI 
restriction site of the original 
pDC2-CAM-X-attP plasmid was 
mutated to an XmaI restriction site. PHluorin was also cloned into the vector using AvrII and XmaI 
restriction sites. 
 
3.1.3.1 Polymerase chain reaction 
For cloning the constructs into the pDC2-CRT-attP plasmid, AvrII and XmaI restriction sites 
had to be added to cytosolic, Api-, and Mito-targeted roGFP2-Orp1, HyPer-3, SypHer, and 
hGrx1-roGFP2. Previously, the XhoI restriction site of the template plasmid pDC2-1600-CRT-
[FA2a-roGFP1]-BSD-attP had been mutated to an XmaI restriction site. The generated 
cytosolic plasmids [≈ 50 ng/µl] pARL1a(+)-roGFP2-Orp1, -HyPer-3, and -SypHer from 3.1.1 
and the pARL1a(+)-Api- and Mito-roGFP2-Orp1 probe from 3.1.2 served as construct 
templates for PCR. The cytosolic pARL1a(+)-hGrx1-roGFP2, -Api- and Mito-roGFP2-hGrx1 
were already present in the lab. The PCR conditions and PCR mixture are shown in Tables 
3.20 and 3.21, whereas the used primers can be found in Table 2.27 (2.3.2). The time for the 
elongation step was 60 sec/1 kb of amplifying PCR construct. Afterwards, the QIAquick PCR 
purification kit (Qiagen) was used according the manufacturer’s instructions to purify the 
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amplified PCR products (DNA elution with 40 µl EB buffer). The sizes of the PCR products 
were checked via agarose gel electrophoresis  (3.1.1.2). 
Table 3.20 PCR conditions for the amplification of cytosolic, Api-, and Mito-targeted roGFP2-
Orp1, HyPer-3, SypHer, and hGrx1-roGFP2 for the pDC2-CRT-X-attP and pDC2-CAM-X-attP 
vectors. 
 
 
roGFP2-Orp1,  
ACP-roGFP2-
Orp1,  
CS-roGFP2-Orp1 
 
 
HyPer-3/ 
SypHer 
 
 
hGrx1-roGFP2,  
ACP-roGFP2-
hGrx1, 
CS-roGFP2-
hGrx1 
 
 
 
pHluorin 
AvrII/XmaI and AvrII/XhoI restriction sites  
Denaturation 3 min, 94 °C 3 min, 94 °C  3 min, 94 °C 3 min, 94 °C 
Cycles 25 x 25 x  25 x 25 x 
Denaturation 30 sec, 94 °C 30 sec, 94 °C  30 sec, 94 °C 30 sec, 94 °C 
Annealing 30 sec, 54 °C 30 sec, 57 °C  30 sec, 57 °C 30 sec, 45 °C 
Elongation 2 min, 64 °C 2 min, 64 °C  2 min, 64 °C 1 min, 64 °C 
Final 
elongation 
5 min, 64 °C 5 min, 64 °C  5 min, 64 °C 5 min, 64 °C 
Hold 4 °C 4 °C  4 °C 4 °C 
 
Table 3.21 PCR mixture for the amplification of cytosolic, Api-, and Mito-targeted roGFP2-Orp1, 
HyPer-3, SypHer, and hGrx1-roGFP2 for the pDC2-CRT-X-attP and pDC2-CAM-X-attP vector. 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1.3.2 Cleavage of double-stranded DNA via restriction endonucleases 
The purified and amplified PCR products as well as the template pDC2-CRT-[FA2a-roGFP1]-
attP vector (SDM of XhoI  XmaI restriction site) and pDC2-CAM-[hGrx1-roGFP2]-attP 
vector (both original with AvrII/XhoI restriction sites and SDM of XhoI  XmaI restriction site) 
were digested with AvrII/XmaI and AvrII/XhoI or AvrII/XmaI, respectively, for 1.5 h at 37 °C 
and purified with the QIAquick PCR purification kit. The condition for digestion is 
demonstrated in Table 3.22. Next, agarose gel electrophoresis (3.1.1.2) of the digested PCR 
products and vector with subsequent gel extraction (Quiagen Gel Extraction Kit) of both were 
performed to remove template DNA of the amplified constructs and the [FA2a-roGFP1]-insert 
of the pDC2-CRT plasmid as well as the [hGrx1-roGFP2]-insert of the pDC2-CAM plasmid. 
Component Volume  
AccuPrimeTM Buffer I (10 x) 4 µl  
Template  1 µl  
Forward primer (5 µM) 4 µl 
 
 
Reverse primer (5 µM) 
 
j 
4 µl  
AccuPrimeTM Taq DNA Polymerase (2 U/µl) 1 µl  
Autoclaved ddH2O 26 µl  
Final volume 40 µl  
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Table 3.22 Digestion mixture of the PCR products and the original pDC2-CRT-[FA2a-roGFP1]-
attP and pDC2-CAM-[hGrx1-roGFP2]-attP plasmids. 
 
Component Volume 
Purified PCR product/vector 12 µl 
CutSmartTM Buffer (10 x) 2 µl 
AvrII 1 µl 
XmaI/XhoI 1 µl 
Autoclaved ddH2O 4 µl 
Final volume 20 µl 
3.1.3.3 Ligation 
To set up the ligation mixture, concentrations of the digested and purified PCR products were 
measured at 260 nm. Ligations of roGFP2-Orp1, HyPer-3, SypHer, hGrx1-roGFP2, pHluorin, 
ACP-/CS-roGFP2-Orp1 and ACP-/CS-roGFP2-hGrx1 PCR products with the restricted 
purified pDC2-CRT-[X]-attP and pDC2-CAM-[X]-attP vector were carried out according to 
Table 3.23 for 10 min at RT. Quick ligations were performed by using the T4-DNA-Ligase 
and the 2 x Rapid Buffer. The volume of the insert was two times higher than of the vector 
(2:1, insert to vector molar ratio). All ligation partners with respective restriction sites are 
summarized in Table 3.24. 
 
Table 3.23 Ligation mixture of roGFP2-Orp1, HyPer-3, SypHer, hGrx1-roGFP2, pHluorin, ACP-
/CS-roGFP2, and ACP-/CS-roGFP2-hGrx1 with the vectors pDC2-CRT-[X]-attP and pDC2-CAM-
[X]-attP. 
 
Component Volume 
Purified restricted PCR products roGFP2-Orp1, HyPer-3, SypHer, hGrx1-roGFP2,  
 
 
 
 
 
 
2 µl 
pHluorin, ACP-/CS-roGFP2-Orp1, ACP-/CS-roGFP2-hGrx1 (≈ 20 ng)  
Purified restricted vector pDC2-CRT-[X]-attP, pDC2-CAM-[X]-attP (≈ 20 ng) 1 µl 
T4 DNA ligase buffer (2 x) 5 µl 
T4 DNA ligase (1-3 U/µl) 1 µl 
Autoclaved ddH2O 1 µl 
Final volume 10 µl 
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Table 3.24 Ligation partners of roGFP2-Orp1, HyPer-3, SypHer, hGrx1-roGFP2, pHluorin, ACP-
/CS-roGFP2, and ACP-/CS-roGFP2-hGrx1 with the vectors pDC2-CRT-[X]-attP and pDC2-CAM-
[X]-attP. 
 
Insert Restriction enzyme Vector 
roGFP2-Orp1 
ACP-roGFP2-Orp1 
CS-roGFP2-Orp1 
AvrII, XmaI 
AvrII, XmaI  
AvrII, XmaI 
pDC2-CRT-[X]-BSD-attP 
pDC2-CRT-[X]-BSD-attP 
pDC2-CRT-[X]-BSD-attP 
HyPer-3 
SypHer 
AvrII, XmaI  
AvrII, XmaI 
pDC2-CRT-[X]-BSD-attP 
pDC2-CRT-[X]-BSD-attP 
hGrx1-roGFP2 
ACP-roGFP2-hGrx1 
CS-roGFP2-hGrx1 
AvrII, XmaI 
AvrII, XmaI 
AvrII, XmaI 
pDC2-CRT-[X]-BSD-attP 
pDC2-CRT-[X]-BSD-attP 
pDC2-CRT-[X]-BSD-attP 
roGFP2-Orp1 
ACP-roGFP2-Orp1 
CS-roGFP2-Orp1 
AvrII, XhoI 
AvrII, XhoI 
AvrII, XhoI  
pDC2-CAM-[X]-BSD-attP 
pDC2-CAM-[X]-BSD-attP 
pDC2-CAM-[X]-BSD-attP 
HyPer-3 
SypHer 
AvrII, XhoI  
AvrII, XhoI 
pDC2-CAM-[X]-BSD-attP 
pDC2-CAM-[X]-BSD-attP 
ACP-roGFP2-hGrx1 
CS-roGFP2-hGrx1 
AvrII, XmaI 
AvrII, XmaI 
pDC2-CAM-[X]-BSD-attP 
pDC2-CAM-[X]-BSD-attP 
pHluorin AvrII, XmaI pDC2-CAM-[X]-BSD-attP 
3.1.3.4 Transformation  
Following ligation, the plasmids were transformed into 50 µl of competent E. coli KRX cells 
using 5 µl of ligation mixtures. Transformations were performed as outlined in 3.1.1.6, plated 
out onto LB agar plates containing Cn (100 µl/ml), and incubated overnight at 37 °C.  
 
Table 3.25 Transformations in E. coli cells. 
 
3.1.3.5 Preparation of plasmid DNA 
To determine successful ligation and thereby the presence of insert DNA in the plasmid 
constructs, colony PCR was performed according to an example displayed in Table 3.26. 
The PCR mixture conditions are shown in Table 3.27. A colony of each transformation was 
added directly to the PCR reaction and lysed during the initial heating step. This led to the 
release of plasmid DNA from the cell and served as a template for the amplification process. 
First, a smear of the colony was made on a new agar plate containing the respective 
Plasmid Resistance of plasmid E. coli cells 
pDC2-CRT-[roGFP2-Orp1]-BSD-attP   Cn KRX 
pDC2-CRT-[roGFP2-Orp1]-BSD-attP Cn KRX 
pDC2-CRT-[roGFP2-Orp1]-BSD-attP Cn KRX 
pDC2-CRT-[HyPer-3]-BSD-attP 
pDC2-CRT-[SypHer]-BSD-attP 
Cn 
Cn 
KRX 
KRX 
pDC2-CRT-[hGrx1-roGFP2]-BSD-attP 
pDC2-CRT-[ACP-roGFP2-hGrx1]-BSD-attP 
pDC2-CRT-[CS-roGFP2-hGrx1]-BSD-attP 
Cn 
Cn 
Cn 
KRX 
KRX 
KRX 
pDC2-CAM-[roGFP2-Orp1]-BSD-attP 
pDC2-CAM-[ACP-roGFP2-Orp1]-BSD-attP 
pDC2-CAM-[CS-roGFP2-Orp1]-BSD-attP 
Cn 
Cn 
Cn 
KRX 
KRX 
KRX 
pDC2-CAM-[HyPer-3]-BSD-attP 
pDC2-CAM-[SypHer]-BSD-attP 
Cn 
Cn 
KRX 
KRX 
pDC2-CAM-[ACP-roGFP2-hGrx1]-BSD-attP 
pDC2-CAM-[CS-roGFP2-hGrx1]-BSD-attP 
Cn 
Cn 
KRX 
KRX 
pDC2-CAM-[pHluorin]-BSD-attP]-BSD-attP Cn KRX 
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antibiotic and was incubated overnight at 37 °C for plasmid preparation if the construct 
contained the DNA fragment of interest. It was then added to the PCR mixture. For PCR, the 
same primers used for cloning the inserts into the plasmids (Table 2.27; 2.3.2) were used to 
target the insert DNA as well as the correspondent annealing temperatures depicted in 
3.1.3.1, Table 3.20. 
  
Table 3.26 Colony PCR conditions for verifying inserted DNA. 
 
 Insert DNA 
 AvrII/XmaI and AvrII/XhoI restriction sites  
Denaturation 10 min, 95 °C 
Cycles 25 x 
Denaturation 30 sec, 95 °C 
Annealing 30 sec, 54 °C 
Elongation 60 sec/1 kb, 64 °C 
Final elongation 5 min, 64 °C 
Hold 4 °C 
 
Table 3.27 PCR mixture for amplifying inserted DNA after colony PCR. 
 
 
 
 
 
 
 
 
 
 
 
 
After colony PCR, agarose gel electrophoresis (3.1.1.2) was carried out to check for the 
putative inserted DNA. If the inserts had the right sizes, 3 ml of LB medium containing Cn 
was inoculated with a bit of the smear from the agar plate cultures that had been grown 
overnight from each transformation. This was then grown overnight while constantly shaking 
at 37 °C. These cultures were extracted and purified by using the QIAprep Spin Miniprep Kit 
(Qiagen) as described in 3.1.1.8 according to the manufacturer’s instructions. Plasmids were 
eluted with 30 µl of elution buffer. Thereafter, the plasmids were sequenced in an in-house 
sequencing facility according to Sanger et al. (1977), and E. coli stock cultures were 
prepared (3.1.1.7). The Qiagen Plasmid Maxi Kit was used to generate a high concentration 
of plasmids in order to transfect P. falciparum according to the manufacturer’s guidelines as 
described above in 3.1.1.8. 
 
3.1.4 Vector construction for heterologous overexpression of HyPer-3 and 
SypHer  
For expressing HyPer-3 and SypHer recombinant proteins, the constructs had to be cloned 
into the expression vector pET28a(+) with a Kan resistance selectable marker. The original 
coding sequence of roGFP2-Orp1 had already been inserted in the pQE60-expression 
vector. Therefore, it could be directly used for heterologous overexpression of the protein. 
Vector construction for heterologous overexpression was performed by my master student 
Stine Weder (Weder, 2015). 
 
Component Volume  
AccuPrimeTM Buffer I (10 x) 2 µl  
Forward primer [5 µM] 2 µl  
Reverse primer [5 µM] 2 µl  
AccuPrimeTM Taq DNA Polymerase (2 U/µl) 0.5 µl  
Autoclaved ddH2O 13.5 µl  
Final volume 20 µl  
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3.1.4.1 Polymerase chain reaction 
HyPer-3 cyto vector and SypHer cyto vector served as templates for PCR. NcoI and XhoI 
restriction sites were introduced (HyPer-3 NX and SypHer NX). The PCR conditions and 
mixture are shown in Tables 3.28 and 3.29. Afterwards, the QIAquick PCR purification kit 
(Qiagen) was used according the manufacturer’s instructions to purify the amplified PCR 
products (DNA elution with 40 µl EB buffer). The sizes of the PCR products were checked via 
agarose gel electrophoresis (3.1.1.2).  
 
Table 3.28 PCR conditions for the amplification of HyPer-3/SypHer for overexpression. 
 
  HyPer-3/SypHer 
Denaturation  2 min, 94 °C 
Cycles  24 x 
Denaturation  30 sec, 94 °C 
Annealing  30 sec, 54 °C 
Elongation  2 min, 72 °C 
Final elongation  4 min, 72 °C 
Hold  8 °C 
 
Table 3.29 PCR mixture to amplify HyPer-3/SypHer for overexpression.  
 
 
 
 
 
 
 
 
The amplified products and the pET-28a(+) vector were restricted with NcoI and XhoI for 
1.5 h at 37 °C and purified again with the QIAquick PCR purification kit (Qiagen). Afterwards, 
the concentrations of the digested vector and PCR products were determined. The ligation 
mixtures were as follows (Table 3.31). 
 
3.1.4.2 Cleavage of double-stranded DNA via restriction endonucleases 
The purified and amplified PCR products as well as the pET28a(+) vector were digested with 
NcoI and XhoI for 1.5 h at 37 °C and purified with the QIAquick PCR purification kit. The 
conditions for digestion are listed in Table 3.30.  
 
 
 
 
 
 
 
 
 
 
Component Volume  
AccuPrimeTM Buffer I (10 x) 5 µl  
Template  1 µl  
Forward primer [100 µM] 1 µl  
Reverse primer [100 µM] 1 µl  
AccuPrimeTM Taq DNA Polymerase (2 U/µl) 1 µl  
Autoclaved ddH2O 41 µl  
Final volume 50 µl 
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Table 3.30 Digestion mixture of the HyPer-3/SypHer PCR products and the pET28a(+) vector.  
 
Component Volume  
Purified PCR product/vector 10 µl  
Buffer R (10 x) 3 µl  
NcoI 1 µl  
XhoI 1 µl  
Autoclaved ddH2O 15 µl  
Final volume 30 µl  
 
3.1.4.3 Ligation 
To set up the ligation mixture, concentrations of the digested and purified PCR products and 
vector were measured at 260 nm. Ligations of HyPer-3 and SypHer PCR products with the 
restricted purified pET28a(+) vector were carried out according to Table 3.31 for 10 min at 
RT. Quick ligations were performed by using the T4 DNA Ligase and the 2 x Rapid Buffer. 
The volume of the insert was two times higher than that of the vector (2:1, insert to vector 
molar ratio). All ligation partners with their respective restriction sites are summarized in 
Table 3.32.  
 
Table 3.31 Ligation mixture of HyPer-3 and SypHer. 
 
Component Volume 
Purified restricted PCR product HyPer-3, SypHer  2 µl 
Purified restricted vector pET28a(+)  
 
2 µl 
T4 DNA Ligase Buffer (2 x) 5 µl 
T4 DNA Ligase (1-3 U/µl) 1 µl 
Final volume 10 µl 
 
Table 3.32 Ligation partners of HyPer-3 and SypHer. 
 
Insert Restriction enzyme Vector 
HyPer-3 
SypHer 
NcoI, XhoI 
NcoI, XhoI 
pET28a(+) 
pET28a(+) 
 
3.1.4.4 Transformation 
Following ligation, the plasmids were transformed into 50 µl competent E. coli KRX cells by 
using 5 µl of the ligation mixtures. Transformations were performed as outlined in 3.1.1.6, 
plated out onto LB agar plates containing Kan (50 µg/ml), and incubated overnight at 37 °C. 
All transformations are depicted in Table 3.33. 
Table 3.33 Transformation of HyPer-3 and SypHer in E. coli cells. 
 
Plasmid Resistance of plasmid E. coli cells 
pET-28a(+)[HyPer-3] Kan KRX 
pET-28a(+)[SypHer] Kan KRX 
 
3.1.4.5 Preparation of plasmid DNA 
3 ml LB medium containing Kan was inoculated with one colony from each transformation 
and grown overnight while constantly shaking at 37 °C. The cultures grown overnight were 
prepared as described in 3.1.1.8. Afterwards, the plasmids were restricted with the 
appropriate enzymes (NcoI and XhoI) for 1 h at 37 °C and then verified using agarose gel 
electrophoresis (3.1.1.2). If the plasmids and inserts had the right sizes, the plasmids were 
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sequenced in an in-house sequencing facility according to Sanger et al. (1977), and E. coli 
stock cultures were prepared (3.1.1.7). 
 
3.1.5 Production of recombinant roGFP2-Orp1, HyPer-3, and SypHer in E. coli 
cells 
3.1.5.1 Heterologous overexpression of recombinant proteins in E. coli cells 
To evaluate the in vitro interactions of drugs and redox-active compounds with the redox 
probes roGFP2-Orp1, HyPer-3, and SypHer, the recombinant proteins were expressed as 
follows. The E. coli M15[pREP4] strain (Qiagen) was transformed with roGFP2-Orp1 in the 
pQE60 plasmid, and E. coli KRX cells were transformed with either HyPer-3 or SypHer in 
pET28a(+) according to 3.1.1.6 and plated out onto agar plates containing Cn (pQE60 with 
CnR) and/or Kan (pREP4 and pET-28a(+) with KanR). Then, the inoculation of 3 ml LB 
medium (containing the relevant antibiotics) with a grown colony was carried out. After 6-7 h 
of incubation, this pre-culture was added to 50 ml of LB medium with antibiotics and grown 
overnight at 37 °C in a shaking incubator. The next day, 500 ml of LB medium containing 
antibiotics was inoculated with 10-15 ml of the overnight culture until an optical density at 
600 nm (OD600) of 0.1 was reached. The culture was grown at 37 °C to an OD600 of 0.6, 
induced with either 1 mM IPTG (to express roGFP2-Orp1) or 0.1% rhamnose (to express 
HyPer-3 and SypHer), and incubated overnight at RT. The cells were harvested via 
centrifugation (8,000 rpm, 15 min, 4 °C) in a Sorvall centrifuge with an SLA 3000 rotor and 
resuspended (1 g pellet/4 ml buffer) in US buffer (50 mM sodium phosphate buffer, 300 mM 
NaCl, pH 8.0). Finally, the protease inhibitors pepstatin (0.5 µl/ml), cystatin (1 µl/ml), and 
PMSF (1 µl/ml) were added, and the resuspended pellets were stored at -20 °C until the 
recombinant proteins were purified. Heterologous overexpression and purification of the 
recombinant proteins were performed by my master student Stine Weder (Weder, 2015). 
  
3.1.5.2 Purification of recombinant proteins 
There are different methods of protein purification to isolate recombinant proteins from the 
cell mixture. Here, metal affinity chromatography using nickel-NTA agarose (Ni-NTA) was 
performed, which allows purification with a reversible interaction between the hexahistidyl tag 
(His-tag) and Ni-NTA. First, the pellet was lysed using lysozyme (16 mg/1 l LB medium), and 
DNaseI resuspended in US buffer was added. The suspension was stirred on ice for 30 min 
and sonicated three times for 30 sec. After centrifugation at 18,000 rpm for 30 min at 4 °C, 
the Ni-NTA column was loaded with the supernatant and washed with ten times the column 
volume with US buffer. The protein was eluted by using rising concentrations of imidazole 
(10 mM, 50 mM, 100 mM, 200 mM, and 500 mM). The eluted protein fractions were analyzed 
via SDS-PAGE (3.4.2). Pure protein containing fractions were pooled and concentrated using 
30 kDa Vivaspin columns (Megafuge, 4,000 rpm, 4 °C). Finally, the protein concentration 
was measured as described in 3.4.1, and the recombinant protein was confirmed via western 
blot analysis (3.4.3) using an α-GFP/α-YFP antibody. The proteins were stored at -20 °C with 
10% glycerol. 
 
3.2 P. falciparum culture methods 
3.2.1 P. falciparum maintenance 
The strains of P. falciparum used were cultured according to Trager et al. (1976) with minor 
modifications. The strains were cultivated in RBCs (A+) in RPMI 1640 medium supplemented 
with 0.5% w/v Albumax, 9 mM glucose, 0.2 mM hypoxanthine, 2.1 mM L-glutamine, 25 mM 
HEPES, and 22 µg/ml gentamycin at 3.3% hematocrit (15 ml culture) and 37 °C in a gaseous 
mixture comprising 3% O2, 3% CO2, and 94% N2. Parasitemia was counted on Giemsa-
stained blood smears. Under these conditions, each RBC multiplication cycle took 44 h for 
the 3D7 strain and 48 h for the NF54-attB strain and resulted in the production of 20-32 new 
merozoites, each capable of invading a new RBC. 
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3.2.2 Sorbitol synchronization 
Sorbitol was used for synchronization of the parasites to the ring-stage. Sorbitol enters 
parasites with developed anion-selective channels that lead to osmotic lysis, while ring-stage 
parasites survive. 10 ml of Plasmodium culture was transferred to a 15 ml Falcon tube and 
centrifuged for 3 min at 2,100 rpm (Megafuge 1.0 R). The supernatant was discarded. 5 ml of 
a pre-warmed 5% (w/v) sorbitol solution (Lambros and Vanderberg, 1979) was added to the 
parasite pellet, mixed thoroughly, and incubated for 8 min at RT. The cells were centrifuged 
as described above, and the pellet was washed with 10 ml complete medium. The culture 
was transferred into a new culture plate and maintained as described above.  
 
3.2.3 Purification and enrichment of trophozoite-stage parasites 
Via magnet separation (Paul et al., 1981), trophozoites were isolated from non-infected 
RBCs and younger stages of P. falciparum. The QuadroMACS separation system was used, 
consisting of LC columns (containing magnetic beads) that were attached to Discofix® three-
way stopcocks with hypodermic needles. The parasite culture was added to the columns, 
and unbound cells were washed with incomplete medium (medium without Albumax). Only 
hemozoin containing parasites (≈ 24 to 38 h trophozoites) bound to the columns. After 
removing the columns from the magnet, the bound trophozoites were eluted with complete 
medium and cultured as described above. The columns were washed subsequently with 
water and increasing concentrations of ethanol (70% and 100%) to prevent oxidation of the 
magnetic beads and let them dry overnight before using the columns again. 
 
3.2.4 In vitro P. falciparum drug susceptibility assays 
Parasite growth inhibition studies and half maximal effective concentration (EC50) calculation 
of antimalarial drugs or compounds against P. falciparum were performed using either the 
[3H]-hypoxanthine incorporation assay (Desjardins et al., 1979; Kasozi et al., 2013) or a 
SYBR Green I-based fluorescence assay for parasite nucleic acid according to Ekland et al. 
(2011) in 96-well format with modifications. For the [3H]-hypoxanthine assay, serial double 
dilutions (100 µl) of the compounds in hypoxanthine-free medium were carried out in 96-well 
microtiter plates. Synchronized ring-stage parasites in hypoxanthine-free complete medium 
(100 µl) were added to each well (0.15% parasitemia, 1.25% final hematocrit). Negative 
control wells contained only RBCs, while positive control wells contained iRBCs. The plate 
was incubated for 48 h under cell culture conditions. Afterwards, [3H]-hypoxanthine was 
added at a final concentration of 0.5 µCi/well, and the plate was further incubated for 24 h. 
The plates were frozen at -80°C for at least 1 h, thawed, and the cells were harvested on 
glass fiber filters. Finally, the radioactivity in counts per minute (cpm) from each well was 
measured after drying and was proportional to the growth of P. falciparum in comparison to 
RBCs and iRBCs. For SYBR Green-I assays, serial double dilutions (50 µl) of the 
compounds in complete medium were executed in 96-well half area microtiter plates (µClear 
bottom). Synchronized ring-stage parasites in complete medium (50 µl) were added to each 
well (0.15% parasitemia, 1.25% final hematocrit) and incubated for 48 h (NF54-attB) or 44 h 
(3D7) at 37 °C. Then, 20 μl of 5 x SYBR Green (10,000 x stock solution) in lysis buffer 
(20 mM Tris-HCl, 5 mM EDTA, 0.16% w/v saponin, and 1.6% v/v Triton X-100) were added 
to each well for 24 h at RT in the dark. Fluorescence was measured in the Clariostar plate 
reader at ex 494 nm/em 530 nm. Curve-fitting the percentage growth inhibition against log 
drug concentration with a variable slope sigmoidal function allowed the determination of EC50 
values. 
 
3.2.5 Preparation of parasite cell extracts with saponin 
Parasites were cultured and synchronized as described above. For analysis, 10 ml of 
transfected P. falciparum 3D7 trophozoite-stage parasites (26-30 h) (6-8% parasitemia, 5% 
hematocrit) were used. The parasite culture was transferred to a Falcon® tube and 
centrifuged for 8 min at 2,300 rpm at RT. Pellets were resuspended with 20 volumes of 
saponin lysis buffer (0.02% saponin, 10 mM NaH2PO4, 10 mM Na2HPO4, 145 mM NaCl, 
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3 mM KCl, pH 7.2), incubated for 10 min at 37 °C with intermittent inverting, and centrifuged 
for 8 min at 2,700 rpm at RT. The supernatant was discarded, and the cells were first 
washed with 10 ml of saponin lysis buffer (incubation at 37 °C for 10 min with inverting) and 
then three times with PBS with decreasing temperature (RT, 15 °C, 4 °C). The cells were 
resuspended in 800 µl ice-cold PBS and centrifuged for 15 min at 3,500 rpm (4 °C). Pellets 
were kept at -80 °C. To prepare the parasite cell extracts, pellets were diluted in an equal 
volume of PBS, and complete protease inhibitor cocktail was added. Parasites were 
disrupted with four cycles of freezing in liquid nitrogen and thawing in a water bath at RT. 
After centrifugation at 50,000 rpm for 30 min at 4 °C in an ultracentrifuge, the resulting 
supernatant was used for western blots. 
 
3.3 P. falciparum transfection methods 
3.3.1 Transient transfection of P. falciparum 
Trophozoite-stage parasites were transferred to fresh RBCs after magnet enrichment. 
Around 15-20 h later, 5 ml of culture (ring-stage 8-10 h, 5-8% parasitemia, 5% hematocrit) 
was centrifuged for 4 min at 2,100 rpm, and the supernatant was discarded. The parasite 
pellet (200 µL) was mixed with 150 µg of purified plasmid (Maxi prep Kit) in 400 µl cytomix 
and electroporated (310 V, 950 µF, capacitance ∞) in a 2 mm electroporation cuvette with 
the Bio-Rad Gene Pulser (Crabb et al., 2004). The resulting time constant was between 10 
and 15 ms. The electroporated sample was returned to a petri dish containing 10 ml culture 
medium with 300 µl of RBCs, and the cuvette was washed with 2 ml of the supernatant of 
this culture medium. The medium was changed between 1-6 h after transfection, and culture 
medium was filled up to a final volume of 15 ml. To select for transfectants, 2 nM WR99210 
was added to the culture of roGFP2-Orp1, HyPer-3, and SypHer 24 h post transfection. The 
culture medium of 3D7[roGFP2-Orp1] was changed every day for the first 5 days under constant 
drug pressure and after that every other day. For 3D7[HyPer-3] and 3D7[SypHer], 2 nM WR99210 
was added constantly for 5 days and after that during every second medium change. The 
drug concentration was increased to 5 nM after the appearance of transfectants (usually after 
3-4 weeks). After one week, 50 µl fresh RBCs were added to the parasites, and thereafter 
the culture was cut 1:2 every week until the parasites started to grow. 
 
3.3.2 Stable transfection of P. falciparum 
The redox and pH probes were genetically integrated into P. falciparum NF54-attB (a clone 
of the 3D7 strain, also CQ-sensitive) via the attB/attP system of integrative recombination. 
The mycobacteriophage Bxb1 serine integrase mediates site-specific recombination between 
the phage attP site and the attB site in Plasmodium. Trophozoite-stage parasites were 
transferred to fresh RBCs after magnet enrichment (5% hematocrit, 10 ml culture). Around 
15 to 20 h later, 5 ml of culture (ring-stage 8-10 h, 5-8% parasitemia) was centrifuged at 
1,500 rpm for 3 min and the supernatant was discarded. NF54-attB parasites were co-
transfected with the attP plasmid (BSD, blasticidin s deaminase selection marker, confers 
resistance to blasticidin S) encoding the respective construct gene, e.g. roGFP2-Orp1, along 
with the integrase-encoding plasmid pINT (neo, neomycin selection marker, confers 
resistance to geneticin). Integrase-mediated attBxattP-based genomic recombination 
facilitates the insertion of DNA into the genomic attB locus. For each transfection, 50 µg of 
purified DNA with the target gene and 50 µg of purified pINT DNA were mixed and put on ice. 
The parasite pellet was resuspended with an equal volume of sterile cytomix and spun down 
at 1500 rpm, 3 min. Excess cytomix was discarded and the volume remaining was brought 
up with extra cytomix, so that the total volume with DNA would be ≈ 450 µl. The culture was 
resuspended and added to the sterile cup containing DNA (on ice). The parasites were 
transferred from the cup to an electroporation cuvette (2 mm) and electroporated (310 V, 
950 µF, capacitance ∞) with the Bio-Rad Gene Pulser (Crabb et al., 2004). The time constant 
was between 10 and 15 ms. After electroporation the parasites were immediately 
resuspended with 1 ml complete medium and transferred to an already-prepared 15 ml 
conical containing 3.5 ml complete medium and RBCs (4% hematocrit). An additional 1 ml 
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complete medium was added to the cuvette to resuspend the parasites and was transferred 
again to the same conical. Furthermore, the 15 ml conical containing the transfected 
parasites was spun down at 1,500 rpm for 3 min, resuspended in new complete medium (5 
ml) and plated out. The parasites were placed into the incubator for at least 1 h until the 
medium was removed and replaced with fresh complete medium. 24 h after transfection, the 
drugs blasticidin [2.5 µg/ml] and geneticin (G418) [125 µg/ml] were added to the cells to 
select for transfectants for six days. Culture medium was changed every day for the first six 
days and thereafter every other day. On day six post-transfection, 50 µl of fresh RBCs were 
added to the cells, and from day seven onwards only blasticidin was used for selection. 
Between days 10 and 13 the parasites were cut 1:2 and again cut 1:2 every week thereafter 
until parasites appeared. After 3-4 weeks the first transfectants appeared, and after 
determining the integration of the DNA of interest, the selection drug blasticidin was omitted 
for maintenance of the culture. Successful integration of the plasmid was confirmed via PCR 
(Tables 3.34 and 3.35) and agarose gel electrophoresis, and the fluorescence signal was 
checked via confocal laser scanning microscopy (CLSM). General primers for verifying stable 
integration that targeted the non-essential cg6-5´ locus (forward primer) in Plasmodium 
NF54-attB parasites and the bsd locus (reverse primer) of the attP plasmid were used and 
created a PCR product 1.6 kb (NF54-attB) in size (Table 2.7; 2.3.2). If PCR and fluorescence 
microscopy were positive for integration, cloning plates of the so-called bulk cultures were 
prepared in order to obtain a homogenous parasite culture expressing the respective 
construct according to 3.3.3.   
 
Table 3.34 Blood PCR for verifying genomically integrated constructs. 
 
  Construct 
Denaturation  10 min, 95 °C 
Cycles  35 x 
Denaturation  30 sec, 95 °C 
Annealing  45 sec, 54 °C 
Elongation  60 sec/1 kb, 62 °C 
Final elongation  6 min, 62 °C 
Hold  4 °C 
 
Table 3.35 PCR mixture for blood PCR. 
 
 
 
 
 
 
 
 
An overview of the genomic integration method is depicted in Figure 3.5.  
 
Component Volume  
Kappa Blood PCR Mix B 10 µl  
Blood culture  2 µl  
Forward primer (5 µM) 1 µl  
Reverse primer (5 µM) 1 µl  
Autoclaved ddH2O 6 µl  
Final volume 20 µl  
Methods 
 
56 
 
 
Figure 3.5 Site-specific integration in the P. falciparum chromosome mediated by 
mycobacteriophage Bxb1 integrase. (Adapted from Stanislav Gabryszewski) 
 
3.3.3 Preparation of cloning plates for stably transfected parasites 
In order to obtain a genomically and phenotypically homogenous parasite culture of 
integrated redox/pH probes expressing NF54-attB parasites, cloning plates were prepared 
after testing positively for integration (3.3.2). Limiting dilution was employed for cloning with 
0.5 iRBC/well and 0.25 iRBC/well in the presence of uninfected erythrocytes. These platings 
were done in black half-area 96-well microplates with 0.2 ml/well corresponding to 
2.5 iRBCs/ml and 1.25 iRBCs/ml. Cloning was initiated with predominantly ring-stage 
parasites (2-5% parasitemia) and fresh RBCs (≤ 7 days). The following formula was used to 
calculate the number of infected RBCs/ml of culture (this assumed that 1 ml of packed RBCs 
equalled 1010 RBCs):  
 
    A  Hematocrit (h; gives the % value)  
    B  iRBCs/ml  = 1 ∙ 1010  ∙ (
ℎ
100
) ∙  (
𝑝
100
) 
    C Note: given a 4% parasitemia at 2.5% hematocrit, this should result in     
         1·107 iRBCs/ml 
 
All dilutions were made with complete medium containing RBCs at 1.8% hematocrit. In order 
to dilute, the original culture was resuspended thoroughly. 6 µl were transferred into a 15 ml 
Falcon® tube containing 12 ml complete medium and 1.8% RBCs. With this intermediate 
dilution, the volume required to achieve final concentrations of 2.5 iRBCs/ml and 
1.25 iRBCs/ml was calculated and was supposed to be approximately 24 ml for each plate. 
The suspension was thoroughly mixed prior to plating out 200 µl in each well with a 6-well 
dispenser at 37 °C under cell culture conditions. At day 7, 150 µl medium was removed 
without disturbing the cell monolayer and was replaced with 200 µl fresh complete medium 
containing 0.4% fresh RBCs. Clean tips for each pipetting step were used to avoid cross-
contamination of wells, and the plates were further incubated. At day 14, the same procedure 
as on day 7 was repeated. On day 20, parasitized wells were detected by using the SYBR 
Green assay, a method for detecting growth without compromising parasite viability based on 
the detection of parasite DNA (Ekland et al., 2011). 15 µl of 3 x SYBR Green I nucleic acid 
gel stain (10,000 x stock solution) in lysis buffer (20 mM Tris-HCl, 5 mM EDTA, 0.16% w/v 
saponin, and 1.6% v/v Triton X-100) was added to each well of a separate clear 96-well 
plate, and 30 µl of the cloning plate culture were mixed with the fluorescence dye. The plates 
were incubated for 30 min at 37 °C and fluorescence was measured (485 nm excitation, 535 
nm emission filters) with a plate reader (Infinite M200, Tecan). Wells containing parasites 
were discernible by their fluorescence in comparison to a background signal of non-
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parasitized wells. Fluorescence intensity is supposed to correlate with parasitemia; therefore, 
wells with high fluorescence signals were avoided as these appeared to result from initial 
inoculation of a multi-parasitized RBC. Subsequently, blood PCR was performed as 
described in Tables 3.34 and 3.35. Approximately eight positive clones from the 96-well 
cloning plates were picked for PCR, and genomic integration of the constructs was verified 
via agararose gel electrophoresis. At least four positive clones (as determined with blood 
PCR) were transferred into a 2 ml culture the same day at 4% hematocrit and were cultured 
as described above. The parasites were scaled up to 5 ml, and finally to 15 ml culture, in 
order to compare fluorescence signals of the different clones via CLSM. Experiments on 
clones with the best fluorescence signals were performed and selected clones were frozen 
down. 
 
3.4 Biochemical methods 
3.4.1 Protein quantification with the Bradford assay 
The Bio-Rad Protein Assay Kit based on the Bradford dye-binding procedure (Bradford, 
1976) was used for protein quantification. The red dye Coomassie Brilliant Blue G-250 binds 
to basic and aromatic amino acid residues of proteins, which changes its color to blue in 
response to protein concentration and can be colorimetrically measured at 595 nm. First, a 
standard curve was created by using bovine serum albumin (BSA) standard solutions (solved 
in ddH2O) with known concentrations from 0 to 20 µg/ml. To 500 µl of either these standards 
or the sample of interest, 125 µl of the dye was added and incubated for 15 min at RT. 
Absorption was then measured against a blank (500 µl ddH2O + 125 µl Bradford reagent) at 
595 nm with a photometer according to Table 3.36. The standard curve was created by 
plotting the known concentrations of BSA against their absorbance. The concentration of the 
protein sample of interest was determined by interpolating the standard curve using its 
absorbance at 595 nm. 
 
Table 3.36 Pipetting scheme of the Bradford assay. 
 
µl BSA  
[2 mg/ml] µl H2O 
Concentration 
in cuvette 
[µg/ml] 
µl of BSA/ 
sample 
dilution 
µl H2O 
µl Bradford 
reagent  
0 200 0 0 500 125 
10 190 1 5 495 125 
25 175 2.5 5 495 125 
50 150 5 5 495 125 
75 125 7.5 5 495 125 
100 100 10 5 495 125 
150 50 15 5 495 125 
200 0 20 5 495 125 
Sample - - 5 495 125 
 
3.4.2 SDS-polyacrylamide gel electrophoresis 
SDS-PAGE is a common technique to separate proteins according to their molecular weight. 
SDS-PAGE was performed according to Laemmli (1970). Protein samples were mixed with 
1 x SDS sample buffer and heated up to 95 °C for 5 min in order to denature the proteins. 
The samples were loaded in pockets of a 12% SDS polyacrylamide gel and put into a Bio-
Rad electrophoresis apparatus containing electrophoresis buffer. The samples were run at 
200 V for 45 min in order to separate the proteins according to their molecular weight. 
Protein weight was confirmed by using an unstained protein marker. Afterwards, the gel was 
stained using the water-based Coomassie Blue staining system in order to make protein 
bands visible. Briefly, the gel was covered with water, heated for 40 sec in the microwave 
(700 mW), and incubated for 2 min at RT on a rocker. This step was repeated. Then, the gel 
was covered with staining solution, heated for 40 sec in the microwave, and incubated for 
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15 min at RT. The staining solution was discarded, and the gel was washed two times. The 
gel was covered again with water, heated for 40 sec in the microwave, and incubated 10 min 
at RT. For western blot analysis no gel was stained.  
 
3.4.3 Western blot analysis 
Western blot identifies proteins with labeled antibodies that bind specifically to the target 
protein. Semi-dry western blotting (Towbin et al., 1979) was used to confirm the production of 
the redox probes in living parasites, and cell lysates were obtained as described in 3.2.5. 
18 µg of proteins from P. falciparum 3D7 and NF54-attB parasite lysates and 0.2 µg of 
recombinant proteins were separated onto 12% SDS gels as described in 3.4.2 without 
staining and were transferred to a polyvinylidene difluoreide (PVDF) membrane activated 
with methanol (Roth, Karlsruhe, Germany). Five filter papers and the SDS gel were soaked 
in cathode buffer, three filter papers in anode buffer I, and two filter papers along with the 
PVDF membrane in anode buffer II. After 5-15 min of incubation, the five filter papers 
(cathode buffer), the SDS gel, the PVDF membrane, and the two (anode buffer II) and three 
filter papers (anode buffer I) were put quickly onto a cathode graphite plate in their respective 
order without creating air bubbles. The proteins were blotted at 13 V for 30 min. Then, the 
membrane was stained with the Ponceau staining solution (30 sec) and washed with 1% 
acetic acid to check whether the transfer process was successful. After de-staining by 
repeated washing with TBST buffer, non-specific binding sites of the PVDF membrane were 
blocked by 5% non-fat milk in TBST (1 h at RT or overnight at 4 °C). The PVDF membrane 
was washed three times with TBST buffer for 5 min and incubated in TBST buffer containing 
the first antibody mouse α-GFP (1:1,000; Roche) for all used constructs for 1 h at RT on a 
rocker. After three washing steps with TBST buffer (5 min), the second antibody α-mouse 
(1:2,000; Dianova, Hamburg, Germany) was added, and the membrane was further 
incubated for 1 h at RT on a rocker. Additionally, a membrane was probed with α-YFP 
(1:1,000; Evrogen) for HyPer-3/SypHer identification following the secondary antibody α-
rabbit (1:10,000; Dianova, Hamburg, Germany). Thereafter, the membrane was washed 
again three times for 5 min with TBST buffer and immunostained with the 
chemiluminescence mixture (see 2.2.2) for 1 min. Finally, the membrane was exposed to an 
X-ray film for 1 min under appropriate dark room conditions. The film was developed using 
an X-ray film exposure machine. No difference to the membranes probed with the α-GFP 
antibody could be detected in comparison to the α-YFP probed membrane. The α-YFP 
antibody could detect GFP proteins, and the α-GFP antibody could detect YFP proteins. All 
antibodies were diluted in 5% non-fat milk in TBST.  
 
3.5 Biosensor methods 
3.5.1 In vitro fluorescence measurements of recombinant proteins with a plate 
reader 
In order to examine whether the antimalarial drugs used in cell culture interacted directly in 
vitro with the respective probes, fluorescence tests were carried out with the recombinant 
proteins roGFP2-Orp1, HyPer-3, SypHer, and hGrx1-roGFP2. For sfroGFP2, interaction 
studies had already been conducted in the Becker lab. The majority of compounds used for 
interaction studies with hGrx1-roGFP2 had already been examined in the Becker lab and 
presented in Kasozi et al., 2013 and Mohring et al., 2017. Stock solutions of CQ, MB, 2-DG, 
DIA, and DTT were dissolved in ddH2O, while ART, ATS, ATM, QN, MQ, AQ, LUM, Rot, 
ML304, compound 1o, compound S, CEA, and FEA were dissolved in DMSO. All drugs and 
compounds, DIA, DTT, and H2O2 were diluted with either a standard reaction buffer (100 mM 
potassium phosphate, 1 mM EDTA, pH 7.0) or a buffer with 50% v/v DMSO to a final 
concentration of 1 mM and equal concentrations of DMSO in every well and were used 
immediately. DIA (1 mM) and DTT (10 mM) served as controls in all experiments for 
identifying maximal oxidation and reduction, respectively. Before the experiments, the 
reaction buffer was degassed via ultrasound for 1 h at RT. Purified recombinant proteins 
were reduced with 20 mM DTT for 30 min at 4 °C, desalinated (ZebaTM Spin Desalting 
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Columns, Thermo Scientific), and diluted in reaction buffer to a final concentration of 5 µM for 
roGFP2-Orp1, HyPer-3, SypHer and 1.25 µM for hGrx1-roGFP2. Protein concentrations 
were determined according to 3.4.1. A 5-fold drug/redox-active compound dilution (10 µl) 
was mixed with 40 µl of respective recombinant protein concentration in a 96-well microplate 
(black, half-area, Greiner Bio-One, Frickenhausen). Prior to fluorescence measurements via 
plate reader, protein concentration and loading time was optimized. For pH measurements 
with recombinant SypHer and HyPer-3, pH values of the standard potassium buffer were 
varied by adding 2[N-morpholino]ethanesulfonic acid (MES) at 20 mM and potassium 
hydroxide (KOH) to 100 ml buffer in order to lower the pH value. To raise the pH value, 
tris(hydroxymethyl)aminomethane (Tris) at 20 mM and hydrochloric acid (HCl) were added to 
100 ml buffer. The pH values (4.5-9.0) were set with a pH meter. The emission of roGFP2-
Orp1 and hGrx1-roGFP2 (510 nm) after excitation at 390 nm and 480 nm and of HyPer-3 
and SypHer (530 nm) after excitation at 420 nm and 500 nm were measured in a plate 
reader (Infinite M200, Tecan or Clariostar, BMG Labtech) with optimal read settings. Short-
term time course measurements, 4 h and 24 h incubation experiments with compounds, and 
pH measurements were carried out at 25 °C. Between measurements, the samples were 
sealed with a plastic film and kept in the dark at RT. The ratios of the fluorescence signals at 
390/480 nm were calculated for roGFP2-Orp1, and the ratios at 500/420 nm were calculated 
for HyPer-3 and SypHer and plotted against either time, concentration of antimalarial 
drugs/redox active compounds, H2O2, or pH values. For excitation spectrum scans, emission 
was measured at 510 nm for roGFP2-Orp1 and at 530 nm for HyPer-3 after excitation from 
340 to 510 nm and 340 nm to 530 nm, respectively. Data from 2-3 independent experiments 
were analyzed. Means and standard errors of the means (SEM) were calculated with 
Microsoft Excel® (2010); for graphic design, linear regression calculation, and statistical 
purposes, GraphPad Prism 5.0 was used. The dynamic range of the probes was determined 
by dividing the fluorescence ratio caused by DIA by the fluorescence ratio caused by DTT. 
Fluorescence measurements of roGFP2-Orp1, HyPer-3, and SypHer with ART, ATM, ATS, 
CQ, QN, MQ, MB, FEA, CEA, H2O2, and pH were performed by my master student Stine 
Weder (Weder, 2015). 
 
3.5.2 Live-cell imaging of P. falciparum via CLSM 
P. falciparum-infected RBCs (trophozoite stage 26-30 h post invasion) were enriched via 
magnet separation as described in 3.2.3. Cells were kept for at least 1 h in standard culture 
conditions (37 °C, 3% O2, 3% CO2, 96% N2) to regenerate the basal redox status and were 
then washed with pre-warmed (37 °C) Ringer’s solution (122.5 mM NaCl, 5.4 mM KCl, 
1.2 mM CaCl2, 0.8 mM MgCl2, 11 mM D-glucose, 25 mM HEPES, 1 mM NaH2PO4, pH 7.4). 
50 µl of cells (1.0 x 106 cells/50 µl) were seeded either onto poly-L-lysine-coated µ-Slides VI 
for time course experiments or onto poly-L-lysine-coated µ-Slides 18 Well (flat) (Ibidi, 
Martinsried, Germany) for endpoint measurements. A Leica confocal system TCS SP5 
inverted microscope equipped with the objective HCX PL APO 63.0x1.30 GLYC 37 °C UV 
connected to a 37 °C temperature chamber was used. The argon laser power was set to 
20%, and it scanned at a 400 Hz frequency with 512 x 512 pixel resolution. Smart gain and 
smart offset were 950 V and -0.9%, respectively. With a sequential scan, the probes were 
excited at 405 and 488 nm and emissions were detected at 500-550 nm. Laser intensity was 
adjusted to match the full dynamic range of the probes to the dynamic range of the detector 
(roGFP2-Orp1: 405 nm: 12%, 488 nm: 4%; HyPer-3/SypHer: 405 nm: 15%, 488 nm: 4%; 
hGrx1-roGFP2/sfroGFP2: 405 nm: 10%, 488 nm: 4%). For time series, images were 
acquired every 5 s over a time course of 3 min after 15 s of basal measurements. 
Autofluorescence images were simultaneously taken at ex 405 nm/em 430-450 nm and 
individually defined together with the background for every image, but no fluorescence signal 
could be detected. The Leica LAS AF Lite software for fluorescence analysis was used. The 
405/488 nm or 488/405 nm ratios were calculated. The graphs were plotted using GraphPad 
Prism 5 software (San Diego, CA, USA). For image processing, Fiji software (Schindelin et 
al., 2012) was used. Only parasites showing fluorescent signals at both 405 and 488 nm 
excitation and an intact host cell were chosen. For endpoint analysis at least 10-15 
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microscopy images were taken. The laser settings were calibrated with 10 mM DTT for the 
fully reduced or 1 mM DIA for the fully oxidized state (each using 2 min incubations). Due to 
the fluctuations in the basal ratio of single parasites, the ratio values obtained for a time 
course were all normalized to the first basal ratio value, which was set to 100. For endpoint 
experiments, the ratio values were normalized to the control value, which was set to 100. All 
experiments included non-treated parasites as controls, and endpoint experiments both fully 
reduced (10 mM DTT) and fully oxidized (1 mM DIA) parasites (each using 2 min incubations 
prior to measurements). To measure potential effects of the lasers on the redox state of the 
cells, trophozoites were monitored over 3 min without treatment under the same 
experimental conditions and served as a control. In order to investigate the short-term effects 
of compounds on the probes, 50 µl of cells (1.0 x 106 trophozoites) were exposed to the 
respective compound, and the fluorescence signals were monitored over a time course of 3 
min. All experiments with P. falciparum 3D7 parasites (transient transfection) were carried 
out within six to eight weeks after the appearance of transfectants. Each incubation time and 
drug concentration treatment was carried out three times. For each time course, at least 
three parasites were assessed, resulting in at least nine experimental values per data point. 
Endpoint experiments comprise at least 10 parasites, resulting in at least 30 experimental 
values per incubation. A one-way ANOVA test with 95% confidence intervals with the 
Dunnett’s multiple comparison test (GraphPad Prism 5.0) was applied for statistical analysis 
of significance (*, p < 0.05; **, p < 0.01; ***, p < 0.001). 
 
3.5.3 Live-cell imaging of P. falciparum with a fluorescence plate reader  
For 4 h and 24 h experiments, NF54-attB parasites stably expressing the respective probes 
were washed and resuspended after incubation in pre-warmed Ringer’s solution to a 
concentration of 2.0 x 105 iRBCs/µl. 10 µl of cells (1 x 106 iRBCs) were transferred to each 
well of a 384-well plate (black, flat bottom, Greiner Bio-One, Frickenhausen) and were 
measured with the plate reader Clariostar (BMG labtech) with excitation wavelengths at 405 
nm and 475 nm (emission 510 nm). In order to investigate the short-term effects of DIA and 
DTT, 10 µl of cells (1.0 x 106 trophozoites) were exposed to 1 mM of DIA for 2 min to fully 
oxidize the redox probes and subsequently to 10 mM of DTT for 2 min to fully reduce the 
probes. For endpoint measurements, 10 µl of cells (1.0 x 106 trophozoites) were transferred 
to the 384-well plate. The gain of the 405 nm and 475 nm excitation wavelengths was 
adjusted to match the full dynamic range of the redox probes. The 405/475 nm ratio was then 
calculated. The graphs were plotted using the GraphPad Prism 5 software (San Diego, CA, 
USA). A one-way ANOVA test with 95% confidence intervals with the Dunnett’s multiple 
comparison test (GraphPad Prism 5.0) was applied for statistical analysis of significance 
(*, p < 0.05; **, p < 0.01; ***, p < 0.001). 
 
3.5.4 Localization studies using fluorescence methods 
The localization of fluorescence sensor signals in P. falciparum subcellular compartments 
was confirmed by employing immunofluorescence assays (IFAs) according to Tonkin et al. 
(2008) and optimized by Jude Przyborski, Marburg University. 4 ml of cell culture was 
transferred to a 15 ml Falcon® tube and centrifuged for 3 min at 2,100 rpm to harvest 200 µl 
of packed cells. The supernatant was discarded; the pellet was resuspended in 1 ml fixation 
buffer to crosslink protein components and was incubated for 30 min at 37 °C with shaking 
(300 rpm, light exposure). The cells were again centrifuged as described above and were 
resuspended in 1 ml permeabilization/quench buffer to allow antibodies to cross membranes 
and to block free reactive aldehyde groups. After 15 min of incubation at RT (shaking at 
300 rpm), cells were centrifuged and resuspended in 1 ml blocking buffer to block non-
specific interactions. After 1 h of incubation (shaking at 300 rpm) the cells were centrifuged 
for 3 min at 2,100 rpm. The first antibody (α-rabbit PfACP, α-rabbit CDC48, α-rabbit PfCRT 
or α-rabbit PfERC) was diluted 1:500 in blocking buffer and incubated overnight at 4 °C. The 
roGFP2/YFP signal was enhanced by using a GFP antibody (α-chicken) 1:200 in blocking 
buffer. Unbound antibodies were removed by washing three times in PBS for 15 min at RT. 
The second antibody (Cy3 α-rabbit, Cy2 α-chicken) was diluted 1:2,000 in blocking buffer 
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and incubated for 1 h at RT. The cells were washed three times including Hoechst 33258 
1:50,000 in the final wash step. To fixate the parasites, 1% paraformaldehyde was used for 
10 min at RT. The samples were kept at 4 °C under rotation until analysis. For the 
mitochondrial localization study, the parasites were incubated with MitoTracker Orange 
1:100,000 for 10-15 min in RPMI and then washed once with RPMI. Images were taken in 
the lab of Jude Przyborski, Marburg University, with a Zeiss Epi-fluorescence microscope.  
 
3.6 Determining H2O2, drug and pH susceptibility of roGFP2-Orp1, 
HyPer-3 and SypHer in P. falciparum via CLSM 
3.6.1 H2O2 susceptibility of roGFP2-Orp1 and HyPer-3 expressing Pf3D7 
parasites with intact and saponin-lysed RBCs 
H2O2 concentrations of 20 µM, 50 µM, 100 µM, 200 µM, 500 µM, and 1 mM were added to 
3D7[roGFP2-Orp1]- and 3D7[HyPer-3]-transfected parasites in short-term (3 min) time course 
experiments. In the experiment with intact iRBCs, trophozoite-stage parasites (26-30 h) were 
magnetically enriched (Miltenyi Biotec, Germany), counted by using an improved Neubauer 
hemocytometer (Brand GmbH, Germany), and returned to cell culture for at least 1 h to 
recover. The cells were washed once with pre-warmed Ringer’s solution and were 
resuspended in Ringer’s solution with a final parasite concentration of 2.0 x 104 
trophozoites/µl. For every H2O2 concentration, three parasites from three independent 
experiments were analyzed per data point. For experiments with lysed erythrocytes, saponin 
lysis was applied. Briefly, trophozoite-stage parasites (26-30 h) were centrifuged in a 15 ml 
Falcon® tube (5 min, 2,100 rpm, RT). 10 ml of pre-warmed saponin lysis buffer was added to 
the cells and incubated for 10 min in a water bath (37 °C), inverting the tube now and then. 
The parasites were again centrifuged (5 min, 2,100 rpm, RT), resuspended with 5 ml saponin 
lysis buffer, and incubated for 5 min at RT. After another centrifugation step as described 
above, the cells were washed once with pre-warmed Ringer’s solution and resuspended in 
Ringer’s solution with a final parasite concentration of 2.0 x 104 trophozoites/µl. The cells 
were returned to the incubator for 10-15 min to regenerate basal redox state, and 
experiments were performed within 2 h after the end of saponin lysis. All experiments 
included non-treated, fully reduced, and fully oxidized parasites as controls and were carried 
out within six to eight weeks after the appearance of transfectants. For dynamic range time 
courses with DIA and DTT, data from three independent experiments of at least three 
parasites each were analyzed per data point. Means and standard errors of the means 
(SEM) are shown. A one-way ANOVA test with 95% confidence intervals with the Dunnett’s 
multiple comparison test (GraphPad Prism 5.0) was applied for statistical analysis of 
significance (*, p < 0.05; **, p < 0.01; ***, p < 0.001). 
 
3.6.2 Drug susceptibility of redox probes 
The EC50 of antimalarial drugs or compounds on P. falciparum 3D7 asexual blood stages 
was determined either with the [3H]-incorporation assay (Kasozi et al., 2010) or the SYBR 
Green I fluorescence assay according to 3.2.4. For short-term and 4 h experiments, 
trophozoite-stage parasites (26-30 h) of 3D7[roGFP2-Orp1] (6-8% parasitemia) were magnetically 
enriched (Miltenyi Biotec, Germany), counted using the improved Neubauer hemocytometer 
(Brand GmbH, Germany), and returned to cell culture (at 2.0 x 104 trophozoites/µl) for at 
least 1 h to recover. 1.0 x 106 cells in 100 µl cell culture medium were placed into LoBind 
tubes (Eppendorf) for 4 h incubation experiments. The parasites were treated with 
antimalarial drugs at 1 x, 25 x, 50 x, and 100 x EC50 and with the redox-active compounds 
DIA (1 mM) and H2O2 (1 mM) for 4 h under cell culture conditions. Subsequently, free thiol 
groups were blocked with 2 mM N-ethylmaleimide (NEM) for 15 min at 37 °C. For 24 h 
experiments, a 5 ml culture (5% hematocrit, 6-8% parasitemia) of ring-stage parasites (6-
10 h post invasion) was treated with antimalarial drugs at 4 x EC50, DIA (100 µM) and H2O2 
(100 µM). Prior to magnetic enrichment, cysteines were blocked with 2 mM NEM. For short-
term, 4 h, and 24 h experiments, cells were washed after incubation, resuspended in 
Ringer’s solution, and measured in the Leica confocal system TCS SP5 with excitation 
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wavelengths at 405 nm and 488 nm. In order to investigate the short-term effects of 
antimalarial drugs and DIA on 3D7[roGFP2-Orp1]-infected parasites, 50 µl of cells (1.0 x 106 
trophozoites) were challenged with 100 µM of each drug or 1 mM of DIA, and the 
fluorescence signals were monitored over a time course of 3 min. All experiments included 
non-treated parasites as controls as well as both fully reduced and fully oxidized parasites. 
Each incubation time and drug concentration treatment was carried out three times. At least 
nine microscopy images were taken. All experiments were carried out within six weeks after 
the appearance of transfectants. 
 
3.6.3 Determining pH susceptibility of SypHer, HyPer-3, and pHluorin in P. 
falciparum  
For cytosolic pH measurements, Pf3D7 parasites expressing SypHer, HyPer-3, and pHluorin 
were used. Single-cell pH measurements of P. falciparum cytosol were carried out according 
to Kuhn et al. (2007). An in-cell fluorescence calibration curve was generated by using 
sodium-free high potassium buffer (calibration buffer) (160 mM KCl, 1.2 mM CaCl2, 0.8 mM 
MgCl2, 11 mM D-glucose, 25 mM HEPES) of varying pH (4.5-9.0). 200 ml of buffer was 
prepared and 100 ml was acidified or alkalized by adding 4-morpholineethanesulfonic acid 
(MES) or 2-amino-2-hydroxymethyl-propane-1,3-diol (TRIS base). The buffers were merged 
to yield pH calibration buffers ranging from pH 4.5 to 9. After magnet enrichment of 
trophozoites, cells were kept under standard culture conditions for at least 1 h. The parasites 
were washed in Ringer’s solution and centrifuged for 4 min at 3,000 rpm in 1.5 ml LoBind 
tubes. The cell pellets were resuspended in 100 µl of the different potassium-rich calibration 
buffers (1.0 x 106 cells), including one with Ringer’s solution serving as the control. A stock 
solution of 1 mM nigericin in 100% ethanol was prepared and stored at -20 °C. Nigericin is an 
ionophore and leads to rapid equilibration of external and internal pH through an exchange of 
internal K+ for external H+ (Thomas et al., 1979). The cells were incubated with 1 µl nigericin 
(cytosol: final concentration of 4 µM, compartments: final concentration of 10 µM) for 20 min 
at RT, and 488/405 nm ratios for SypHer/HyPer-3 and 405/488 nm ratios for pHluorin were 
subsequently measured via CLSM. The ratios were plotted against pH by using GraphPad 
Prism 5. A trend line was created via exponential (SypHer, HyPer-3) and linear regression 
(pHluorin), and the pH for the respective 488/405 nm or 405/488 nm ratio of the non-
nigericin-treated cells was calculated. 
3.6.4 Determining H2O2 susceptibility of P. falciparum 3D7 transfected with 
roGFP2-Orp1 after priming with stress factors 
To determine whether a pre-incubation with antimalarial drugs and heat shock would 
increase the H2O2 susceptibility of P. falciparum, priming experiments were performed for 
4 h. Trophozoite stages (26-30 h) of 3D7[roGFP2-Orp1]-transfected parasites (6-8% parasitemia) 
were magnetically enriched (Miltenyi Biotec, Germany), counted using the improved 
Neubauer hemocytometer (Brand GmbH, Germany), and returned to cell culture (at 2.0 x 104 
trophozoites/µl) for at least 1 h to recover. 1.0 x 106 cells in 100 µl cell culture medium were 
placed into LoBind tubes (Eppendorf) and were treated in four separate experiments with 
either 50 x EC50 of ART, CQ, and QN or as an additional stress factor with heat shock at 
42 °C for 4 h. After incubation, 50 µl of cells (5.0 x 105 trophozoites) were exposed to varying 
H2O2 concentrations of 20 µM, 50 µM, 100 µM, 200 µM, 500 µM, and 1 mM, and the 
fluorescence signals were monitored over a time course of 3 min. All experiments included 
pre-incubated, non-H2O2-treated parasites as controls. Each experiment and H2O2 
concentration treatment was carried out three times. 
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4 Results 
4.1 In vitro measurements with the plate reader 
4.1.1 In vitro characterization of recombinant roGFP2-Orp1 and HyPer-3  
To analyze the in vitro redox-sensing properties of roGFP2-Orp1 and HyPer-3, excitation 
spectrum scans were performed at RT using a microplate reader (Infinite M200, Tecan). 
5 µM of recombinant proteins previously reduced with DTT were exposed to 1 mM DIA, 10 
mM DTT, and different H2O2 concentrations, which caused concentration-dependent changes 
in the excitation spectra. The recombinant proteins roGFP2-Orp1 and HyPer-3 have two 
excitation maxima at 390 nm and 480 nm (emission at 510 nm), and 420 nm and 500 nm 
(emission at 530 nm), respectively, for the two conformations of the proteins (Figure 4.1A, B). 
Oxidation of roGFP2-Orp1 caused an increase in fluorescence intensity at 500 nm and a 
decrease at 420 nm, whereas oxidation of HyPer-3 led to a decrease in fluorescence 
intensity at 390 nm, while the intensity at 480 nm increased. The redox-active agents DIA 
(1 mM) and DTT (10 mM) were used to completely oxidize and reduce the probes, 
respectively.  
 
 
Figure 4.1 In vitro excitation spectra of recombinant roGFP2-Orp1 and HyPer-3. 5 µM of roGFP2-
Orp1 (A) and HyPer-3 (B) were exposed to 1 mM DIA, 10 mM DTT, and different H2O2 concentrations 
in the Tecan microplate reader, which led to concentration-dependent changes in the excitation 
spectra. The recombinant proteins roGFP2-Orp1 and HyPer-3 have two excitation maxima at 390 nm 
and 480 nm (emission at 510 nm) (A), and 420 nm and 500 nm (emission at 530 nm) (B), respectively. 
(Adapted from Rahbari et al., 2017a) 
 
Furthermore, after 1.5 min of baseline monitoring, recombinant roGFP2-Orp1 and HyPer-3 
were treated with different concentrations of H2O2, 1 mM DIA, or 10 mM DTT, and 
fluorescence ratio changes were monitored for 15 min and plotted against time (Figure 4.2A, 
B). As depicted, DIA oxidized both probes immediately. Adding H2O2 caused concentration-
dependent changes in the fluorescence ratio of both probes. Notably, 5 µM of H2O2 fully 
oxidized roGFP2-Orp1, whereas 20 µM of H2O2 had to be applied in order to fully oxidize 
HyPer-3. To determine the dynamic ranges of recombinant roGFP2-Orp1 and HyPer-3 
proteins with DIA and DTT, the ratios of oxidized and reduced forms of roGFP2-Orp1 and 
HyPer-3 (390 nm/480 nm and 500 nm/420 nm, respectively) were calculated. The dynamic 
range of roGFP2-Orp1 was determined to be 7.2, and HyPer-3’s was 5.0. To examine the 
reversibility of the probes after oxidation, DTT was added to the recombinant proteins, and 
fluorescence intensity was monitored over time. RoGFP2-Orp1 could be reduced with 10 mM 
of DTT within 5 min, whereas 20 mM of DTT and 15 min were needed for HyPer-3 to reach 
the baseline ratio level. Moreover, in vitro measurements showed that air continued oxidizing 
HyPer-3 over time (Figure 4.2B). Detailed in vitro characterizations of roGFP2-Orp1 and 
HyPer-3 can be found in the master thesis of Stine Weder (Weder, 2015).  
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Figure 4.2 In vitro characterization of recombinant roGFP2-Orp1 and HyPer-3. After 1.5 min of 
baseline monitoring, 5 µM of recombinant roGFP2-Orp1 (A) and HyPer-3 (B) were treated with 
different concentrations of H2O2, 1 mM DIA, or 10 mM DTT, and ratio changes were monitored for 15 
min. For each concentration, data from three independent experiments were analyzed per data point. 
Means and standard errors of the means (SEM) are shown. (Adapted from Rahbari et al., 2017a) 
 
4.1.2 Direct interactions of antimalarial drugs and redox-active compounds 
with recombinant roGFP2-Orp1, HyPer-3, and hGrx1-roGFP2  
In vitro interaction studies with the recombinant proteins roGFP2-Orp1 and HyPer-3 with the 
selected antimalarial drugs were performed in order to differentiate between pharmacological 
effects of antimalarial drugs on parasite H2O2 signaling and the direct drug-probe 
interactions. The drugs tested on both sensors included the artemisinins ART, ATM, and 
ATS; the quinoline drugs CQ, QN, and MQ; the redox cycler MB; and the EA derivatives FEA 
and CEA. First, the recombinant proteins were reduced with DTT, and then all compounds 
were tested at concentrations ranging from 1 µM to 1 mM in degassed standard reaction 
buffer for different incubation periods. Tables 4.1 and 4.2 present the effects of the 
compounds on the fluorescence ratios 390/480 nm and 500/420 nm of roGFP2-Orp1 and 
HyPer-3, respectively, as determined in the microplate reader (Infinite M200, Tecan) after 
0 min, 5 min, 4 h, and 24 h incubation at 25 °C. As indicated, even high concentrations (1 
mM) of the compounds ART, ATM, ATS, CQ, QN, and MQ had hardly any effect on the 
fluorescence ratio of roGFP2-Orp1 (Table 4.1) or HyPer-3 (Table 4.2). In comparison, the 
redox cycler MB and the EA derivatives FEA and CEA led to a significant, immediate 
increase in fluorescence ratios of both probes, which was already visible even at the lowest 
concentration of 1 µM. Therefore, these compounds were excluded from cell culture studies. 
Detailed in vitro characterizations of roGFP2-Orp1 and HyPer-3 incubated with the 
antimalarial drugs can be found in the master thesis of Stine Weder (Weder, 2015).  
 
Table 4.1 Effects of antimalarial drugs on the redox ratio of recombinant roGFP2-Orp1. (Rahbari 
et al., 2017a) 
 
Drugs Increase in fluorescence ratio 
a 
Fold change in fluorescence ratio 
b 
[1 mM] 0 min 5 min 4 h 24 h 0 min 5 min 4 h 24 h 
ART  No effect  No effect  0.24  0.39  0.44  0.56  –  – 1.63  1.27  
ATM  No effect  No effect  No effect  No effect  –  –  –  –  
ATS  No effect  No effect  No effect  No effect  –  –  –  –  
CQ No effect  No effect  No effect  No effect  –  –  –  –  
MQ No effect  No effect  No effect  No effect  –  –  –  –  
QN No effect  No effect  No effect  No effect  –  –  –  –  
CEA 0.16  0.54  0.17  0.71  0.24   0.62  0.44  0.60  3.38  4.18  2.58  1.36  
FEA 0.16  0.64  0.17  0.84  0.24   0.61  0.44  0.55  4.00  4.94  2.54  1.25  
MB 0.16  0.73  0.17  1.07  0.24   1.03  0.44  0.95  4.56  6.29  4.29  2.16  
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a 
In this column the absolute change in the fluorescence ratio 390/480 nm of isolated recombinant 
roGFP2-Orp1 after incubation with the antimalarial compounds at 1 mM and at different time points is 
shown. The basal ratio 390/480 nm of recombinant roGFP2-Orp1, which served as the starting point 
for the experiments, is also given.  
b 
In this column the fold change in the fluorescence ratio 390/480 nm of isolated recombinant roGFP2-
Orp1 after incubation with the compounds at given concentrations and time points is shown. 
 
Table 4.2 Effects of antimalarial drugs on the redox ratio of recombinant HyPer-3. (Rahbari et 
al., 2017a) 
 
Drugs Increase in fluorescence ratio 
a 
Fold change in fluorescence ratio 
b
 
[1 mM] 0 min 5 min 4 h 24 h 0 min 5 min 4 h 24 h 
ART  No effect No effect No effect No effect – – – – 
ATM  No effect No effect No effect No effect – – – – 
ATS  No effect No effect No effect No effect – – – – 
CQ No effect No effect No effect 0.71 0.95 – – – 1.34 
MQ No effect No effect No effect No effect – – – – 
QN No effect No effect No effect No effect – – – – 
CEA 0.31  0.47 0.34  0.72 0.46   1.13 0.71  0.89 1.52 2.12 2.46 1.25 
FEA 0.31  0.58 0.34  1.02 0.46  0.93 0.71  0.93 1.87 3.00 2.02 1.31 
MB 0.31  0.44 0.34  0.56 0.46  0.50 0.71  1.14 1.42 1.65 1.08 1.61 
 
a 
In this column the absolute change in the fluorescence ratio 500/420 nm of isolated recombinant 
HyPer-3 after incubation with the antimalarial compounds at 1 mM and different time points is shown. 
The basal ratio 500/420 nm of recombinant HyPer-3, which served as starting point for the 
experiments, is also given. 
b 
In this column the fold change in the fluorescence ratio 500/420 nm of isolated recombinant HyPer-3 
after incubation with the compounds at given concentrations and time points is shown. 
 
Additionally, the drugs AQ, ATQ, LUM, PQ, compound 1o, ML304, compound S, Rot, and 2-
DG were tested on the redox sensor roGFP2-Orp1. All compounds were used at 
concentrations of 10 nM to 1 mM in degassed standard reaction buffer. Purified recombinant 
roGFP2-Orp1 protein was reduced with 20 mM DTT for 30 min at 4 °C, desalinated, and 
diluted in reaction buffer to a final concentration of 5 µM. Figure 4.3 summarizes the effects 
of the above mentioned compounds on the fluorescence ratios 405/480 nm of recombinant 
roGFP2-Orp1 as determined in the Clariostar plate reader (BMG Labtech) in a 5 min time 
course, after 4 h, and after 24 h incubation at 25 °C. As shown, the compounds tested did 
not even have an effect on the fluorescence ratio at the highest concentrations, 1 mM. The 
maximal concentrations used in cell culture in this study were in the lower micromolar range.  
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Figure 4.3 Effects of antimalarial drugs on the reduced roGFP2-Orp1 protein. Recombinant 
roGFP2-Orp1 protein was reduced by 20 mM DTT, desalted, and resuspended in standard reaction 
buffer. The recombinant protein was incubated with 10 nM to 1 mM of AQ, ATQ, LUM, PQ, compound 
1o, ML304, compound S, Rot, and 2-DG. The 405/480 nm ratios were measured with the Clariostar 
plate reader during a 5 min time-course, after 4 h, and after 24 h incubation at RT. The data were 
normalized to the CTL value. In the short-term time course experiments not all the graphs of the 
different concentrations used are clearly visible because they did not show any effect on the redox 
probe and overlap with the CTL values around the ratio of 0.5. 
 
 
For direct interaction studies with the recombinant protein hGrx1-roGFP2, the drugs PQ, 
LUM, compound 1o, ML304, compound S, Rot, and 2-DG were tested. All compounds were 
used at concentrations of 10 nM to 1 mM in degassed standard reaction buffer. Purified 
recombinant hGrx1-roGFP2 protein was reduced with 20 mM DTT for 30 min at 4 °C, 
desalinated, and diluted in reaction buffer to a final concentration of 1.25 µM. Figure 4.4 
summarizes the effects of the aforementioned compounds on the fluorescence ratios 
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405/480 nm of recombinant hGrx1-roGFP2 as determined in the Clariostar plate reader in a 
5 min time course, after 4 h, and after 24 h incubation at 25 °C. As shown, the tested 
compounds did not even have an effect on the fluorescence ratio at the highest 
concentration, 1 mM. The maximal concentrations used in cell culture were in the lower 
micromolar range. 
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Figure 4.4 Effects of antimalarial drugs on the reduced hGrx1-roGFP2 protein. Recombinant 
protein was reduced by 20 mM DTT, desalted, and resuspended in standard reaction buffer. The 
recombinant protein was incubated with 10 nM to 1 mM of PQ, LUM, compound 1o, ML304, Rot, and 
2-DG. The 405/480 nm ratios were measured with the Clariostar plate reader during a 5 min time 
course, after 4 h, and after 24 h incubation at RT. The data were normalized to the CTL value. In the 
short-term time course experiments not all the graphs of the different concentrations used are clearly 
visible because they did not show any effect on the redox probe and overlap with the CTL values 
around the ratio of 0.5. 
 
4.2 Determining cytosolic pH with SypHer and pHluorin 
Due to the pH sensitivity of HyPer-3, the H2O2 insensitive form SypHer, which was reported 
to have similar pH sensitivity (Lukyanov, 2014; Poburko, 2011), was also characterized in 
vitro and in cells. HyPer-3 and SypHer were both successfully expressed in the cytosol of P. 
falciparum (Figure 4.5B). The expression rate in trophozoites enriched with 3D7[HyPer-3]- and 
3D7[SypHer] was only 10%, which is rather low. The in vitro pH-sensing properties of HyPer-3 
and SypHer were investigated with the recombinant proteins in the microplate reader (Infinite 
M200, Tecan). Recombinant HyPer-3 and SypHer were suspended in pH buffers ranging 
from 5.5 to 8.5. SypHer showed the same excitation maxima as HyPer-3 at 420 nm and 
500 nm for the two conformations of the protein (master thesis of Stine Weder; Weder 2015) 
by using a spectral excitation scan (emission 530 nm) as previously reported (Belousov, 
2006; Poburko, 2011). Relative fluorescence units (RFUs) were measured at an emission 
wavelength of 530 nm and the 500/420 nm ratio was calculated. At pH ranging from 4.5 to 
7.5, the fluorescence signal at 420 nm increased, while an increase in pH (> pH 8) shifted the 
fluorescence signal towards the 500 nm peak, confirming its ratiometric properties in 
response to pH. As indicated in Figure 4.5A, HyPer-3 and SypHer both showed an 
exponential relationship between the 500/420 nm ratio and a value from pH of 5.5 to 8.5 in 
vitro (20 min incubation). This was also observed via CLSM (488/405 ratio) for the probes 
targeted to the parasite cytosol (Figure 4.5B). However, HyPer-3 and SypHer had slightly 
different susceptibility to pH changes as indicated by lower fluorescence ratios for SypHer 
measured both in vitro and in-cell. Only between pH 7 and 7.5 did 3D7[SypHer] and 3D7[HyPer-3] 
parasites exhibit the same fluorescence ratio. This makes SypHer in P. falciparum – under 
the given conditions – only suitable as a direct pH control for HyPer-3 in pH ranging from 7.0 
to 7.5. A pH greater than 7.5 seemed to increase the fluorescence ratio of HyPer-3 more 
than that of SypHer, as indicated by in vitro and in-cell data.  
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Figure 4.5 The pH characteristics of HyPer-3 and SypHer measured in vitro and in-cell. (A) 
Recombinant HyPer-3 and SypHer were suspended in pH buffers ranging from pH 5.5 to 8.5. Relative 
fluorescence units (RFUs) were measured at the emission wavelength of 530 nm and the 500/420 nm 
ratio of both proteins was calculated. (B) In parallel, P. falciparum 3D7
[HyPer-3]
- and 3D7
[SypHer]
-
transfected parasites were examined at different pH values and the 488/405 ratio was determined. 
The pH sensitivities of HyPer-3 and SypHer in the parasites were only comparable at pH 7 to 7.5. For 
each pH value measured in vitro with the microplate reader (Tecan), data from three independent 
experiments were included per data point. In living parasites, each data point represents ≥ 24 
trophozoites analyzed in three independent experiments (CLSM). Means and standard errors of the 
means (SEM) are shown. (Rahbari et al., 2017a) 
 
Furthermore, the fluorescence ratio of SypHer starting from pH 7.0 remained constant over 
time in vitro (Figure 4.6A), while the fluorescence ratio of HyPer-3 increased constantly 
(Figure 4.6B). None of the drugs tested on HyPer-3 (excluding directly interacting 
compounds MB, FEA, and CEA) affected the 500 nm/420 nm ratio of SypHer. 
 
Figure 4.6 In vitro time course of SypHer and HyPer-3 at different pH values. Panels (A) and (B) 
show a time course for both sensors at different pH values in vitro. The data indicate that the SypHer 
probe is more stable. For each pH value measured in vitro with the Tecan microplate reader, data 
from three independent experiments were included per data point. Means and standard errors of the 
means (SEM) are shown. (Adapted from Rahbari et al., 2017a) 
 
The cytosolic pH of P. falciparum was determined with SypHer and pHluorin by using the 
high potassium/nigericin calibration method via CLSM. For SypHer, pH calibration curves 
revealed a value of 7.17 ± 0.11 (n = 3). An example of a calibration curve is given in 
Figure 4.7A. As indicated, an exponential relationship exists between the 488/405 ratio of the 
sensor and its pH. The in vitro pH-sensing properties of pHluorin were investigated with the 
isolated recombinant protein with excitation maxima at 390 nm and 480 nm for the two 
conformations of the protein (Mohring et al., 2017). For pHluorin, calibration curves revealed 
a cytosolic pH value of 7.16 ± 0.18 (n = 3) in P. falciparum. An example of a calibration curve 
is given in Figure 4.7B. As indicated, a linear relationship exists between the 405/488 ratio of 
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the sensor and the pH. At a low pH the fluorescence signal at 488 nm was increased, while 
an increase in pH shifted the fluorescence signal towards the 405 nm maximum, confirming 
its ratiometric properties analogously to roGFP.  
 
 
Figure 4.7 Determining the cytosolic pH of P. falciparum 3D7
[SypHer] 
and 3D7
[pHluorin]
 parasites. 
3D7
[SypHer]
 and 3D7
[pHluorin]
 trophozoite-stage parasites were magnetically enriched and maintained at 
least for 1 h in cell culture conditions in order to recover. For calibration, parasites were washed and 
resuspended in pre-warmed sodium-free high potassium buffer with varying pH values. Nigericin was 
added; the mixture was incubated for 20 min at RT; and the 488/405 nm (SypHer) and 405/488 nm 
(pHluorin) ratios of single cells were immediately measured via CLSM. (A) By using calibration curves 
and nonlinear regression with the pH sensor SypHer, the cytosolic pH of P. falciparum 3D7 was 
determined to be 7.17 ± 0.11. (B) For pHluorin, a linear relationship between the 405/488 ratio of the 
sensor and its pH was detected, and the cytosolic pH of P. falciparum 3D7 using pHluorin was 
determined to be 7.16 ± 0.18. Each data point represents ≥ 24 trophozoites analyzed in three 
independent experiments (CLSM). Means and standard errors of the means (SEM) are shown. 
(Adapted from Rahbari et al., 2017a; Mohring et al., 2017) 
 
4.3 Determining EC50 values of P. falciparum 3D7 and NF54-attB 
parasites 
The EC50 of drugs on P. falciparum 3D7 and NF54-attB asexual blood stages was 
investigated by using the [3H]-incorporation and SYBR Green assays, respectively. The 
results are depicted in Tables 4.3 and 4.4. 
 
Table 4.3 EC50 of compounds on P. falciparum 3D7 parasites via the [
3
H]-incorporation assay. 
 
Compound EC50 value Compound EC50 value 
ART 17.3 ± 6.1 nM FEA 94 nM 
ATM 5.9 nM MB 3.3 nM 
ATS 4.4 nM Compound 1o 2.4 ± 0.1 nM 
CQ 8.6 ± 0.4 nM ML304 471.3 ± 39.5 nM 
QN 210 nM Compound S 22.5 ± 2.2 nM 
MQ 8.0 nM Rot 10.7 ± 0.9 µM  
CEA 42 nM 2-DG 3.2 mM 
 
Table 4.4 EC50 of compounds on P. falciparum NF54-attB parasites via the SYBR Green assay. 
 
Compound  EC50 value Compound  EC50 value  
ART 5.7 ± 0.9 nM LUM 10.7 ± 1.8 nM 
ATM 3.4 ± 0.4 nM Compound 1o 5.6 ± 1.5 nM 
ATS 4.2 ± 0.6 nM ML304 1.7 µM 
CQ 6.9 ± 0.8 nM Compound S 83.8 ± 17.3 nM 
QN 66.2 ± 8.2 nM Rot 22.9 ± 6.3 µM 
MQ 23.4 ± 2.8 nM 2-DG 6.7 ± 0.6 mM 
ATQ 
AQ 
0.5 nM 
3.4 ± 0.15 
PQ 8.1 ± 0.2 µM 
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Table 4.5 Concentrations of compounds used in P. falciparum 3D7 experiments. 
 
Compound EC50 value 24 h incubation 
4 x EC50  
4 h incubation 
50 x EC50 
ATS 4 nM 16 nM 200 nM 
CQ 7 nM 28 nM 350 nM 
Compound 1o 5 nM 20 nM 250 nM 
ML304 1 µM (fixed) 10 µM (fixed) 100 µM (fixed) 
Compound S 65 nM  – 3.25 µM 
MQ 10 nM 40 nM 500 nM 
Rot 10 µM (fixed) 10 µM (fixed) 10 µM (fixed) 
2-DG 10 µM (fixed) 10 µM (fixed) 10 µM (fixed) 
 
Table 4.6 Concentrations of compounds used in P. falciparum NF54-attB experiments. 
 
Compound EC50 value 24 h incubation 
10 x EC50  
4 h incubation 
100 x EC50 
ART 6 nM 60 nM 600 nM 
ATM 3.5 nM 35 nM 350 nM 
ATS  4 nM 40 nM 400 nM 
CQ 7 nM 70 nM  700 nM 
QN 66 nM 660 nM 6.6 µM 
MQ 23 nM 230 nM 2.3 µM 
AQ 3.5 nM 35 nM 350 nM 
PQ 1 µM (fixed) 1 µM (fixed) 1 µM (fixed) 
LUM 11 nM 110 nM 1.1 µM 
ATQ 0.5 nM 5 nM 50 nM 
Compound 1o 5 nM 50 nM 500 nM 
ML304 1.3 µM 1 µM/10 µM (fixed) 1 µM/100 µM (fixed) 
Compound S 65 nM 65 nM (fixed) 65 nM (fixed) 
Rot 10 µM (fixed) 10 µM (fixed) 10 µM (fixed) 
2-DG 1 mM 10 µM (fixed) 10 µM (fixed) 
 
4.4 In-cell expression of the roGFP2-Orp1, HyPer-3, SypHer, hGrx1-
roGFP2, and sfroGFP2 probes in P. falciparum 
The redox and pH sensors were cloned under the control of the pfcrt promoter (Crabb et al., 
2004). Parasites in cell culture came up three weeks after episomal and stable transfection. 
Full-length expression of the probes in transfected P. falciparum 3D7 trophozoites was 
analyzed via western blot. The full-length roGFP2-Orp1 (49 kDa), HyPer-3 (52 kDa), SypHer 
(52 kDa), hGrx1-roGFP2 (47 kDa), and sfroGFP2 (27 kDa) probes were clearly detectable at 
the protein level. For roGFP2-Orp1, proteins approximately 27 kDa in size (corresponding to 
roGFP2 without Orp1 and linker sequence) were also observed (Figures 4.8, 4.9, and 4.10), 
which might represent degraded proteins as artifacts upon cell lysis or not fully 
transcribed/translated proteins. Since the probe is ratiometric, absolute levels of intact probe 
are not considered to be crucial as long as the fluorescence signal is strong enough to be 
determined.  
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Figure 4.8 Western blots of 3D7 parasite lysates transfected with roGFP2-Orp1, HyPer-3, and 
SypHer and the corresponding recombinant purified proteins. 0.2 µg of each recombinant purified 
protein was loaded along with 5 µg of parasite lysate expressing HyPer-3 and roGFP2-Orp1, 
respectively. For SypHer, 18 µg of parasite lysate had to be applied because of its low transfection 
rate. Full-length roGFP2-Orp1 (49 kDa), HyPer-3 (52 kDa) and SypHer (52 kDa) probes are 
highlighted. For roGFP2-Orp1, a second band of ≈ 27 kDa was also detected. (Adapted from Rahbari 
et al., 2017a) 
 
 
Figure 4.9 Western blot of NF54-attB (CRT promoter) parasite lysates transfected with roGFP2-
Orp1, HyPer-3, and SypHer and the corresponding recombinant purified proteins. 0.2 µg of each 
recombinant purified protein was loaded along with19 µg of parasite lysate expressing HyPer-3 and 
Mito-roGFP2-Orp1, respectively. For SypHer, 19 µg of parasite lysate had to be applied because of its 
low transfection rate. Full-length Mito-roGFP2-Orp1 (49 kDa), HyPer-3 (52 kDa) and SypHer (52 kDa) 
probes are highlighted. For Mito-roGFP2-Orp1, also a second band of ≈ 27 kDa was also detected.  
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Figure 4.10 Western blots of NF54-attB (CAM promoter) parasite lysates transfected with 
roGFP2-Orp1, HyPer-3, SypHer, roGFP2-Orp1, and Mito-roGFP2-Orp1 and the corresponding 
recombinant purified proteins. 0.2 µg of each recombinant purified protein was loaded along with 
19 µg of parasite lysates. Full-length roGFP2-Orp1/Mito-roGFP2-Orp1 (49 kDa), HyPer-3 (52 kDa), 
and SypHer (52 kDa) probes are highlighted. For roGFP2-Orp1/Mito-roGFP2-Orp1, a second band of 
≈ 27 kDa was also detected (A, B). In A, the roGFP2-Orp1 lane does not represent the total amount of 
19 µg due to spillage of the sample. 
 
 
Figure 4.11 Western blots of NF54-attB (CAM promoter) parasite lysates transfected with 
hGrx1-roGFP2 and sfroGFP2 and the recombinant sfroGFP2 protein. 0.2 µg of recombinant 
purified sfroGFP2 protein was loaded along with 19 µg of parasite lysate expressing hGrx1-roGFP2 
and sfroGFP2, respectively. The full-length hGrx1-roGFP2 (47 kDa) and sfroGFP2 (26 kDa) probes 
are shown. The recombinant hGrx1-roGFP2 is reported in Kasozi et al., 2013. 
 
4.5 In-cell measurements with P. falciparum 3D7 parasites (CLSM) 
4.5.1 Determining of H2O2 effects on P. falciparum 3D7 transfected with 
roGFP2-Orp1 and HyPer-3 
The redox probes roGFP2-Orp1 and HyPer-3 were successfully targeted to the cytosol of P. 
falciparum 3D7. The expression rate in 3D7[roGFP2-Orp1]-enriched trophozoites was 
approximately 60%, whereas only 10% of the enriched trophozoites expressed HyPer-3. This 
led to an assessment of H2O2 susceptibility and dynamic range experiments, however, more 
complex in-cell studies were not carried out with HyPer-3. To measure the effects of H2O2 on 
the redox sensors in the parasites, enriched 3D7[roGFP2-Orp1] (Figure 4.12A) and 3D7[HyPer-3] 
trophozoites (Figure 4.12C) were exposed to H2O2 concentrations ranging from 20 µM to 
1 mM and were monitored for 3 min via CLSM. Only parasites that exhibited fluorescent 
signals at both 405 and 488 nm excitation and with an intact host cell were used for imaging. 
The probes were calibrated with 10 mM DTT or 1 mM DIA for the fully reduced and the fully 
oxidized states (each using 2 min incubations), respectively. To better compare the 
functionality of the two sensors, the ratio values obtained for each time course were all 
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calibrated to the first basal ratio value, which was set to 100. To monitor potential effects of 
the excitation light on the redox state of the cells, trophozoites were imaged for 3 min under 
the same experimental conditions, only without any treatment, and served as controls. Upon 
adding H2O2, both 3D7
[roGFP2-Orp1]- and 3D7[HyPer-3]-transfectants showed a concentration-
dependent increase in the 405/488 nm and 488/405 nm ratios, respectively (Figure 4.12A, 
C), in which 3D7[HyPer-3] exhibited higher H2O2 susceptibility and faster oxidation (within 
seconds) and reduction rates than 3D7[roGFP2-Orp1]. Oxidation of 3D7[roGFP2-Orp1] at 100 µM to 
1 mM H2O2 remained rather constant over time. As determined via microscopy, both probes 
were present only in the parasites’ cytosol. However, after short-term treatment with high 
H2O2 concentrations (≥ 100 μM), the roGFP2-Orp1 and HyPer-3 probes were found to be 
leaking into the erythrocyte cytosol. Additional experiments with isolated parasites (directly 
after saponin lysis of the iRBCs) were carried out (Figure 4.12B, D; Figure 4.13) in order to 
determine the influence of the erythrocyte, which surrounds the parasite and might quench 
H2O2 before it reaches the redox probes. Expsoure of 3D7
[roGFP2-Orp1] iRBCs lysed with 
saponin to different concentrations of H2O2 again showed time- and dose-dependent 
responses in fluorescence ratio measurements (Figure 4.12B); however, 1 mM H2O2 led to a 
faster oxidation of the probe than in parasites within intact RBCs (Figure 4.12A). 
Interestingly, a constant decrease of the fluorescence ratio occurred over time in controls 
and treated parasites, which is most likely due to an H2O2- and light-induced bleaching of the 
probe (Figure 4.12B) (Hoebe et al., 2007). In contrast, 3D7[HyPer-3] parasites after RBC lysis 
exhibited a constant control but in comparison to parasites in intact RBCs (Figure 4.12C) a 
more pronounced increase (1.4 to 1.6-fold) in the 488/405 nm ratio upon addition of 50 µM to 
1 mM H2O2 (Figure 4.12D). Both experimental setups (Figure 4.12B, D) indeed indicate that 
the parasites are more susceptible to H2O2 after removal of the host cell, however, the two 
redox sensors respond differently to the oxidative challenge imposed on host cell-deprived 
parasites. 
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Figure 4.12 Effect of H2O2 on P. falciparum parasites transfected with 3D7
[roGFP2-Orp1]
- and 
3D7
[HyPer-3]
 within intact RBCs and after RBC lysis. After 15 s of baseline monitoring, 3D7
[roGFP2-Orp1]
 
(A) and 3D7
[HyPer-3]
 parasites (C) in intact RBCs as well as 3D7
[roGFP2-Orp1]
 (B) and 3D7
[HyPer-3]
 parasites 
(D) after saponin lysis of their host cells were exposed to H2O2 (20 µM to 1 mM) and monitored for 3 
min via CLSM. For each H2O2 concentration, data from a total of nine trophozoites examined in three 
independent experiments were analyzed per data point. Means and standard errors of the means 
(SEM) are shown. (Rahbari et al., 2017) 
 
 
 
 
 
Figure 4.13  Comparison of 3D7
[roGFP2-Orp1]
 parasites within intact RBCs and 3D7
[roGFP2-Orp1]
 
parasites lysed with saponin.  
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4.5.2 Determining of the dynamic range of roGFP2-Orp1 and HyPer-3 in 
transfected P. falciparum 3D7 parasites 
In order to measure the direct interaction of DIA with roGFP2-Orp1 and HyPer-3 in cells, 
trophozoites (in intact RBCs and RBCs lysed with saponin) that had been enriched with 
3D7[roGFP2-Orp1]- and 3D7[HyPer-3] were exposed to 1 mM DIA and then monitored for 2 min via 
CLSM. Reversibility after DIA treatment was investigated via subsequent treatment with 
10 mM DTT. To measure the presumably completely oxidized and reduced state of the 
probes, the cells were incubated for 2 min with 1 mM DIA or 10 mM DTT, respectively, and 
reactions were blocked thereafter with 2 mM NEM. Pretests with NEM are shown in Figure 
4.14. The dynamic range of the two redox probes expressed in the parasites was calculated 
by dividing the fluorescence ratios of fully oxidized 3D7[roGFP2-Orp1] and 3D7[HyPer-3] by the 
fluorescence ratios of their fully reduced state. As shown in Figure 4.15, 1 mM DIA treatment 
led to a significant increase in the fluorescence ratios of both 3D7[roGFP2-Orp1] (Figure 4.15A, B) 
and 3D7[HyPer-3] transfectants (Figure 4.15C, D). 3D7[roGFP2-Orp1] within intact RBCs exhibited a 
4.8-fold increase and after RBC lysis a 3.4-fold increase in the 405/488 nm ratio (Figure 
4.15B). 3D7[HyPer-3] within intact RBCs showed a 6.6-fold increase, and after RBC lysis a 5.6-
fold increase in the 488/405 nm ratio (Figure 4.15D). Interestingly, roGFP2-Orp1 (Figure 
4.15A) was oxidized more rapidly in the parasites than HyPer-3 (Figure 4.15C), and it 
recovered quickly after adding 10 mM DTT to values below the basal state. The dynamic 
ranges of 3D7[roGFP2-Orp1] parasites within intact RBCs and parasites after RBC lysis were 
determined to be 5 and 5.5, respectively. 3D7[HyPer-3] showed a dynamic range of 7.3 within 
intact RBCs and about 12 after lysis of the host cells (Figure 4.15B, D). 
 
 
 
Figure 4.14 Real-time imaging of P. falciparum 3D7 control parasites transfected with roGFP2-
Orp1 and 2 mM NEM pre-blocked parasites after exposure to DIA. P. falciparum 3D7
[roGFP2-Orp1]
 
enriched trophozoites were distributed to LoBind tubes (1 x 10
6
 iRBCs/100 µl) and incubated with 
100 µM, 500 µM, 1 mM, 2 mM, 5 mM, 10 mM, 15 mM, and 20 mM NEM for 15 min in order to block 
the cysteine SH groups. The parasites were then exposed to 1 mM DIA in order to test the blocking of 
the different NEM concentrations. The 405/488 nm ratio was measured via CLSM. Only the data of the 
2 mM NEM incubation are shown, which was the lowest concentration with a fully protective effect. 
(Rahbari et al., 2017a) 
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Figure 4.15 Dynamic range of roGFP2-Orp1 and HyPer-3 expressed in transfected parasites 
within intact RBCs and after host cell lysis. After 15 s of baseline monitoring, 3D7
[roGFP2-Orp1] 
(A) and 
3D7
[HyPer-3]
 (C) parasites with intact or lysed host cells were exposed to 1 mM DIA and monitored for 
2 min before adding 10 mM DTT via CLSM. The fluorescence ratio (405/488 nm, 3D7
[roGFP2-Orp1] 
and 
488/405 nm, 3D7
[HyPer-3]
) (A, C) at different time points are plotted against time. 3D7
[HyPer-3]
 (C) showed 
higher DIA sensitivity than 3D7
[roGFP2-Orp1]
 (A) in both parasites residing in intact RBCs and those 
deprived of their host cell. Data from at least three trophozoites in three independent experiments 
were analyzed per data point. For measuring the dynamic range of both redox sensors in the 
parasites, the 405/488 nm ratio (3D7
[roGFP2-Orp1]
) (B) and the 488/405 nm ratio (3D7
[HyPer-3]
) (D) of fully 
oxidized and reduced probes were computed. The basal ratio, the ratio for 1 mM DIA, and 10 mM DTT 
(each using 2 min incubations) (n > 27) of three independent experiments are shown. Mean values 
and standard error of the mean (SEM) are shown for all experiments. A one-way ANOVA test with 
95% confidence intervals with the Dunnett’s multiple comparison test was applied for statistical 
analysis of significance (***, p < 0.001). (Rahbari et al., 2017a) 
 
4.5.3 Determining drug effects on P. falciparum 3D7 parasites transfected with 
roGFP2-Orp1 and HyPer-3 
In order to analyze whether antimalarial drugs have an effect on the H2O2 level in P. 
falciparum, short-, medium-, and long-term experiments were performed via CLSM on 
3D7[roGFP2-Orp1]-transfected parasites. Studies with HyPer-3 were no longer included since its 
low expression rate in Plasmodium and its pH sensitivity required time-consuming SypHer 
controls. Figure 4.16 shows the increase in the 405/488 nm fluorescence ratio of 3D7[roGFP2-
Orp1]-enriched trophozoites after short-term treatment (3 min) with high concentrations 
(100 µM) of selected antimalarial drugs. The artemisinins ART, ATM, and ATS and the 
quinolines CQ, QN, and MQ led to an approximately 1.4-fold increase in fluorescence ratio, 
which is similar to an addition of 20 µM H2O2 (Figure 4.12A). The increase induced by MQ 
remained rather constant for the duration of the experiment, while it was transient for all other 
drugs. Control studies excluded a direct interaction of the tested drugs with the purified 
roGFP2-Orp1 probe.  
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Figure 4.16 Short-term effects of antimalarial drugs on the redox ratio of P. falciparum 
3D7
[roGFP2-Orp1]
-transfected parasites. After 15 s of baseline monitoring, the parasites were exposed 
to 100 µM antimalarial drugs and monitored for 3 min via CLSM. After adding all drugs, an increase in 
the 405/488 nm ratio was detected which was more pronounced for the quinolines, particularly MQ. 
Each data point (mean ± SEM) is composed of values from nine trophozoites analyzed in three 
independent experiments. (Rahbari et al., 2017a) 
 
In order to investigate mid-term effects of antimalarial drugs and redox-active compounds on 
roGFP2-Orp1 in living parasites, 3D7[roGFP2-Orp1]-enriched trophozoites were exposed to 1 x, 
25 x, 50 x, and 100 x EC50 of ART, ATM, ATS, QN, CQ, and MQ, incubated for 4 h and 
subsequently were blocked with 2 mM NEM. EC50 values determined in the 72 h 
hypoxanthine incorporation assay were confirmed to be in the known nanomolar range and 
are shown in Table 4.3. For long-term drug exposure experiments (24 h), ring-stage 
parasites were incubated with 4 x EC50 of the drugs. Prior to magnetic enrichment, cysteines 
were blocked with 2 mM NEM. None of the tested drugs showed significant effects on the 
405/488 nm ratio in either 4 h (Table 4.7) or 24 h incubations (Table 4.8). However, trends 
towards oxidation were observed for 4 h incubation with ART, ATM (50 x EC50, 1.31-fold, 
respectively), and MQ (100 x EC50, 1.5-fold) (Table 4.7), and for 24 h incubation with ART 
(1.24-fold) (Table 4.8). 
 
Table 4.7 Effects of antimalarial drugs on the redox ratio of 3D7
[roGFP2-Orp1]
 parasites after 4 h 
incubation. 
 
Drugs Increase in fluorescence ratio
 a
  Fold change in fluorescence ratio 
b
 
CTL 0.35  – 
DIA [1 mM] 1.59  4.50 
H2O2 [1 mM] 0.35  1.00 
 EC50  EC50 
 1 x 25 x 50 x 100 x 1 x 25 x 50 x 100 x 
ART 0.35 0.32 0.46 0.42 0.99 0.92 1.31 1.32 
ATM 0.39 0.39 0.46 0.43 1.13 1.11 1.32 1.23 
ÂTS 0.28 0.27 0.31 0.28 0.79 0.78 0.90 0.79 
CQ 0.27 0.29 0.28 0.34 0.76 0.81 0.79 0.98 
QN 0.33 0.35 0.30 0.33 0.93 0.99 0.85 0.93 
MQ 0.29 0.29 0.34 0.52 0.83 0.84 0.97 1.50 
a 
In this column the absolute change in the fluorescence ratio 405/488 nm of 3D7
[roGFP2-Orp1]
 parasites 
after incubation with the antimalarial drugs and redox-active compounds at given EC50 values is 
shown. The 405/488 nm basal ratio of the control (CTL) is also given.  
b 
In this column the fold change in the fluorescence ratio 405/488 nm of 3D7
[roGFP2-Orp1]
 parasites after 
incubation with the compounds at given EC50 values is shown. The fold change ratios are all 
normalized to the control. 
 
Results 
 
80 
Table 4.8 Effects of antimalarial drugs on the redox ratio of 3D7
[roGFP2-Orp1]
 parasites after 24 h 
incubation. 
 
Drugs Increase in fluorescence ratio
 a
 Fold change in fluorescence ratio 
b
 
CTL 0.37 – 
DIA [100 µM] 0.36 0.97 
H2O2 [100 µM] 0.37 1.00 
 EC50 EC50 
 4 x 4 x 
ART 0.46 1.24 
ATM 0.40 1.08 
ÂTS 0.31 0.84 
CQ 0.31 0.84 
QN 0.35 0.95 
MQ 0.31 0.84 
a 
In this column the absolute change in the fluorescence ratio 405/488 nm of 3D7
[roGFP2-Orp1]
 parasites 
after incubation with the antimalarial drugs and redox-active compounds at 4 x EC50 is shown. The 
405/488 nm basal ratio of the control (CTL) is also given.  
b 
In this column the fold change in the fluorescence ratio 405/488 nm of 3D7
[roGFP2-Orp1]
 parasites after 
incubation with the compounds at 4 x EC50 values is shown. The fold change ratios are all normalized 
to the control. 
 
4.5.4 Determining H2O2 susceptibility of P. falciparum 3D7
[roGFP2-Orp1]-
transfected parasites after priming with antimalarial drugs and heat 
shock  
In order to investigate whether pre-incubation with antimalarial drugs or heat shock affects 
the H2O2 susceptibility of P. falciparum, 3D7
[roGFP2-Orp1] parasites were incubated for 4 h with 
50 x EC50 ART, CQ, or QN, or at 42 °C (Figure 4.17) and then further challenged with 
different concentrations of H2O2 in a time course of 3 min via CLSM. Moreover, the increase 
in fluorescence ratio was corrected for the control (without H2O2) and the non-priming control 
served as a reference experiment. Interestingly, pre-incubating 3D7[roGFP2-Orp1]-enriched 
trophozoites with ART, CQ, or QN led to a slower initial increase in the redox ratio upon 
contact with H2O2 than it did in the control cells. This effect was most pronounced in parasites 
pretreated with QN. After a few seconds, however, a constantly progressing oxidation of the 
probe was observed, which was particularly pronounced in the parasites pretreated with CQ 
and at higher H2O2 concentrations (Figure 4.17A, B, C). In contrast, 20 to 200 µM of H2O2 
had hardly any effect on the 405/488 nm ratio of the sensor in pretreated parasites, where 
only a slight but constant oxidation of the probe could be detected over time. A higher redox 
stress tolerance was also observed in parasites pre-incubated for 4 h at 42 °C (Figure 
4.17D). 
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Figure 4.17 Real-time imaging of the effect of H2O2 on P. falciparum 3D7
[roGFP2-Orp1]
-transfected 
parasites after 4 h pre-incubation with antimalarial compounds and heat shock. 3D7
[roGFP2-Orp1]
 
parasites were exposed for 4 h to 50 x EC50 ART (A), CQ (B), QN (C) or 42 °C (D). After 15 s of basal 
ratio measurements 20 µM to 1 mM H2O2 was added and fluorescence intensity was monitored over 
3 min via CLSM. The increases in 3D7
[roGFP2-Orp1]
 fluorescence ratios (405/488 nm) at different time 
points are plotted against time. Additionally, this ratio increase was corrected for the control in all 
experiments, and the control without stressors (E) served as a reference experiment. Each data point 
(mean ± SEM) is composed of values from nine trophozoites analyzed in three independent 
experiments. (Adapted from Rahbari et al., 2017a) 
4.5.5 Investigating the cytosolic glutathione redox state using 3D7[hGrx1-roGFP2]-
transfected parasites 
In order to study the effect of the novel steroid compound 1o on the glutathione redox state, it 
was tested in cell culture on the P. falciparum 3D7 strain transiently expressing the cytosolic 
glutathione redox sensor hGrx1-roGFP2. No direct interaction was detected for compound 1o 
within the range of 10 nM to 100 µM for the recombinant hGrx1-roGFP2 protein for 4 h and 
Results 
 
82 
24 h incubations (Figure 4.4C). The EC50 of compound 1o used in the P. falciparum 3D7 
experiment was 5 nM (Table 4.5). The effect of compound 1o on P. falciparum was 
investigated in 4 h and 24 h incubations. The parasites were treated with compound 1o at 
50 x, and 100 x EC50, and with MQ as a standard antimalarial drug reference at 1 µM 
(EC50 = 8 nM) (Table 4.3)
 for 4 h under cell culture conditions and subsequently were blocked 
with 2 mM NEM. For 24 h experiments, cells were treated with compound 1o at 4 x, 10 x, 
and 20 x EC50 and with 100 nM MQ. Figure 4.18A shows an approximately 1.5-fold oxidizing 
effect of compound 1o for both 250 nM (50 x EC50) and 500 nM (100 x EC50) on 3D7
[hGrx1-
roGFP2]-enriched parasites after 4 h of incubation, which is comparable to the result of the 
treatment with 1 µM MQ. 24 h incubation (Figure 4.18B) with compound 1o resulted in a 
higher increase in the fluorescence ratio in a concentration-dependent manner. Interestingly, 
20 nM of compound 1o (4 x EC50) exhibited a greater oxidation of the hGrx1-roGFP2 redox 
probe (1.8-fold) than the incubation with the antimalarial drug MQ at 100 nM (1.5-fold). In 
comparison, 100 nM of compound 1o (20 x EC50) led to a 2.4-fold change in fluorescence 
ratio. However, the results failed to reach significance. The effects of clinically used drugs on 
the hGrx1-roGFP2 sensor were previously reported in Kasozi et al., 2013. 
 
 
Figure 4.18 Mid- and long-term effects of compound 1o on the redox ratio of P. falciparum 
3D7
[hGrx1-roGFP2]
 parasites. P. falciparum cells were treated with compound 1o at 50 x and 100 x EC50, 
and 1 µM MQ for 4 h (A). For 24 h incubations (B) cells were treated with compound 1o at 4 x, 10 x, 
and 20 x EC50, and with 100 nM MQ. Free thiols were subsequently blocked with 2 mM NEM. Both 4 h 
and 24 h incubations of 3D7
[hGrx1-roGFP2]
 parasites with compound 1o showed an increase in the 
405/488 nm fluorescence ratio in a concentration-dependent manner. Non-treated parasites served as 
controls. All experiments included fully oxidized (1 mM DIA) and fully reduced (10 mM DTT) parasites 
(each using 2 min incubations) prior to blocking with NEM. Data (mean ± SEM) of three independent 
experiments are shown. A one-way ANOVA test with 95% confidence intervals with the Dunnett´s 
multiple comparison test was applied for statistical analysis of significance (***, p < 0.001) and 
indicated significant changes compared to the respective control. (Adapted from Krieg et al., 2017) 
 
The effects of the G6PDH inhibitor ML304 and its derivative compound S on the glutathione 
homeostasis were tested on P. falciparum 3D7[hGrx1-roGFP2]-transfected parasites. No direct 
interaction was detected for either compounds ranging from 10 nM to 100 µM and the 
recombinant hGrx1-roGFP2 protein during 4 h and 24 h incubations (Figure 4.4D, E). The 
effects of ML304 and compound S on P. falciparum were investigated in 4 h and 24 h 
incubations. The parasites were treated with different concentrations of ML304, compound S 
and the standard antimalarial drugs ATS, CQ, and MQ based on their EC50 values for 4 h 
and 24 h under cell culture conditions and were subsequently blocked with 2 mM NEM. 
Figure 4.19A shows that ML304 and compound S had significant effects at all concentrations 
used in the 4 h incubation experiments. ML304 had an approximately 2.2-fold oxidizing effect 
at 1 µM, and 4.9-fold at both 50 µM and 100 µM that seemed to completely oxidize the 
sensor, which was comparable to treatment with 1 mM DIA. Therefore, higher concentrations 
above 50 µM did not increase oxidation of the probe. Even concentrations in the lower 
nanomolar range of compound S (65 nM) affected the 405/488 nm fluorescence ratio 2.5-fold 
and at 3.25 µM 3.9-fold. The antimalarial drugs ATS, CQ, and MQ hardly affected the 
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405/488 nm ratio at the concentrations used in the experiment. Only MQ at 1 µM increased 
the redox ratio 1.5-fold. Again 24 h incubation (Figure 4.19B) of the parasites with both 
ML304 and compound S significantly affected the fluorescence ratio at all concentrations 
used. 1 µM ML304 led to a 2.7-fold change in fluorescence ratio, which is slightly higher than 
the 4 h incubation. Both 5 µM and 10 µM of ML304 increased the 405/488 nm ratio 4.7-fold, 
which is comparable to the 4 h incubation with 50 µM and 100 µM. Low concentrations of 
65 nM compound S led to a significant 4-fold increase in redox ratio, which is higher than 
with 1 µM ML304. Again, 24 h incubation with ATS, CQ, and MQ hardly affected the 
405/488 nm ratio at the concentrations used in the experiment. Only CQ increased the redox 
ratio 1.5-fold, and 40 nM and 100 nM MQ 1.3-fold and 1.5-fold, respectively.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.19 Mid- and long-term effects of ML304 and its novel derivative compound S on the 
redox ratio of P. falciparum 3D7
[hGrx1-roGFP2]
 parasites. P. falciparum cells were treated with ML304 
at 1 µM, 50 µM, and 100 µM and with compound S at 65 nM and 3.25 µM for 4 h (A). For 24 h 
incubations (B), cells were treated with ML304 at 1 µM, 5 µM and 10 µM and with compound S at 
65 nM. The antimalarial drugs ATS, CQ, and MQ were also tested in both 4 h and 24 h experiments 
as comparison. Free thiols were subsequently blocked with 2 mM NEM. Both 4 h and 24 h incubations 
of 3D7
[hGrx1-roGFP2]
 parasites with ML304 and compound S showed significant increases in the 405/488 
nm fluorescence ratio. Non-treated parasites served as controls. All experiments included fully 
oxidized (1 mM DIA) and fully reduced (10 mM DTT) parasites (each using 2 min incubations) prior to 
blocking with NEM. Data (mean ± SEM) of three independent experiments are shown. A one-way 
ANOVA test with 95% confidence intervals with the Dunnett´s multiple comparison test was applied for 
statistical analysis of significance (*, p < 0.05; **, p < 0.01; ***, p < 0.001) and indicated significant 
changes compared to the respective control.
 
  
The effects of the electron transport chain blocker (ETCB) Rot and the inhibitor of glucose 
metabolism 2-DG on 3D7[hGrx1-roGFP2]- (Figure 4.20A) and 3D7[Mito-roGFP2-hGrx1]- (Figure 4.20B) 
enriched trophozoites were analyzed in 24 h incubation experiments via CLSM. Rot and 2-
DG had an EC50 of 10.7 ± 0.9 µM and 3.2 mM, respectively, against P. falciparum 3D7 in the 
[3H]-hypoxanthine assay (Table 4.3). Direct interaction studies with these compounds and 
the recombinant hGrx1-roGFP2 protein revealed a maximal concentration of 10 μM (Figure 
4.4F, G), which can be used for experiments in cell culture for both Rot and 2-DG for better 
comparison of their effects on glutathione homeostasis. The potential of the combination of 
Rot and 2-DG to enhance oxidative stress was also determined. To test further whether 
treatment with 2-DG and mitochondrial ETCBs enhanced levels of intracellular prooxidants, 
parasites were treated with 10 μM 2-DG for 24 h, and for the last 2 h of treatment, they co-
incubated with 10 μM Rot, and vice versa. In both 3D7[hGrx1-roGFP2] and 3D7[Mito-roGFP2-hGrx1] 
parasites Rot treatment alone resulted in a slight increase in oxidation of the redox probe 
(approx. 1.4-fold) compared to control cells. 2-DG treatment alone also resulted in a slight 
increase of oxidation in 3D7[hGrx1-roGFP2] cells (Figure 4.20A) but led to a significant increase in 
3D7[Mito-roGFP2-hGrx1] parasites (2.2-fold) (Figure 4.20B). Co-incubation of Rot and 2-DG for 24 
h, and treatment with Rot for 24 h and co-incubation with 2-DG during the last 2 h of 
treatment resulted in the same 1.4-fold increase in fluorescence ratio for parasites 
transfected with the cytosolic probe. In comparison, these incubation conditions led to a 2-
fold higher increase in oxidation of the mitochondrial probe. Moreover, 2-DG treatment for 24 
h with Rot added during the last 2 h of incubation, resulted in significant increases in 
oxidation for both the cytosolic and mitochondrial probes (3-fold and 2.6-fold, respectively). 
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Figure 4.20 Long-term incubation (24 h) of 3D7
[hGrx1-roGFP2]
 and 3D7
[Mito-roGFP2-hGrx1]
 parasites with 
Rot and 2-DG. (A) 24 h treatment with ETCB Rot and the glycolysis inhibitor 2-DG at 10 μM increased 
the 405/488 nm ratio of 3D7
[hGrx1-roGFP2]
. 2-DG treatment for 24 h with Rot added during the last 2 h of 
incubation resulted in a significant increase in oxidation. (B) 24 h treatment with ETCB Rot and the 
glycolysis inhibitor 2-DG at 10 μM increased the 405/488 nm ratio of 3D7
[Mito-roGFP2-hGrx1]
. 2-DG 
treatment for 24 h with Rot added during the last 2 h of incubation resulted in a significant increase in 
oxidation. Non-treated parasites served as controls. All experiments included fully oxidized (1 mM 
DIA) and fully reduced (10 mM DTT) parasites (each using 2 min incubations) prior to blocking with 
NEM. Data (mean ± SEM) of three independent experiments are shown. A one-way ANOVA test with 
95% confidence intervals with the Dunnett´s multiple comparison test was applied for statistical 
analysis of significance (*, p < 0.05; **, p < 0.01; ***, p < 0.001) and indicated significant changes 
compared to the respective control. (Adapted from Mohring et al., 2017) 
 
4.6 Targeting roGFP2-Orp1, HyPer-3, and SypHer to subcellular 
compartments of P. falciparum 3D7 parasites 
In order to analyze the H2O2 homeostasis of P. falciparum compartments, probes that had 
signal sequences for their respective organelles cloned into the pARL1a(+) expression vector 
were transfected into P. falciparum 3D7. After three to four weeks of selection with 2 nM 
WR99210, transfectants appeared in cell culture. For IFAs the roGFP2 fluorescence signals 
were enhanced by using α-GFP-antibodies. Co-localization of the sensors with α-ACP 
antibody (Api), α-ERC (a calcium-binding protein residing in the ER) antibody (ER), α-PfCRT 
antibody (DV), MitoTracker Orange (Mito), and Hoechst (nucleus) was investigated via 
fluorescence microscopy. Examples of successful targeting for each compartment are shown 
in Figure 4.21 with one sensor each. By inserting the plasmepsin IV target sequence into 
pARL1a(+), the DV was successfully targeted for each probe, but the fluorescence signals 
were too low to take images. The biosensors were successfully targeted to the ER, but 
fluorescence signals were too low to measure. CLSM of the parasites targeted to the 
different compartments also revealed parasites with cytosolic expression of the respective 
biosensors. This might have been based on some issues during the first transfection of the 
probes. More attempts to transfect the targeted probes were not performed due to the focus 
of studies on the cytosolic probes. In future, transfection of these targeted probes should be 
repeated several times in order to increase the probability of correctly expressed sensors. 
Moreover, CLSM revealed highly oxidized sensors targeted to the ER and DV; for roGFP2-
Orp1, for example, a roGFP2-iX variant or a sfroGFP2-iX variant (higher fluorescence 
intensity of sfroGFP2 than roGFP2) (insertion of amino acid X, (E or L)) with a with midpoint 
potentials of -220 mV to -240 mV, and improved folding in an oxidized milieu would therefore 
be needed.  
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Figure 4.21 Immunofluorescence assays of P. falciparum 3D7
[Mito-roGFP2-Orp1]
, 3D7
[Api-SypHer]
, and 
3D7
[ER-HyPer]
. Fluorescence microscopy of P. falciparum 3D7
[Mito-roGFP2-Orp1]
 shows mitochondrion 
localization; 3D7
[Api-SypHer] 
shows apicoplast localization, and 3D7
[ER-HyPer] 
shows ER localization of the 
target sequences of citrate synthase (CS), apicoplast (ACP) and ER (STEVOR-SDEL). An antibody 
against ACP was used to indicate Api; MitoTracker Orange was used to indicate Mito. Anti-
endoplasmic reticulum-resident calcium-binding protein (ERC) antibody was used to indicate the ER. 
Nuclei were stained with Hoechst 33258.  
 
4.7 Optimizing H2O2 homeostasis imaging via stable integration into 
NF54-attB parasites 
Episomal expression of roGFP2-Orp1 in P. falciparum led to strong fluorescence signals in 
the corresponding parasite compartment; however, only a small percentage of parasites 
carried the plasmid, whereas the majority seemed to acquire resistance to the selection drug 
WR99210. Parasites can only be used for measurements for a short amount of time (eight or 
nine weeks) post transfection due to growing resistance and a loss of fluorescence intensity. 
In order to optimize live-cell imaging of P. falciparum, parasites that stably express H2O2 
biosensors were generated via genomic integration into the NF54-attB strain, which is a 
clone of the 3D7 strain and sensitive to CQ. For stable integration, two different promoters 
were used for expressing the probes in order to check whether the CAM (calmodulin) 
promoter, which is thought to be a strong promoter, has a stronger effect on the expression 
of the inserted constructs than the weak CRT promoter. Only cytosolic roGFP2-Orp1, HyPer-
3, SypHer, and subcellular compartment-targeted Mito-roGFP2-Orp1 could be stably 
expressed with both promoters, but initial microscopic studies (CLSM) did not reveal any 
major difference in expression intensity. Only a subjectively better fluorescence signal could 
be detected by using the CAM promoter. The intensity difference could be still adjusted by 
increasing the laser intensities. Nevertheless, more detailed studies need to be carried out to 
confirm the stronger effect of the CAM promoter on the expression level of the probes. 
Unfortunately, either repeated stable transfections with both promoters of Api-roGFP2-Orp1 
led to cytosolic localization of the probes, or transfected parasites did not even appear after 
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months of cultivation (n > 5). NF54-attB parasites that express genomically integrated 
roGFP2-Orp1 and HyPer-3, as well as SypHer, were directly compared. Due to the fact that 
the fluorescence intensities of genomically integrated HyPer-3 and SypHer were lower than 
that of roGFP2-Orp1, and because of the pH sensitivity of HyPer-3, additional stable 
integration studies were only performed on parasites that express the cytosolic roGFP2-Orp1 
sensor and the mitochondrion-targeted Mito-roGFP2-Orp1 in order to elucidate H2O2 
homeostasis in the NF54-attB strain. Furthermore, a plate reader detection method was 
established for high-throughput screening (see 4.8). The optimal iRBC density for plate 
reader (Clariostar) measurements (trophozoite-stage) in 384-well plates was previously 
investigated in our lab. Cells were counted in a Neubauer improved hemocytometer, and cell 
densities of 0.25 to 2 million cells/well in 10 µl volumes were measured with the Clariostar 
plate reader. Cell densities between 1 and 2 million cells/well showed the best fluorescence 
signals and dynamic ranges of the redox probes, and were henceforth used. However, the 
fluorescence signals of NF54[roGFP2-Orp1], NF54[HyPer-3], and NF54[SypHer] parasites were not high 
enough to get reliable results with the plate reader. Measurements with targeted subcellular 
compartments are and were impossible (NF54[Mito-roGFP2-Orp1]) due to their small size and 
therefore overall low fluorescence intensity.  
 
4.7.1 Stably integrated roGFP2-Orp1 improves detection of H2O2 levels 
In cooperation with the lab of Prof. David Fidock, Columbia University, New York (USA) 
parasites that stably express roGFP2-Orp were generated by using the attB/attP integration 
method (Nkrumah et al., 2006; Adjalley et al., 2010). After transfection and selection of 
positive clones, P. falciparum NF54[roGFP2-Orp1] parasites were analyzed via CLSM and 
compared to transiently transfected 3D7[roGFP2-Orp1] ones (Figure 4.22). Stable integration of 
the biosensor led to fluorescence signals in 100% of the parasites.  
 
 
 
 
Figure 4.22 Comparison of 3D7
[roGFP2-Orp1]
 and NF54
[roGFP2-Orp1]
 parasites. In P. falciparum 
3D7
[roGFP2-Orp1]
 parasites approx. 60% of the parasites expressed the redox sensor roGFP2-Orp1, 
whereas in NF54
[roGFP2-Orp1]
 cells the expression rate was 100%. (Adapted from Rahbari et al., 2017b) 
 
4.7.2 Targeting roGFP2-Orp1 to the cytosol and mitochondrion of P. 
falciparum NF54-attB parasites 
The H2O2 redox sensors roGFP2-Orp1 and Mito-roGFP2-Orp1 were stably transfected into 
the NF54-attB strain (CQ-sensitive) under control of the calmodulin (CAM) promoter by using 
the pDC2-CAM-[X]-BSD-attP plasmid. Following a three to four-week selection with Bsd 
[2.5 µg/ml] (the initial six days with G418 [125 µg/ml] as well), the transfectants were 
detectable in blood smears and showed an expression rate of the roGFP2-Orp1 and Mito-
roGFP2-Orp1 probes of 100%. For targeting the mitochondrion, the signal sequence of 
citrate synthase (CS) was fused to roGFP2-Orp1. The presence of the probes in transfected 
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P. falciparum NF54-attB trophozoites was analyzed by fluorescence microscopy. 
Mitochondrial localization of the sensor was confirmed by using MitoTracker Orange. The 
nucleus was stained with Hoechst 33258. As shown in Figure 4.23A, B, the biosensors were 
successfully targeted to the cytosol and the mitochondrion of the parasite.  
 
 
Figure 4.23 Confirming cytosolic and mitochondrial localization of the roGFP2-Orp1 probe in P. 
falciparum NF54
[roGFP2-Orp1]
 and NF54
[Mito-roGFP2-Orp1]
 parasites, respectively. Fluorescence 
microscopy of P. falciparum NF54
[roGFP2-Orp1]
 parasites shows cytosolic localization (A) and NF54
[Mito-
roGFP2-Orp1]
 shows mitochondrial localization of the target sequence of citrate synthase (CS) (B). As the 
parasite matures, the mitochondrion grows over time and forms a net-like shape. MitoTracker Orange 
was used to indicate the mitochondrion. The nucleus was stained with Hoechst 33258. (Adapted from 
Rahbari et al., 2017b) 
 
In order to measure the completely oxidized and reduced state of the probes, NF54[roGFP2-
Orp1]- and NF54[Mito-roGFP2-Orp1]-enriched trophozoites were incubated for 2 min with 1 mM DIA 
or 10 mM DTT, respectively, reactions were blocked thereafter with 2 mM NEM, and 
monitored via CLSM (Figure 4.24). To calculate the dynamic range of the two redox probes 
in the parasites, the fluorescence ratio of fully oxidized NF54[roGFP2-Orp1]- and NF54[Mito-roGFP2-
Orp1] was divided by the fluorescence ratio of the fully reduced state. As shown in Figure 4.24, 
1 mM DIA treatment led to a significant increase in the fluorescence ratio in both NF54[roGFP2-
Orp1]- and NF54[Mito-roGFP2-Orp1] transfectants. NF54[roGFP2-Orp1] showed a dynamic range of 5.5 
and NF54[Mito-roGFP2-Orp1] a slightly lower dynamic range of 4.5.  
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Figure 4.24 Dynamic range of roGFP2-Orp1 and Mito-roGFP2-Orp1 in transfected NF54-attB 
parasites. NF54-attB parasites transfected with roGFP2-Orp1 or Mito-roGFP2-Orp1 were exposed to 
1 mM DIA or 10 mM DTT for 2 min before blocking with 2 mM NEM. Fluorescence ratios of 
405/488 nm were detected using CLSM. NF54
[roGFP2-Orp1]
 parasites showed a slightly higher DIA 
sensitivity than NF54
[Mito-roGFP2-Orp1]
 parasites. CLSM data were composed of values from at least 10–
20 trophozoites analyzed per experiment. Mean values and standard errors of the means (±SEM) are 
shown for three independent experiments. A one-way ANOVA test with 95% confidence intervals with 
the Dunnett’s Multiple Comparison Test was applied for statistical analysis of significance 
(***p < 0.001). (Adapted from Rahbari et al., 2017b)  
 
4.7.3 Real-time imaging of cytosolic H2O2 homeostasis in NF54
[roGFP2-Orp1] and 
NF54[Mito-roGFP2-Orp1] parasites 
In order to measure the effects of H2O2 on the redox probes in the parasites, enriched 
NF54[roGFP2-Orp1] (Figure 4.25) and NF54[Mito-roGFP2-Orp1] trophozoites (Figure 2B) were exposed 
to H2O2 concentrations ranging from 10 µM to 1 mM and monitored for 3 min via CLSM. For 
live-cell imaging, only parasites that showed fluorescent signals at both 405 and 488 nm 
excitation and resided within an intact host cell were chosen (≥99% of the cells fulfilled these 
requirements). As determined by CLSM, both probes were only present in either the 
parasites’ cytosol (roGFP2-Orp1) or the parasites’ mitochondrion (Mito-roGFP2-Orp1). Upon 
exposure to H2O2, both NF54
[roGFP2-Orp1] and NF54[Mito-roGFP2-Orp1] transfectants showed a 
comparable concentration-dependent increase in the 405/488 nm ratio, in which a mere 10 
µM H2O2 led to an increase in fluorescence ratio (1.5-fold) (Figure 4.25A, B). At 20 µM, H2O2 
seemed to directly oxidize the mitochondrial probe (1.6-fold), which was followed by a 
reduction of H2O2 (Figure 4.25B), whereas the cytosolic probe was oxidized in a slower but 
more pronounced manner (Figure 4.25A). Adding 50 µM and 100 µM H2O2 increased the 
405/488 nm ratio approx. 2 to 2.3-fold for both sensors. While parasites that expressed 
roGFP2-Orp1 were maximally oxidized (up to 2.5-fold) by 200 µM and 500 µM H2O2, a 1.8-
fold increase in fluorescence ratio could be detected for the mitochondrial probe. Exposure to 
1 mM H2O2 led to a similar increase in 405/488 nm ratio for NF54
[Mito-roGFP2-Orp1] transfectants 
(2.0-fold) and for NF54[roGFP2-Orp1] parasites (1.9-fold), in which oxidation remained rather 
constant over time. NF54[Mito-roGFP2-Orp1] parasites exhibited a control (CTL) that remained 
constant over time (Figure 4.25B) in comparison to NF54[roGFP2-Orp1] parasites, which showed 
a 1.3-fold increase in the 405/488 nm ratio over time (Figure 4.25A). NF54[Mito-roGFP2-Orp1] 
showed faster rates of H2O2 reduction as compared with NF54
[roGFP2-Orp1]. However, after 
short-term treatment with high H2O2 concentrations (100 µM and higher), leakage of the 
roGFP2-Orp1 probe into the erythrocyte cytosol became visible (Figure 4.26). 
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Figure 4.25 Effect of H2O2 on P. falciparum NF54
[roGFP2-Orp1]
- and NF54
[Mito-roGFP2-Orp1]
-transfected 
parasites. After 15 s of baseline monitoring, NF54
[roGFP2-Orp1]
 (A) and NF54
[Mito-roGFP2-Orp1]
 parasites (B) 
were exposed to H2O2 (10 µM to 1 mM) and monitored for 3 min via CLSM. Non-treated parasites 
served as controls. NF54
[roGFP2-Orp1]
 and NF54
[Mito-roGFP2-Orp1]
 showed comparable sensitivities towards 
H2O2. For each H2O2 concentration, data from at least nine trophozoites in total, examined in three 
independent experiments, were analyzed per data point. Means and standard errors of the means 
(SEM) are shown. (Adapted from Rahbari et al., 2017b) 
 
In cooperation with the lab of Prof. Georges Grau, Sydney University (Australia), enriched 
NF54[roGFP2-Orp1] trophozoites (26-30 h) exposed to different H2O2 concentrations ranging from 
20 µM to 1 mM were imaged at high-resolution. The fluorescence signals were dynamically 
monitored using z-stacks at a Leica SP8 confocal fluorescence microscope. Deconvolution, 
3D visualization and movie making were performed by using the deconvolution software 
Huygens (Scientific Volume Imaging) and the image processing software Fiji (Schindelin et 
al., 2012). Each frame of the video showing the exposure to 500 µM H2O2 (Figure 4.26) was 
converted into single images for presentation in this work. The first is a steady-state image of 
the first frame of the time series, indicating the basal redox state of the parasites. After 45 s, 
500 µM H2O2 was added to the parasites, and the effects on the green (405 nm) and red 
(488 nm) fluorescence signals became visible. After 2 min, leakage of the parasites became 
detectable, showing a fully oxidized roGFP2-Orp1 sensor gradually leaking into the host cell. 
At 6:45 min, a steady-state image of the last frame of the time series is shown. 
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Figure 4.26 High-resolution imaging of the effects of H2O2 on P. falciparum NF54
[roGFP2-Orp1]
 
parasites over time. Enriched NF54
[roGFP2-Orp1]
 trophozoites (26-30 h) were exposed to 500 µM H2O2 
at the Leica SP8 confocal fluorescence microscope. The fluorescence signals were dynamically 
monitored over time using z-stacks. Each frame of the time series video was converted into single 
images for presentation. (Adapted from Rahbari et al., 2017b, Supplementary Video) 
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4.7.5 Mid- and long-term drug effects on H2O2 homeostasis in NF54
[roGFP2-Orp1] 
and NF54[Mito-roGFP2-Orp1] parasites 
In order to test whether selected antimalarial drugs and redox-active agents can directly 
affect the H2O2 level in the cytosol and mitochondrion of P. falciparum N54-attB parasites, 
mid- and long-term experiments were carried out with NF54[roGFP2-Orp1]- and NF54[Mito-roGFP2-
Orp1]-transfected parasites via CLSM. To measure the completely oxidized and reduced state 
of the probes, magnetically-enriched trophozoites were incubated for 2 min with 1 mM DIA or 
10 mM DTT, respectively, and reactions were blocked thereafter with 2 mM NEM. Control 
studies excluded a direct interaction of the chosen drugs with the purified H2O2 probes. For 
mid-term experiments (4 h), 26-30 h post-invasion trophozoites were incubated with 100 x 
EC50 of ART, ATM, ATS, CQ, QN, MQ, AQ, or LUM, and reactions were subsequently 
blocked with 2 mM NEM. EC50 values for the NF54-attB strain determined using SYBR Green 
assays (Ekland et al., 2011) with minor modifications, were confirmed to be in the known 
nanomolar range and are shown in Table 4.4. Concentrations used for these experiments 
are depicted in Table 4.6. Both ART and ATM increased the 405/488 nm ratio of both probes 
by 2-fold, an increase that was significant with the mitochondrial probe (Figure 4.27A). ATS 
and LUM only oxidized the sensors approximately 1.1- to 1.4-fold, whereas CQ had a 
significant effect on the cytosolic probe (2.6-fold) and hardly any effect on the mitochondrial 
probe (1.2-fold). QN and MQ oxidized NF54[roGFP2-Orp1] parasites only 1.3-fold, but they 
oxidized NF54[Mito-roGFP2-Orp1]-transfected parasites significantly (1.7 to 2.0-fold). AQ affected 
the fluorescence ratio of roGFP2-Orp1 with only a 1.7-fold increase and the ratio of Mito-
roGFP2-Orp1 1.2 times more. For long-term drug exposure experiments (24 h), ring-stage 
parasites were incubated with 10 x EC50 of the aforementioned drugs. Prior to magnetic 
enrichment, cysteines were blocked with 2 mM NEM. None of the tested drugs reached 
statistical significance (Figure 4.27B). However, oxidation of both the cytosolic and 
mitochondrial probes was observed during incubation with all drugs in the range of 2.0 to 3.3-
fold. Interestingly, 24 h incubation with ATM led to a partially cytosolic fluorescence signal of 
the Mito-roGFP2-Orp1 sensor in both the 405 nm and 488 nm channels (Figure 4.27B). DIA 
significantly increased the 405/488 nm ratio of both probes. The CLSM data used 10-20 
trophozoites per experiment for each incubation time. Means and standard errors of the 
means (SEM) are shown for three independent experiments.  
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Figure 4.27 Mid- and long-term effects of ART, ATM, ATS, CQ, QN, MQ, AQ, and LUM on the 
redox ratio of P. falciparum NF54
[roGFP2-Orp1]
- and NF54
[Mito-roGFP2-Orp1]
-transfected parasites. 4 h 
incubation of NF54
[roGFP2-Orp1]
 transfectants with CQ led to a significant increase in fluorescence ratio 
as detected using CLSM. ART, ATM, QN, and MQ significantly oxidized NF54
[Mito-roGFP2-Orp1]
-
transfectants (A). 24 h incubation oxidized both probes but did not lead to a significant increase in the 
405/488 nm ratio (B). DIA led to a significant increase in the fluorescence ratio for both probes. CLSM 
data were obtained from 10-20 trophozoites for each experiment and each incubation time. Mean 
values and standard errors of the means (± SEM) are shown for three independent experiments. A 
one-way ANOVA test with 95% confidence intervals with the Dunnett’s multiple comparison test was 
applied for statistical analysis of significance (*, p < 0.05; **, p < 0.01; ***, p < 0.001). (Adapted from 
Rahbari et al., 2017b) 
 
The phenomenon of cytosolic localization of the Mito-roGFP2-Orp1 probe after 24 h 
incubation with 10 x EC50 ATM, probably due to disruption of the mitochondrial membrane, is 
shown in Figure 4.28. Interestingly, not all of the parasites had a cytosolic localization of the 
biosensor. 
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Figure 4.28 CLSM images of P. falciparum NF54
[Mito-roGFP2-Orp1] 
parasites after 24 h of treatment 
with ATM. CLSM indicates disruption of the mitochondrion after 24 h of treatment with 10 x EC50 ATM 
in some parasites in comparison to CTL and parasites treated with DIA (2 min incubation). 
 
Moreover, the compounds Rot, 2-DG, ATQ, PQ, compound 1o, and ML304 were tested in 
mid- and long-term experiments with NF54[roGFP2-Orp1]- and NF54[Mito-roGFP2-Orp1]-transfected 
parasites via CLSM. Control studies excluded a direct interaction of the selected drugs with 
the purified H2O2 probes. For mid-term experiments (4 h), 26-30 h trophozoites were 
incubated with 100 x EC50 or fixed values of Rot, 2-DG, ATQ, PQ, compound 1o, and ML304, 
and reactions were subsequently blocked with 2 mM NEM. EC50 values for the NF54-attB 
strain are shown in Table 4.4, and the concentrations used for the experiments are depicted 
in Table 4.6. Rot and 2-DG alone led to a 2.1 to 2.5-fold and 1.5-fold increase of 
fluorescence ratio via CLSM, respectively, for both sensors (Figure 4.29A). Combining Rot 
and 2-DG again increased the 405/488 nm ratio for both roGFP2-Orp1 and Mito-roGFP2-
Orp1. ATQ and PQ led to a higher increase in 405/488 nm ratio for the mitochondrial probe 
(1.6 to 2-fold) than for the cytosolic probe (1.2-fold). Compound 1o increased the 
fluorescence ratio of Mito-roGFP2-Orp1 by 2.3 and of roGFP2-Orp1 by 1.6. ML304 
significantly oxidized NF54[roGFP2-Orp1] parasites (2.3-fold), whereas the 405/488 nm ratio of 
NF54[Mito-roGFP2-Orp1] parasites increased by 1.7-fold. Compound S led to an increase in 
fluorescence ratio of the mitochondrial probe by 1.8-fold, whereas the cytosolic probe was 
significantly oxidized by 3-fold. For long-term drug exposure experiments (24 h), ring-stage 
parasites were incubated with 10 x EC50 or fixed concentrations of the compounds Rot, 2-
DG, ATQ, PQ, compound 1o, and ML304 as shown in Table 4.6. Prior to magnetic 
enrichment, cysteines were blocked with 2 mM NEM. Rot, 2-DG, ATQ, and PQ caused a 
higher increase in the 405/488 nm ratio of NF54[Mito-roGFP2-Orp1] parasites (2.0 to 2.5-fold) than 
of NF54[roGFP2-Orp1] parasites (1.0 to 1.5-fold) (Figure 4.29B). Compound 1o had a significant 
effect on the 405/488 nm ratio of Mito-roGFP2-Orp1 (3.4-fold) and increased the 
fluorescence ratio of roGFP2-Orp1 by a factor of 1.8. ML304 increased the 405/488 nm ratio 
of both the cytosolic and the mitochondrial probe (by 2.8-fold), with the increase being 
significant for roGFP2-Orp1. Compound S led to a significant increase in fluorescence ratio 
of both the cytosolic and mitochondrial probes by 3.0-fold. DIA increased the 405/488 nm 
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ratio of both probes significantly. CLSM data are composed of 10-20 trophozoites per 
experiment for each incubation. Means and standard errors of the means (SEM) are shown 
for three independent experiments.  
 
 
Figure 4.29 Mid- and long-term effects of Rot, 2-DG, ATQ, PQ, compound 1o, ML304, and 
compound S on the redox ratio of P. falciparum NF54
[roGFP2-Orp1]
 and NF54
[Mito-roGFP2-Orp1]
-
transfected parasites. 4 h incubation of NF54
[roGFP2-Orp1]
 transfectants with the compounds led to an 
increase of fluorescence ratio for both sensors via CLSM (A). ML304 and compound S in particular 
significantly increased the 405/488 nm ratio of roGFP2-Orp1. 24 h incubations with the drugs seemed 
to have a higher influence on the fluorescence ratio for NF54
[Mito-roGFP2-Orp1]
 transfectants, in which 
compound 1o and compound S significantly increased the mitochondrial probe signal (B). NF54
[roGFP2-
Orp1]
 transfectants were significantly oxidized by ML304 as well as by compound S. CLSM data 
comprises 10-20 trophozoites analyzed per experiment for each incubation. Mean values and 
standard errors of the means (± SEM) are shown for three independent experiments. A one-way 
ANOVA test with 95% confidence intervals with the Dunnett’s multiple comparison test was applied for 
statistical analysis of significance (*, p < 0.05; **, p < 0.01; ***, p < 0.001). (Adapted from Rahbari et 
al., 2017b) 
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4.8 Optimizing glutathione homeostasis imaging via stable integration 
into NF54-attB parasites 
In order to optimize live-cell imaging of the glutathione homeostasis of P. falciparum, 
parasites that stably express cytosolic hGrx1-roGFP2 and sfroGFP2 biosensors were 
generated by genomically integrating them into the NF54-attB strain. Furthermore, 
subcellular compartment-targeted Api-roGFP2-hGrx1 and Mito-roGFP2-hGrx1 were 
transfected into NF54-attB parasites. For stable integration, plasmids with the CRT and the 
CAM promoter were used to express the probes hGrx1-roGFP2, Api-roGFP2-hGrx1, and 
Mito-roGFP2-hGrx1. The sensor sfroGFP2 was only cloned into the pDC2 vector with the 
CAM promoter. Initially, Stanislav Gabryszewski from the lab of David Fidock cloned the 
hGrx1-roGFP2 probe into the pDC2-CAM-X-BSD-attP plasmid and Roman Deniskin from the 
lab of Myles Akabas cloned the sfroGFP2 sensor into the pDC2-CAM-X-BSD-attP plasmid 
(AvrII/XhoI). Stanislav Gabryszewski transfected and successfully expressed both sensors in 
the NF54-attB strain. Cytosolic hGrx1-roGFP2 could be also stably expressed with the CRT 
promoter but the expression intensity was higher with the CAM promoter. Unfortunately, Api-
roGFP2-hGrx1 could only be partly expressed in the apicoplast by using the vector with the 
CRT promoter; in 50% of the parasites, the fluorescence signal was localized in the 
apicoplast, and in the other 50%, the probe was expressed in the cytosol. Nevertheless, it is 
worth trying to generate cloning plates using limited dilutions in order to select parasites that 
express the glutathione probe in the apicoplast. Using the CAM promoter, the Api-roGFP2-
hGrx1 probe was expressed in the cytosol (n > 5). For Mito-roGFP2-hGrx1, either no 
parasites were detectable, not even after two months of cultivation, or only cytosolic 
localization of the sensor was detected with either promoters (n > 5). It might be worth trying 
to target the sensor sfroGFP2 to the apicoplast and the mitochondrion, which might be more 
compatible to the parasites and might lead to higher fluorescence intensities at the same 
time. Furthermore, a plate reader detection method (Clariostar) was established in order to 
increase sample throughput with NF54-attB parasites stably expressing the hGrx1-roGFP2 
and sfroGFP2 sensors with the CAM promoter. Cell densities between 1 and 2 million 
cells/well showed the best fluorescence signals and dynamic ranges of the redox probes and 
were used for plate reader measurements. EC50 values for the NF54-attB strain determined 
using SYBR Green assays (Ekland et al., 2011) are shown in Table 4.4. The concentrations 
used for these experiments are depicted in Table 4.6. 
  
The direct response of NF54[hGrx1-roGFP2] and NF54[sfroGFP2] parasites to oxidation and reduction 
was measured with the Clariostar plate reader. As indicated in Figure 4.30, 1 mM DIA 
immediately led to strong oxidation of both probes. Adding 10 mM DTT again enabled 
complete reduction of the redox sensors. The dynamic range was slightly higher for the 
sfroGFP2 probe, which might be due to higher fluorescence signals. In fact, CLSM data 
showed that NF54[sfroGFP2]-transfected parasites had higher fluorescence intensities compared 
to NF54[hGrx1-roGFP2]-transfected parasites (Figure 4.31). 
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Figure 4.30 Dynamic response of NF54
[hGrx1-roGFP2]
 and NF54
[sfroGFP2]
 parasites to DIA and DTT 
using plate reader detection. P. falciparum NF54
[hGrx1-roGFP2]
 and NF54
[sfroGFP2]
 trophozoite-stage 
parasites were magnetically enriched and maintained at cell conditions for 2 h in order to recover. The 
405/475 nm ratio was measured with the Clariostar plate reader in a 384-well plate under basal 
conditions, and after adding 1 mM DIA and 10 mM DTT.  
 
 
 
Figure 4.31 Comparison of NF54
[hGrx1-roGFP2]
 and NF54
[sfroGFP2]
 parasites. In P. falciparum 
NF54
[sfroGFP2]
 parasites the fluorescence intensity is higher than in NF54
[hGrx1-roGFP2]
 parasites.  
 
In cooperation with the lab of Prof. Georges Grau, Sydney University (Australia), high-
resolution imaging of enriched NF54[hGrx1-roGFP2] trophozoites (26-30 h) exposed to different 
H2O2 concentrations ranging from 20 µM to 1 mM was performed. The fluorescence signals 
were dynamically monitored using z-stacks at a Leica SP8 confocal fluorescence 
microscope. Deconvolution, 3D visualization and movie making were performed using the 
deconvolution software Huygens (Scientific Volume Imaging) and the image processing 
software Fiji (Schindelin et al., 2012). Each frame of the video showing exposure to 500 µM 
H2O2 (Figure 4.32) was converted into single images for presentation in this work. The first is 
a steady-state image of the first frame in the time series, indicating the basal redox state of 
the parasites. After 45 s, 500 µM H2O2 was added to the parasites, and the effects on the 
green (405 nm) and red (488 nm) fluorescence signals became visible. After 2 min, leakage 
of the parasites became detectable showing a fully oxidized hGrx1-roGFP2 sensor gradually 
leaking into the host cell. At 6:32 min, a steady-state image of the last frame of the time 
series is presented. 
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Figure 4.32 High-resolution imaging of the effects of H2O2 on P. falciparum NF54
[hGrx1-roGFP2]
 
parasites over time. Enriched NF54
[hGrx1-roGFP2]
 trophozoites (26-30 h) were exposed to 500 µM H2O2 
at a Leica SP8 confocal fluorescence microscope. The fluorescence signals were dynamically 
monitored over time using z-stacks. Each frame of the time series video was converted into single 
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images for presentation. The brightfield images were inverted in intensity as they were too bright to be 
visualized in normal mode. 
 
4.8.1 Stably integrated hGrx1-roGFP2 improves detection of the glutathione 
redox state 
The applicability of plate reader detection to NF54[hGrx1-roGFP2] parasites was studied in mid- 
and long-term experiments. Cells were incubated with different concentrations of the G6PDH 
inhibitor ML304 for 4 h at trophozoite stage or 24 h at ring-stage, and reactions were 
subsequently blocked with 2 mM NEM. The effects of ML304 on the probe were monitored 
using the Clariostar plate reader. As depicted in Figure 4.33A and B, ML304 oxidized the 
probe in a concentration-dependent manner for both incubation periods. Treatment with 
8.88 µM ML304 for 24 h significantly increased the 405/475 nm fluorescence ratio (3-fold).  
 
Figure 4.33  Mid- and long-term effects of ML304 on the glutathione redox ratio of P. falciparum 
NF54
[hGrx1-roGFP2]
 parasites. 4 h incubation of NF54
[hGrx1-roGFP2]
-transfectants with ML304 led to a 
concentration-dependent increase in fluorescence ratio as detected using the Clariostar plate reader 
(A). 24 h incubation with varying ML304 concentrations led to increases in 405/475 nm fluorescence 
ratios with a significant effect of the highest compound concentration (8.88 µM) (B). Mean values and 
standard errors of the means (± SEM) are shown for three independent experiments. A one-way 
ANOVA test with 95% confidence intervals with Dunnett’s multiple comparison test was applied for 
statistical analysis of significance (**, p < 0.01; ***, p < 0.001).  
 
To analyze the effects of clinically used antimalarial drugs on the glutathione redox ratio of 
NF54[hGrx1-roGFP2] parasites using the plate reader detection method, 4 h incubations with 50 x 
EC50 and 24 h  incubations with 4 x EC50 of the drugs were performed. As shown in Figure 
4.34A no drug affected the 405/475 nm fluorescence ratio of the sensor in 4 h incubations. 
Only 24 h incubation with MQ caused a significant increase in the 405/475 nm ratio of 
NF54[hGrx1-roGFP2] cells (Figure 4.34B). Interestingly, for QN and MQ a decrease in parasitemia 
was observed after 24 h incubations, meaning the minimum cell density of 1 million 
trophozoite-stage cells important for fluorescence signal detection could not be reached. 
Therefore, the increase in oxidation of the glutathione sensor by these drugs is not reliable. 
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Figure 4.34 Mid- and long-term effects of antimalarial drugs at 4 x EC50 (24 h) and 50 x EC50 
(4 h) on the glutathione redox ratio of P. falciparum NF54
[hGrx1-roGFP2]
 parasites. 4 h incubation of 
NF54
[hGrx1-roGFP2]
-transfectants with antimalarial drugs using the Clariostar plate reader did not affect 
the fluorescence ratio of the probe (A). Only MQ led to a significant increase in 405/475 nm 
fluorescence ratio after 24 h of incubation (B). Mean values and standard errors of the means (± SEM) 
are shown for three independent experiments. A one-way ANOVA test with 95% confidence intervals 
with the Dunnett’s multiple comparison test was applied for statistical analysis of significance (***, p < 
0.001). 
 
In order to directly compare microscopic and plate reader-based detection methods and 
evaluate plate reader-based measurements of bulk cell culture as an alternative to single 
live-cell imaging, an aliquot of selected compound-treated cells after 4 h or 24 h was 
analyzed via CLSM, and an aliquot of the same compound-treated incubation was used for 
Clariostar measurement (Figure 4.35). Notably, a comparison of CLSM and Clariostar data 
did not show a consistent increase in the fluorescence ratio. 1 µM and 100 µM of ML304 
significantly increased the 405/488 nm ratio of NF54[hGrx1-roGFP2]-transfectd parasites (2.8-fold 
and 3.9-fold, respectively), whereas 65 nM of compound S was already sufficient for a 
significant effect (2.4-fold) on the probe using CLSM (Figure 4.35A). Using the plate reader 
for fluorescence detection, the effect of 100 µM could not been reproduced (Figure 4.35B).  
24 h treatment of the parasites with 10 µM of ML304 caused a 4.1-fold increase in 
fluorescence ratio detected via CLSM compared to 2-fold using the plate reader (Figure 
4.35C, D). Notably, 20 nM of compound 1o increased the 405/475 nm ratio significantly (4.6-
fold), whereas a higher concentration 50 nM only increased the ratio by 2.8-fold. It should be 
considered that 24 h incubation with compound 1o decreased parasitemia, meaning the 
minimum cell density of 1 million trophozoite-stage parasites could not be reached here 
either. Therefore, the high impact of 20 nM and 50 nM on oxidation of the sensor is 
questionable (Figure 4.35D). 
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 Figure 4.35 Mid- and long-term effects of compound 1o, ML304, and its derivative compound S 
on the glutathione redox ratio of P. falciparum NF54
[hGrx1-roGFP2]
 parasites. 4 h incubation of 
NF54
[hGrx1-roGFP2]
 transfectants with ML304 (1 µM and 100 µM) and compound S (65 nM) significantly 
affected the 405/488 nm fluorescence ratio of the redox sensor when using CLSM (A) and showed no 
effect when using the plate reader (B). 24 h incubation of the parasites with 10 µM of ML304 
significantly affected the 405/488 nm ratio when using CLSM (C) and 20 nM of compound 1o 
significantly affected the 405/475 nm ratio when using the plate reader (D). CLSM data is composed of 
10-20 trophozoites analyzed per experiment for each incubation time point. Mean values and standard 
errors of the means (± SEM) are shown for three independent experiments. A one-way ANOVA test 
with 95% confidence intervals with the Dunnett’s multiple comparison test was applied for statistical 
analysis of significance (*, p < 0.05; **, p < 0.01; ***, p < 0.001).  
 
Due to the fact that no effect of antimalarial drugs on the glutathione redox state of 
NF54[hGrx1-roGFP2]-transfected parasites could be determined with 4 x EC50 (24 h) and 50 x 
EC50 (4 h) drug concentrations when using the plate reader (Figure 4.34), further 
experiments were performed using higher concentrations: 10 x EC50 (24 h) and 100 x EC50 
(4 h) (CLSM and Clariostar). As depicted in Figure 4.36 no drug significanty increased the 
fluorescence ratio of the hGrx1-roGFP2 probe after 4 h incubation when using both CLSM 
and Clariostar detection methods. Only 24 h incubation with MQ caused a significant effect 
on the redox ratio of the probe while using the Clariostar plate reader (Figure 4.36D). Since 
MQ decreased parasitemia after 24 h, and the minimum cell density could not be ensured for 
this detection method, this result is not reliable and is also not consistent with CLSM data 
(Figure 4.36C). The same is true for CQ and QN, which also decreased parasitemia and led 
to an increase in fluorescence ratio, which did not reach significance (Figure 4.36D). 
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Figure 4.36 Mid- and long-term effects of antimalarial drugs at 10 x EC50 (24 h) and 100 x EC50 
(4 h) on the glutathione redox ratio of P. falciparum NF54
[hGrx1-roGFP2]
 parasites. 4 h incubation of 
NF54
[hGrx1-roGFP2]
-transfectants with antimalarial drugs using CLSM and the Clariostar plate reader did 
not affect the fluorescence ratio of the probe (A, B). Only MQ led to a significant increase in the 
405/475 nm fluorescence ratio after 24 h of incubation via plate reader detection (D). Mean values and 
standard errors of the means (± SEM) are shown for three independent experiments. A one-way 
ANOVA test with 95% confidence intervals with the Dunnett’s multiple comparison test was applied for 
statistical analysis of significance (*, p < 0.05; ***, p < 0.001). 
 
4.8.2 Stably integrated sfroGFP2 improves detection of the glutathione redox 
state 
In order to investigate whether the antimalarial drugs and novel compounds have the same 
effect on the redox probes hGrx1-roGFP2 (see 4.8.1) and sfroGFP2 in P. falciparum, mid- 
and long-term experiments were also performed with NF54[sfroGFP2]-transfected parasites at 
the same time as with the aforementioned NF54[hGrx1-roGFP2] strain, using both the CLSM and 
plate reader. An aliquot of selected compound-treated cells afer 4 h or 24 h was analyzed via 
CLSM, and an aliquot of the same compound-treated incubation was used for Clariostar 
measurement (Figure 4.37). Notably, a comparison of CLSM and Clariostar data did not 
show a consistent increase in the fluorescence ratio. 1 µM and 100 µM of ML304 significantly 
increased the 405/488 nm ratio of NF54[sfroGFP2]-transfectd parasites (3.0-fold and 3.4-fold, 
respectively), whereas 65 nM of compound S was already sufficient for a significant effect 
(2.2-fold) on the probe when using CLSM (Figure 4.37A). Using the plate reader for 
fluorescence detection, a 3.4-fold increase of 100 µM could not been reproduced, but it 
nevertheless showed a significant increase of 2.0-fold (Figure 4.37B). 24 h treatment of the 
parasites with 10 µM of ML304 caused a 3.7-fold increase in the fluorescence ratio as 
detected via CLSM compared to a 2.9-fold increase using the plate reader (Figure 4.37C, D). 
50 nM of compound 1o significantly increased both the 405/488 nm and 405/475 nm ratios 
(2.5-fold) using CLSM and plate reader detection (2.7-fold), respectively. The results are 
consistent with the effects observed for hGrx1-roGFP2 (Figure 4.35). 
 
 
Results 
 
102 
Figure 4.37 Mid- and long-term effects of compound 1o, ML304, and its derivative compound S 
on the glutathione redox ratio of P. falciparum NF54
[sfroGFP2]
 parasites. 4 h incubation of 
NF54
[sfroGFP2]
 transfectants with ML304 (1 µM and 100 µM) and compound S (65 nM) significantly 
affected the 405/488 nm fluorescence ratio of the redox sensor when using CLSM (A), whereas 
100 µM of ML304 also showed a significant oxidizing effect on sfroGFP2 when using the plate reader 
(B). 24 h incubation of the parasites with 10 µM of ML304 and 50 nM of compound 1o significantly 
affected the 405/488 nm ratio when using CLSM (C), and 50 nM compound of 1o significantly affected 
the 405/475 nm ratio when using the plate reader (D). CLSM data consists of 10-20 trophozoites 
analyzed per experiment for each incubation time point. Mean values and standard errors of the 
means (± SEM) are shown for three independent experiments. A one-way ANOVA test with 95% 
confidence intervals with Dunnett’s multiple comparison test was applied for statistical analysis of 
significance (*, p < 0.05; **, p < 0.01; ***, p < 0.001).  
 
As shown in Figure 4.34A, no drug affected the 405/475 nm fluorescence ratio of the sensor 
in 4 h incubations. Only 24 h incubation with MQ caused a significant increase in 405/475 nm 
ratio of NF54[hGrx1-roGFP2] cells (Figure 4.34B). Interestingly, for QN and MQ, a decrease in 
parasitemia was observed after 24 h incubations, meaning the minimum cell density of 
1 million trophozoite-stage cells important for fluorescence signal detection could not be 
reached. Therefore, the increase in oxidation of the glutathione sensor by these drugs is not 
reliable. Additional experiments were performed on NF54[sfroGFP2]-transfectants using 10 x 
EC50 (24 h) and 100 x EC50 (4 h) of clinically used antimalarial drugs (CLSM and Clariostar) 
(Figure 4.38) at the same time as experiments on NF54[hGrx1-roGFP2]-transfectants were 
performed (Figure 4.36). As depicted in Figure 4.38, no drug significanty increased the 
fluorescence ratio of the sfroGFP2 probe after 4 h incubation using both CLSM and 
Clariostar detection methods. Only 24 h incubation with MQ caused a significant effect on the 
redox ratio of the probe when using the Clariostar plate reader (Figure 4.38D). Since MQ 
decreased parasitemia after 24 h, and the minimum cell density could not be ensured for this 
detection method, this result is not reliable and is also not consistent with CLSM data either 
(Figure 4.38C). The same is true for CQ and QN, which also decreased parasitemia and led 
to an increase of fluorescence ratio for the latter, yet nonetheless did not reach significance 
(Figure 4.38D). These data are consistent with those obtained for the hGrx1-roGFP2 
biosensor (Figure 4.36). 
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Figure 4.38 Mid- and long-term effects of antimalarial drugs at 10 x EC50 (24 h) and 100 x EC50 
(4 h) on the redox ratio of P. falciparum NF54
[sfroGFP2]
 parasites. 4 h incubation of NF54
[sfroGFP2]
-
transfectants with antimalarial drugs using CLSM and the Clariostar plate reader did not affect the 
fluorescence ratio of the probe (A, B). Only MQ led to a significant increase in the 405/475 nm 
fluorescence ratio after 24 h of incubation via plate reader detection (D). Mean values and standard 
errors of the means (± SEM) are shown for three independent experiments. A one-way ANOVA test 
with 95% confidence intervals with Dunnett’s multiple comparison test was applied for statistical 
analysis of significance (***, p < 0.001). 
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5 Discussion 
5.1 RoGFP2-Orp1 and HyPer-3 as dynamic H2O2 biosensors in P. 
falciparum 3D7 parasites 
H2O2 plays a crucial role in cellular redox signaling; however, neither molecular targets nor 
regulatory mechanisms nor dynamic changes to H2O2-mediated signaling in P. falciparum 
have been described. One pathway to novel drug discovery is to exploit the susceptibility of 
the parasite to oxidative damage (Schirmer et al., 1987) (Figure 5.1). The parasite uses the 
host erythrocyte’s hemoglobin as a major nutrient source and takes it up into the DV for 
degradation into amino acids. This also leads to the production of free heme 
(ferriprotoporphyrin IX, FP IX), which is mostly detoxified by conversion into hemozoin. Small 
amounts of FP IX are released into the cytosol, causing major oxidative damage. Cytosolic 
superoxide dismutase 1 (SOD) catalyzes the conversion of O2
•− released from the oxidation 
of hemoglobin-bound iron, into H2O2. H2O2 can be detoxified by Trx-dependent 
peroxiredoxins or can react with O2
•− through the Fenton reaction to form highly reactive HO• 
that can induce lipid peroxidation and DNA oxidation. Another source of ROS is the ETC of 
the mitochondrion. The parasite lacks the enzymes catalase and glutathione peroxidase, 
indicating that peroxiredoxins are likely to be essential for detoxifying H2O2 (Jortzik and 
Becker, 2012). 
 
 
Figure 5.1 Sources of oxidative stress in P. falciparum. (Jortzik and Becker, 2012) 
 
Genetically encoded fluorescent probes are valuable tools to study H2O2 production in living 
cells of different scales and complexities. In order to analyze H2O2 fluctuations in malaria 
parasites without harming the cells, the redox probes roGFP2-Orp1 and HyPer-3 were 
established in asexual blood stages of transiently transfected P. falciparum 3D7 parasites, 
and their functionality was characterized in vitro and in living cells (via CLSM). These 
sensors offer high specificity, reversibility, subcellular targeting, and transgenic options and 
can be employed as reliable tools with individual strengths to study parasite-host cell 
interactions and mechanisms of drug action. Both roGFP2-Orp1 and HyPer-3 sensors were 
successfully targeted to the cytosol of P. falciparum 3D7 parasites. They showed a rapid, 
dynamic, and ratiometric response in vitro upon oxidation with DIA or H2O2 and reduction 
with DTT (Figure 4.1), which are also reported in cell systems other than Plasmodium (Veal 
et al., 2007; Poburko et al., 2011). Both redox probes are sensitive to sub-micromolar 
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concentrations of H2O2, in vitro and in cells (Gutscher et al., 2009; Belousov et al., 2006). 
Equimolar concentrations of H2O2 oxidized roGFP2-Orp1 (5 µM) (4.7-fold ratio increase), 
whereas 20 µM of H2O2 had to be applied in order to fully oxidize HyPer-3 (5 µM) (3.8-fold 
ratio increase). Both probes were suitable for monitoring low H2O2 concentrations in vitro and 
in cells; however, HyPer-3 seemed better suited for monitoring higher H2O2 concentrations in 
the parasites. The in vitro dynamic range of roGFP2-Orp1 was determined to be 7.2 (Figure 
4.2), which is comparable to a value of 8 reported by Gutscher et al. (2009) but it was only 5 
in cells. A dynamic range of approximately 6 was reported in Drosophila (Albrecht et al., 
2011). For HyPer-3 the in vitro dynamic range (5.0) was similar to the in-cells value (5.5). In 
zebrafish a dynamic range of only 2.5 was reported for HyPer-3 (Bilan et al., 2013). 
RoGFP2-Orp1 could be reduced with 10 mM of DTT within 5 min, whereas 20 mM of DTT 
and 15 min were needed for HyPer-3 to reach the baseline ratio level. The in vitro 
proceeding oxidation of HyPer-3 by air over time showed in Figure 4.2B was also previously 
seen for roGFP2 by Dooley et al. (2004). Therefore, inclusion of controls and/or 
measurements under anaerobic conditions should be considered for further in vitro 
experiments. Under cell culture conditions the sensors are not affected by air due to the well-
buffered cellular environment. Not even high percentages of oxygen (100%) could oxidize 
roGFP2 in the cytoplasm of different cell types (Dooley et al., 2004).  
 
In P. falciparum 3D7 parasites, the biosensor HyPer-3 responded more quickly than roGFP2-
Orp1, which is most likely due to the decelerated reaction between the thiol-disulfide 
exchange of two protein domains in roGFP2-Orp1 compared to the one disulfide bridge 
formation within HyPer-3. The difference in the minimal amount of H2O2 required to fully 
oxidize roGFP2-Orp1 and HyPer-3 in vitro (5 µM and 20 µM, respectively) (Figure 4.2) and in 
living malaria parasites (1 mM) (Figure 4.12) (is likely due to the antioxidant capacity of the 
parasite-host cell unit, including catalase and peroxiredoxins (Fourquet et al., 2008). 
Interestingly, HyPer-3 showed a faster and higher oxidation-reduction rate towards H2O2 than 
roGFP2-Orp1 in Plasmodium 3D7 parasites (Figure 4.1). The Orp1 intramolecular disulfide is 
reduced naturally by the thioredoxin system (TrxS) (consisting of Trx1, Trx reductase, and 
NADPH) (Gutscher et al., 2009). TrxS had been identified to enzymatically reduce OxyR 
under oxidative stress (Wei et al., 2012), although glutaredoxin 1 seems to be the preferred 
reductant of OxyR in cells (Aslund et al., 1999). The oxidation of both probes is also 
reversible in cells, which was shown by adding DTT, which decreased the ratio to the 
baseline redox state by reducing the disulfide bonds (Figure 4.15). This reversibility indicates 
the suitability of both sensors to measure dynamic redox changes in living cells. To analyze 
the extent to which the erythrocytes quench H2O2 before it reaches the parasite, experiments 
were performed after RBC lysis (Figure 4.12). HyPer-3 exhibited a higher dynamic range in 
cells for parasites both with (7.3) and without (12.6) intact RBCs than roGFP2-Orp1 did (5 
and 5.5) (Figure 4.15), which might imply a higher in-cell sensitivity of HyPer-3 to oxidation 
and/or a higher reduction of roGFP2-Orp1 by the efficient TrxS in Plasmodium. Interestingly, 
after short-term treatment with high H2O2 concentrations (≥ 100 μM), leakage of the roGFP2-
Orp1 and HyPer-3 probes into the erythrocyte cytosol could be detected. Due to the pH 
sensitivity of HyPer-3, SypHer has been proposed as a pH control (Lukyanov and Belousov, 
2014). Alkaline pH increased and acidic pH decreased the redox ratio of both probes (Figure 
4.5), which is in line with the results of Poburko et al. (2011). Furthermore, SypHer was 
shown to be insensitive to even 10 mM of H2O2. When monitoring HyPer-3 in vitro over time, 
a slight but constant increase in the fluorescence ratio could be observed at pH > 7.0, which 
questions the use of SypHer as a direct control for certain pH ranges (Figure 4.6). To 
analyze whether pH variations can be determined via SypHer in cells, the probe was 
successfully targeted to the cytosol of P. falciparum 3D7 parasites. PH calibration curves 
were generated for both probes in cells, indicating that only in a pH range of 7.0-7.5 were the 
ratio responses of SypHer and HyPer-3 identical (Figure 4.5). Therefore, SypHer can only be 
used as a direct pH control for HyPer-3 in this pH range. Furthermore, the cytosolic pH of P. 
falciparum 3D7 was determined to be 7.17 ± 0.11 using SypHer and 7.16 ± 0.18 using 
pHluorin as a pH probe (Figure 4.7). These values are highly comparable and previous 
studies by Kuhn et al. (2007) using pHluorin for the cytosol in CQ-resistant and -sensitive P. 
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falciparum parasites support them. In yeast, cytosolic pH determined via pHluorin was 7.5 
(Orij et al., 2009). For HeLa cells the cytosolic pH was determined to be 7.19 by using 
SypHer (Poburko et al., 2011).  
 
5.2 Effects of antimalarial drugs on cytosolic roGFP2-Orp1 and HyPer-3 
in Plasmodium 3D7 parasites 
Live-cell imaging of the episomally expressed H2O2 sensors after short-, mid- and long-term 
antimalarial drug incubations showed that the mode of action of ART, ATM, ATS, CQ, QN, 
and MQ may not be linked to an increase in H2O2 levels. Interestingly, quinolines, especially 
MQ, showed a longer-lasting effect on the redox sensor – a phenomenon that might be worth 
studying in more detail. The tested drugs should be considered not to directly act at the 
cytosol level but mainly at organelle sites such as the DV, which most likely explains the 
results. When using a peroxidase-probe, it is also not possible to differentiate between a lack 
of H2O2 increase and rapid H2O2 reduction by endogenous peroxiredoxins or other electron 
donors. Due to HyPer-3 pH sensitivity and its low transfection rate, complex in-cell drug 
studies were not carried out with this probe. A pH-insensitive version of HyPer-3 would be 
very beneficial for future studies. Pre-incubation with the antimalarial drugs ART, CQ, and 
QN or heat shock at 42 °C for 4 h affected the H2O2 susceptibility of P. falciparum 3D7
[roGFP2-
Orp1] parasites (Figure 4.17). Under all conditions a slower initial increase of the redox ratio 
was observed after H2O2 treatment, which was most pronounced in parasites pretreated with 
QN. The higher tolerance towards exogenous H2O2 after priming with drugs pointing towards 
upregulation of the peroxide defense system (Fourquet et al., 2008; Cox et al., 2010), which 
rapidly reduces H2O2 (Cox et al., 2009; Parsonage et al., 2010; Peskin et al., 2007). As the 
same effect was seen upon heat stress, this might represent a rather general stress-induced 
upregulation of primary defense systems. In bacteria and unicellular eukaryotes, the induced 
expression of detoxifying enzymes in response to H2O2 plays an important role in protecting 
the cell against oxidative damage (Chen et al., 2003; Gasch et al., 2000; Smith et al., 2004; 
Zheng et al., 1998). In yeast cells, induction of antioxidant gene expression in response to 
non-lethal doses of H2O2 allows adaptation and survival after following exposure to usually 
lethal doses of H2O2 (Collinson and Dawes, 1992; Davies et al., 1995; Jamieson, 1998). H2O2 
can be seen as a sensor and alarm preparing the cell to fight against oxidative stress. In 
Plasmodium, the glutathione and thioredoxin system contribute to redox homoeostasis 
(Jortzik and Becker, 2012). So far, no drug with strong effects on the cytosolic H2O2 redox 
state could be found, but many drugs that might be interesting candidates have not been 
investigated yet. The probes used in this study were also targeted to different organelles in 
the parasite in order to determine compartment-specific drug effects, but experimental 
studies could not be carried out due to low transfection rates and weak fluorescence 
intensities of the targeted sensors. Stable integration of redox probes into the genome of P. 
falciparum NF54-attB parasites considerably improved their fluorescence intensities and 
transfection rates, which is discussed in the following sections.  
 
5.3 Optimizing detection of H2O2 levels in P. falciparum 
So far, measurements of the H2O2 level in cytosol and subcellular compartments of P. 
falciparum have been very time consuming since single-+cell microscopy needs to be 
applied and the transfection rate is not really high, varying among the parasites transfected 
with different constructs. Moreover, for subcellular compartments, only a small portion of 
parasites express the redox sensors at a level high enough for detection, which also varies 
among the parasites transfected with different constructs. This amount decreases over time 
due to resistance against the selection drug WR99210. The stable genomic integration of the 
cytosolically expressed roGFP2-Orp1 and the mitochondrially expressed Mito-roGFP2-Orp1 
sensors in asexual blood-stages of P. falciparum NF54-attB parasites drastically improved 
measurements and paved the way for measuring dynamic redox changes induced by H2O2 in 
living Plasmodium parasites in subcellular compartments, while preserving cell integrity. This 
is an advantage over other currently available imaging agents such as Amplex Red (Zhou et 
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al., 1997) or CM-H2DCFDA (Fu et al., 2010), which have serious pitfalls, are prone to 
artefacts, and preclude compartment-specific monitoring of H2O2 dynamics (reviewed in 
Rahbari et al., 2015). Live-cell imaging experiments with the stably expressed sensors (using 
CLSM) showed that they can be employed as reliable tools for studying H2O2 oxidation and 
reduction. The advantages over single-cell imaging via CLSM are the detection of a bulk cell 
population, fast, simultaneous measurements of various drug treatments, and the high 
reproducibility of data. The disadvantages of plate reader detection are the need to 
determine cell densities prior to measurements, the need for large amounts of cells, and the 
inability to physically inspect their condition.  
 
In line with a previous study using transiently expressed roGFP2-Orp1 in P. falciparum 
(Rahbari et al., 2017a), a rapid, dynamic, and ratiometric response of stably transfected 
roGFP2-Orp1 and Mito-roGFP2-Orp1 upon oxidation with DIA or H2O2 and reduction with 
DTT could be observed (Figures 4.24 and 4.25). The dynamic ranges of roGFP2-Orp1 and 
Mito-roGFP2-Orp1 (DIA/DTT) were determined to be 5.5 and 4.5, respectively, which is 
comparable to earlier reports of 5 and 6 in P. falciparum and Drosophila, respectively 
(Rahbari et al., 2017a; Albrecht et al, 2011). Notably, NF54[roGFP2-Orp1] transfectants were 
susceptible to phototoxicity as confirmed via short-term time courses presented as CTL 
(Figure 4.25A) and exhibited an approximately 1.3-fold increase in the 405/488 nm 
fluorescence ratio over time. In contrast, the fluorescence ratio of NF54[Mito-roGFP2-Orp1] 
transfectants remained rather constant over time (Figure 4.25B). Phototoxicity is one of the 
major problems in live-cell imaging, occurring upon illumination of fluorescently labelled cells 
(Kaludercic et al., 2014). This leads to the production of free radicals (Kaludercic et al., 2014) 
and ROS (Dailey et al., 2006) that damage cells. Interestingly, P. falciparum 3D7 parasites 
transiently expressing the cytosolic roGFP2-Orp1 sensor showed a constant control 
regarding the 405/488 nm fluorescence ratio over time. Only parasites deprived of their host 
cell were susceptible to phototoxicity but with the opposite outcome, i.e. the reduction of the 
fluorescence signal (light-induced bleaching) (Figure 4.12B). The mitochondrial inner 
membrane is permeable to H2O2 as the externally added oxidant was able to induce 
immediate changes in the 405/488 nm fluorescence ratio (Figure 4.25B). Notably, already 
low H2O2 concentrations of 10 µM affected both the roGFP2-Orp1 and Mito-roGFP2-Orp1 
probes to the same extent. The leakage phenomenon of the roGFP2-Orp1 sensor into the 
host cell upon adding 500 µM H2O2, as monitored in a high-resolution video, is illustrated 
here in single images (Figure 4.26).   
 
The results of live-cell imaging with the cytosolically and mitochondrially expressed H2O2 
biosensors roGFP2-Orp1 and Mito-roGFP2-Orp1, respectively, in asexual blood-stages of 
stably transfected P. falciparum NF54-attB parasites indicated that the mode of action of 
some antimalarial drugs and some of the novel compounds may be linked to a disturbance of 
H2O2 homeostasis. The overall oxidizing effects of the antimalarial drugs ART, ATM, ATS, 
CQ, QN, MQ, AQ, and LUM depicted in Figure 4.27 appeared to be more pronounced 
(although with higher variability between single cells) after 24 h of incubation (10 x EC50) than 
after 4 h (100 x EC50), indicating that long exposure to a drug increases its impact on the 
H2O2 level. ART and ATM led to significant increases (2-fold) in the 405/488 nm fluorescence 
ratio of the mitochondrial Mito-roGFP2-Orp1 probe after 4 h incubation (Figure 4.27A). 
Longer (24 h) incubations of these drugs led to more pronounced increases in the ratio (3-
fold), but these did not reach significance (Figure 4.27B). Notably, after 24 h incubation with 
ATM, a partially cytosolic expression of the mitochondrial probe was observed in the 405 nm 
and 488 nm channels, indicating putative disruption of the mitochondrion and leakage of the 
probe into the cytosol of the parasite (Figure 4.28). This phenomenon was also observed 
recently with the mitochondrial glutathione probe Mito-roGFP2-hGrx1 and ART in P. 
falciparum 3D7 parasites (Mohring et al., 2017) (Franziska Mohring, pers. comm.) and might 
be worth studying in more detail. These data are consistent with the leakage of the cytosolic 
probe roGFP2-Orp1 in P. falciparum 3D7 transfectants into the host cell upon exposure to 
high H2O2 concentrations (100 µM to 1 mM). Among the quinolines CQ, QN, MQ, and AQ, 
only CQ significantly increased the ratio of roGFP2-Orp1 during a 4 h treatment, whereas a 
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significant ratio increase of Mito-roGFP2-Orp1 was detected with QN and MQ (Figure 4.27A). 
Rot and 2-DG increased intracellular H2O2 levels; however, the effects failed to be 
statistically significant. Similar studies with these compounds have already been performed 
on P. falciparum 3D7 parasites transiently expressing the glutathione redox sensors hGrx1-
roGFP2 and Mito-roGFP2-hGrx1 in the cytosol and the mitochondrion, respectively. 
Significant disruption of intercellular thiol metabolism by 2-DG in the mitochondrion and by 
the combination of 2-DG and Rot using both cytosolic and mitochondrial probes was 
determined (Mohring et al., 2017). ATQ and PQ hardly affected cytosolic H2O2 levels in 4 h 
incubations but increased mitochondrial H2O2 levels 2-fold and 1.8-fold, respectively (Figure 
4.29A). Longer (24 h) treatments with ATQ and PQ again affected roGFP2-Orp1 only slightly 
but increased the fluorescence ratio of Mito-roGFP2-Orp1 2.5-fold and 8-fold, respectively. 
These results are consistent with the putative mechanisms of action of both ATQ and PQ 
through targeting the mitochondrion and thereby increasing oxidative stress. The steroid 
compound 1o increased both cytosolic and mitochondrial H2O2 levels in 4 h and 24 h 
incubation experiments, with a significant effect on Mito-roGFP2-Orp1 after 24 h (Figure 
4.29A, B). These findings suggest a putative impact of compound 1o on mitochondrial 
metabolism, leading to increasing H2O2 levels, a phenomenon that merits further analysis. 
G6PD is a novel target for antimalarial drug design, based on observations that G6PD 
deficiency in humans protects the carrier from malaria infections (Cappellini and Fiorelli, 
2008). In this study, inhibiting cytosolic PfGluPho by 1 µM ML304 led to a signifcant increase 
in the fluorescence ratio (2.3-fold) of the cytosolic roGFP2-Orp1 sensor in 4 h experiments 
(Figure 4.29), indicating its impact on H2O2 homeostasis in the cytosol. Following 24 h 
treatment the effect of ML304 on the 405/488 nm ratio of cytosolic roGFP2-Orp1 is more 
pronounced (2.8-fold) and reached significance (Figure 4.29B). In comparison, ML304 
affected the fluorescence ratio of the mitochondrial probe only by 1.8-fold in 4 h experiments. 
In 24 h incubations, ML304 also increased the 405/488 nm ratio of the Mito-roGFP2-Orp1 by 
2.8-fold, to the same extent as the cytosolic probe, but this change failed to reach 
significance. Compound S, a derivative of ML304 led to significant increases in fluorescence 
ratio of both the cytosolic and mitochondrial probe already at 65 nM in 24 h incubations and 
of the cytosolic probe in 4 h incubations, which makes it a potent novel agent for killing 
Plasmodium. Overall, all the drugs tested here affected H2O2 efflux either in the cytosol, the 
mitochondrion, or both compartments of P. falciparum NF54-attB parasites in 4 h and 24 h 
incubation experiments. It should be, however, also considered that not all of the tested 
drugs directly act at the cytosol or mitochondrion levels that might account for the obtained 
non-significant effects. 
 
5.4 Effects of novel compounds on hGrx1-roGFP2 expressing P. 
falciparum 3D7 parasites 
Studies employing the cytosolic glutathione redox sensor hGrx1-roGFP2 transiently 
expressed in P. falciparum 3D7 parasites supported the antiparasitic effect of compound 1o 
(Krieg et al., 2017). Incubation with subnanomolar concentrations of compound 1o led to a 
dose-dependent increase in the redox ratio indicating oxidation and alterations in the 
intracellular redox potential (Figure 4.18). Although the results failed to reach significance, 
they indicate a trend towards oxidation. Therefore, the influence of compound 1o on 
glutathione redox homeostasis should be studied in more detail. The effects of the G6PDH 
inhibitor ML304 (Preuss et al., 2012) and its derivative compound S on glutathione 
homeostasis reached significance at all concentrations used in 4 h and 24 h incubation 
experiments (Figure 4.19A). As little as 1 µM of ML304 oxidized the sensor significantly, 
50 µM completely (compared to DIA). However, it should be considered that concentrations 
< 50 µM might also have oxidized the sensor completely since 100 µM of ML304 did not lead 
to a further increase in oxidation. Long-term treatment with 5 µM of ML304 completely 
oxidized the sensor. The derivative compound S improved the oxidative effect of ML304 by 
increasing oxidative stress starting at subnanomolar concentrations (65 nM) in 4 h and 24 h 
incubations, whereas the clinically used drugs ATS, CQ, and MQ hardly affected the 
405/488 nm ratio at the concentrations used in the experiment (Figure 4.19A, B). Therefore, 
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compound S seemed to be a potent novel agent for killing Plasmodium and should be 
studied in more detail. Long-term incubations of 3D7[hGrx1-roGFP2] and 3D7[Mito-roGFP2-hGrx1] with 
the experimental agent Rot significantly enhanced the oxidizing effect of 2-DG (Figure 4.20). 
In line with a previous report for human cancer cells using higher compound concentrations, 
the parasites were more susceptible to inhibition of glucose metabolism in the presence of 
Rot (Fath et al., 2009). Therefore, ETCBs can significantly enhance 2-DG-induced oxidative 
stress in cells. A combination of 2-DG and Rot led to significant oxidations in both parasites, 
disrupting intracellular thiol metabolism, which indicates changes in redox status consistent 
with cells undergoing oxidative stress. 2-DG treatment alone resulted in a significant increase 
in probe oxidation in 3D7[Mito-roGFP2-hGrx1]-transfected cells. Overall, all the novel compounds 
and experimental agents tested here affected the glutathione redox state in the cytosol and 
when tested, in the mitochondrion as well. For ML304 and compound S, disruption of GSH 
homeostasis plays a major role in their mode of action in parasites since their effects on 
increasing oxidative stress were highly significant, which is consistent with the role of the 
G6PD target of the drugs. However, it should also be considered that the other tested 
compounds and experimental agents might not directly act at only the cytosolic or 
mitochondrial level but also at organelle sites such as the DV or apicoplast.  
5.5 Optimizing glutathione redox potential detection in P. falciparum 
By using two genetically encoded fluorescent redox sensors, the glutathione redox probe 
hGrx1-roGFP2 and sfroGFP2, their characteristics could be directly investigated in parallel 
regarding their sensitivity to changes in GSH/GSSG ratios in stably transfected strains of P. 
falciparum. Previous methods evaluating intracellular redox state have employed 
fluorescence microscopy. To improve glutathione redox state determination in P. falciparum, 
plate reader detection was used for real-time imaging of fast events as well as of fixed redox 
states after mid- and long-term incubations. Advantages and disadvantages over the 
commonly used microscopic analyses have already been discussed in 5.3. Only parasites 
that express genomically integrated biosensors give signals that are strong enough for plate 
reader detection. Overall, it is a very useful tool for quickly analyzing the effects of a broad 
range of drugs on the glutathione redox state of P. falciparum, but at the same time, the 
parasites should also be monitored using CLSM in order to follow morphological changes in 
the parasites due to the effect of different drugs. Moreover, due to the dependancy of the 
plate reader on specific cell densities that cannot be ensured for all drug treatments because 
of their possible decreasing effect on parasitemia, CLSM measurements should also be 
directly performed in order to prevent false positive readouts. The sensor sfroGFP2 showed 
much higher fluorescence intensity (Figure 4.31), which might be useful for fusing specific 
proteins to sfroGFP2 for better future monitoring. Since targeting the sensor hGrx1-roGFP2 
to the apicoplast and mitochondrion of NF54-attB parasites failed, the sensor sfroGFP2 could 
be targeted to these organelles, which might be more compatible for the parasites and at the 
same time will lead to higher fluorescence intensities. The oxidation of both probes was 
reversible and was demonstrated by adding DTT, which decreased the ratio to the baseline 
redox state by reducing the disulfide bonds (Figure 4.30). This reversibility also showed the 
suitability of both sensors for measuring dynamic redox changes in living cells. The leakage 
phenomenon of the hGrx1-roGFP2 probe in P. falciparum NF54-attB transfectants into the 
host cell upon exposure to high H2O2 concentrations (e.g. 500 µM) (Figure 4.32) is consistent 
with the observation using the roGFP2-Orp1 probe (Figure 4.26) under the same conditions 
(high-resolution microscopy). This might suggest that the parasite’s membrane becomes 
poriferous due to high H2O2 concentrations and intracellular molecules spread out in the host 
cell. In the cytosol, sfroGFP2 is just as suitable for detecting changes in the glutathione redox 
state as hGrx1-roGFP2; however, in subcellular organelles without Grx or in Grx knockdown 
mutants, sfroGFP2 fused to hGrx1 needs to be used in order to ensure sensitivity to GSSG. 
For highly oxidized compartments, e.g. the DV or the ER, hGrx1-sfroGFP2-iX (insertion of 
amino acid X, (E or L)) might be more advantageous. The results of live-cell imaging with the 
cytosolically expressed hGrx1-roGFP2 and sfroGFP2 biosensors in asexual blood-stages of 
stably transfected P. falciparum NF54-attB parasites indicated that the mode of action of 
some novel compounds (compound 1o, ML304, and compound S) may be linked to a 
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disturbance of the GSH redox state (Figures 4.33, 4.35, and 4.37) due to significantly 
increasing the fluorescence ratio in either 4 h or 24 h incubations using CLSM detection. 
Among the antimalarial drugs tested here using CLSM (ART, ATM, ATS, CQ, QN, MQ, AQ, 
ATQ, LUM), none significantly increased the fluorescence ratio of both NF54[hGrx1-roGFP2] and 
NF54[sfroGFP2] parasites (Figures 4.34, 4.36, and 4.38). Therefore, increased oxidative stress 
does not play a role in their mode of action in parasites. These results are not comparable to 
the results of Kasozi et al. (2013), where drug effects of antimalarials on P. falciparum 3D7 
parasites that had been episomally transfected with hGrx1-roGFP2 were observed via 
CLSM. This might be due to strain-specific characteristics. However, both hGrx1-roGFP2 
and sfroGFP2 sensors responded to the same extent upon exposure to the different drugs, 
which indicates that the probes are both sensitive and suitable tools for studying GSH redox 
homeostasis in the cytosol of P. falciparum. The significant effects MQ had on the 
fluorescence ratio using plate reader detection was most likely a false positive readout 
derived from a low density of parasites due to its antiparasitic effect, which did not lead to 
reliable fluorescence signals. This is why CLSM detection always needs to be used in 
parallel in order to confirm the results of plate reader detection.  
 
5.6 Future perspectives 
5.6.1 Malaria control 
There is a broad spectrum of interventions to control malaria: eradication of transmitting 
Anopheles mosquitoes, inhibition of gametocyte formation in the human host, and protection 
against infection by using insecticides and vaccination. Insecticidal bed nets and spraying 
insecticide for indoor use are major interventions for malaria control. In fact, insecticide-
treated nets have helped reduce child mortality and episodes of clinical malaria (Lengeler, 
2004); however, mosquitos have built up resistance to some of these insecticides. Repellants 
also provide useful protection against malaria. Current research activities include genetically 
modified mosquitoes to suppress mosquito species that function as vectors for parasite 
transmission, i.e. releasing sexually active but genetically sterile male mosquitoes that 
produce no viable progeny into the wild (Catteruccia et al., 2007; Paton et al., 2013). To date, 
an effective vaccine for malaria, which could intervene at one stage or a combination of 
stages in the parasite’s life cycle, still remains elusive. Malaria vaccines could be directed at 
the sporozoite stage in order to prevent infection against the asexual stages in human blood 
and prevent clinical disease or at the sexual stage in order to prevent transmission. Although 
more than 30 P. falciparum vaccine candidates are at either advanced preclinical or clinical 
stages of evaluation, only the RTS,S/AS01 vaccine, which targets the circumsporozoite 
protein and is dispensed with an adjuvant system, has completed pivotal Phase 3 trials. It 
showed a protection rate of 35% against severe malaria in children and infants in a Phase 3 
clinical study over a 3-4 year period. The efficacy of the vaccine could be increased with a 
booster dose (Agnandji et al., 2011; WHO 2016). Discovering and implementing a safe and 
effective vaccine against malaria is a major priority in controlling the disease. A new 
approach is aimed at probiotic vaccines (Ngwa et al., 2015). Yilmaz et al. (2014) showed that 
Plasmodium and the human gut pathobiont E.coli O86:B7 both exhibit the glycan Galα1-
3Galβ1-4GlcNAc-R (α-gal) on their surfaces in contrast to humans. This enables the 
expression of anti-α-gal-antibodies in humans, which confers protection against malaria 
transmission in both humans and mice (Yilmaz et al., 2014). Understanding the biology and 
behavior of Anopheles mosquitoes can help researchers understand how malaria is 
transmitted when designing appropriate control strategies. 
 
5.6.2 Genetic markers of resistance 
Generating various redox probes as part of this dissertation has paved the way for more 
detailed antimalarial drug discovery studies in the future. Novel compounds can now be 
tested with regard to their ability to increase H2O2 levels or disturb GSH homeostasis in the 
cytosol or subcellular compartments within the malaria parasite. Based on this, the structures 
of the compounds can be further altered in order to increase the oxidative burden on 
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Plasmodium and efficiently kill the parasite. The emergence of drug-resistant Plasmodium 
strains demands the development of new antimalarial drugs or drug combinations in order to 
improve their antiparasitic activity. 
Now, 30 years after the first observation of CQ resistance, 80% of the field isolates 
worldwide carry resistance (Ginsburg, 2005). A mutation in the first transmembrane domain 
of the P. falciparum CQ resistance transporter (PfCRT) in the DV, K76T, has been correlated 
with CQ resistance (CQR) (Fidock et al., 2000; Lakshmanan et al., 2005). Glutathione 
metabolism has been associated with CQ resistance (Becker et al., 2004; Ginsburg et al., 
1998), in which GSH levels were observed to be lower in the cytosol of CQ-resistant parasite 
lines (Patzewitz et al., 2012). GSH forms a complex with heme in the DV of the parasite in 
order to prevent oxidative damage, whereas the CQ-heme complex is toxic (Nayyar et al., 
2012). Ginsburg and Golenser (2003) reported an increase in glutathione-S-transferase 
(GST) activity and a reduction in hemozoin levels within the parasite compartment. PfCRT is 
also able to transport glutathione (Patzewitz et al., 2012). Single point mutations in the DV 
transporter gene PfMDR1, a parasite homolog of the mammalian multidrug resistance 
gene 1 (MDR1), also confer resistance to this class of drugs. PfMDR1 encodes a 12-
transmembrane domain protein, which is a DV importer (Ferreira et al., 2011). Other known 
drug resistance genes and mechanisms include the multidrug resistance-associated protein 
(PfMRP), and P. falciparum Na+/H+ exchanger (Pfnhe) (Petersen et al., 2011). None of these 
resistance markers have been associated with GSH. Drug resistance, in particular CQ 
resistance, is a major public health problem in malaria control. The natural protective 
immunity against malaria in adults living in malaria-endemic zones provides hope that a 
vaccine against malaria could be developed. ACTs have replaced CQ as the gold standard 
treatment against uncomplicated malaria in all areas where the WHO deems malaria to be 
endemic (Dondorp et al., 2009). However, this treatment is also threatened by newly 
emergent and spreading resistance to ART, which is the key compound in effective 
antimalarial medicine. Recently, mutations in the propeller domain of the Kelch protein K13 
of P. falciparum were detected as markers of ART resistance, in which K13 is putatively 
linked to oxidative stress as one possible functional role in parasites (Ariey et al., 2014; 
Straimer et al., 2014; Adams et al., 2000; Mohon et al., 2014; Mbengue et al., 2015; Tilley et 
al., 2016). Very recently, it was proposed that after iron (Fe2+) activation of ART, the drug 
causes oxidative stress and cellular damage, indicated by an increase in ubiquitination, while 
ART-resistant parasites with K13 mutations show lower levels of ubiquitinated proteins due 
to an increase in stress response (Dogovski et al., 2015). The role of glutathione in this 
stress response needs to be further investigated. 
Plasmodium strains with mutations in the propeller domain of the K13 protein can be used, 
for example, to stably integrate H2O2 or GSH redox sensors into the genome in order to 
investigate the effects of antimalarial drugs and novel compounds on the resistant strain in 
comparison to the strain complemented with the wild type version of the protein. These data 
can be then used to elucidate whether that mutation confers resistance to specific 
antimalarial drugs or compounds that would increase H2O2 levels or would lead to GSH 
disturbance in the wild type strain. Acquiring this information will lead to a better 
understanding of resistance mechanisms in the malaria parasite. 
 
5.6.3 Further development of redox sensor methodology 
The future understanding of interlinked processes of organisms will depend on the ability to 
acquire data with high resolution in time and space. While the redox sensors roGFP2-Orp1, 
HyPer-3, and roGFP2-Orp1 have already shown their ability to deliver dynamic data, 
additional improvements and extensions can still be performed. There are different options 
for further improvement of current redox sensors and for the development of novel redox 
probes with altered properties and specificities. Current ratiometric redox probes based on 
roGFPs all emit green light of the same wavelength. Therefore, monitoring redox changes in 
multiple compartments is technically difficult. Comparison of H2O2 levels or the glutathione 
potential in different compartments and investigation of redox communication between 
organelles often requires separate measurements for each compartment. The creation of 
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additional color-compatible redox probes would be necessary for simultaneous 
measurements in two or more subcellular compartments. The development of a ratiometric 
redox-sensitive fluorescent protein with emission peaks shifted far more towards the red end 
of the visible spectrum would be favorable to avoid interference with roGFP fluorescence. 
Ro-GFP2-Orp1, HyPer-3, and hGrx1-roGFP2 are already highly responsive to changes in 
H2O2 or GSH levels and equilibrate on a second-to-minute timescale. Nevertheless, the 
response time of roGFP and YFP-based probes could be further shortened in order to allow 
the detection of highly transient events on even shorter timescales. Furthermore, the 
influence of linker length on redox relay efficiency has not yet been systematically 
investigated. The catalytic efficiency of two fusion domains such as roGFP2-Orp1 and 
hGrx1-roGFP2 might also be affected by the length of the linker between the two fusion 
proteins. The generation of probes with modified midpoint potentials especially for targeting 
the ER lumen of cells or the DV of Plasmodium is also important, which would allow redox 
studies in highly oxidized compartments. A range of novel roGFP versions with modified 
redox potentials have been generated (Lohman and Remington, 2008), but it remains to be 
seen whether these midpoint potentials are high enough to dynamically resolve the actual 
glutathione redox potential in organelles such as the ER lumen. Redox probes can be 
specifically targeted to subcellular compartments, e.g. the mitochondrion or apicoplast of 
Plasmodium, by using appropriate N-terminal targeting sequences. HGrx1-roGFP2 was 
successfully targeted to mitochondria in HeLa cells (Gutscher et al., 2008). However, the 
same hGrx1-roGFP2 fusion protein was not imported into mitochondria of P. falciparum 
(Mohring et al., 2017). This might indicate that human Grx1 prevents correct mitochondrial 
targeting of the probe when expressed in heterologous systems. This might be overcome 
either by using species-specific Grxs for the fusion protein or by inverting the order of 
domains and fusing hGrx1 C-terminally to roGFP2. Indeed, recent results demonstrated that 
the inverted probe with human Grx1 fused to the C-terminus of roGFP2 (roGFP2-Grx1) is 
successfully targeted to mitochondria in P. falciparum (Mohring et al., 2017). Another 
possible goal is the development of a Trx-specific redox biosensor. Future work is needed in 
order to further expand the toolbox of redox probes to other important reactive species such 
as HO•, NO•, or superoxide radical. This could provide more information about the 
interconversion and interplay of ROS/RNS and, regarding malaria, about the mechanisms of 
the antimalarial drugs on the plasmodial redox system. Regarding the biosensor HyPer-3, 
pH-stable versions of HyPer are necessary for imaging in cells. Until now, redox-sensitive 
fluorescent proteins have proven to be valuable tools for providing new insights into cellular 
redox biology.  
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roGFP2-Orp1 
 
     1 - AGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGAC - 60  
     1 - S  K  G  E  E  L  F  T  G  V  V  P  I  L  V  E  L  D  G  D   - 20  
 
    61 - GTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAG - 120  
    21 - V  N  G  H  K  F  S  V  S  G  E  G  E  G  D  A  T  Y  G  K   - 40  
 
   121 - CTGACCCTGAAGTTCATCTCCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTG - 180  
    41 - L  T  L  K  F  I  S  T  T  G  K  L  P  V  P  W  P  T  L  V   - 60  
 
   181 - ACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCAC - 240  
    61 - T  T  L  T  Y  G  V  Q  C  F  S  R  Y  P  D  H  M  K  Q  H   - 80  
 
   241 - GACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAG - 300  
    81 - D  F  F  K  S  A  M  P  E  G  Y  V  Q  E  R  T  I  F  F  K   - 100  
 
   301 - GACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAAC - 360  
   101 - D  D  G  N  Y  K  T  R  A  E  V  K  F  E  G  D  T  L  V  N   - 120  
 
   361 - CGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTG - 420  
   121 - R  I  E  L  K  G  I  D  F  K  E  D  G  N  I  L  G  H  K  L   - 140  
 
   421 - GAGTACAACTACAACTGCCACAACGTCTATATCATGGCCGACAAGCAGAAGAACGGCATC - 480  
   141 - E  Y  N  Y  N  C  H  N  V  Y  I  M  A  D  K  Q  K  N  G  I   - 160  
 
   481 - AAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCAC - 540  
   161 - K  V  N  F  K  I  R  H  N  I  E  D  G  S  V  Q  L  A  D  H   - 180  
 
   541 - TACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTG - 600  
   181 - Y  Q  Q  N  T  P  I  G  D  G  P  V  L  L  P  D  N  H  Y  L   - 200  
 
   601 - AGCACCTGCTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTG - 660  
   201 - S  T  C  S  A  L  S  K  D  P  N  E  K  R  D  H  M  V  L  L   - 220  
 
   661 - GAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGACTAGTGGT - 720  
   221 - E  F  V  T  A  A  G  I  T  L  G  M  D  E  L  Y  K  T  S  G   - 240  
 
   721 - GGTTCAGGTGGTGGTGGTTCAGGTGGTGGTGGTTCAGGTGGAGGAGGATCAGGAGGAGGA - 780  
   241 - G  S  G  G  G  G  S  G  G  G  G  S  G  G  G  G  S  G  G  G   - 260  
 
   781 - GGATCAGGAGGAGGAGGATCAGGAGGAGAATTCGATATCTCAGAATTCTATAAGCTAGCA - 840  
   261 - G  S  G  G  G  G  S  G  G  E  F  D  I  S  E  F  Y  K  L  A   - 280  
 
   841 - CCTGTTGACAAGAAAGGCCAACCATTCCCCTTCGACCAATTAAAGGGAAAAGTGGTGCTT - 900  
   281 - P  V  D  K  K  G  Q  P  F  P  F  D  Q  L  K  G  K  V  V  L   - 300  
 
   901 - ATCGTTAATGTTGCCTCCAAATGTGGATTCACTCCTCAATACAAAGAACTAGAGGCCTTG - 960  
   301 - I  V  N  V  A  S  K  C  G  F  T  P  Q  Y  K  E  L  E  A  L   - 320  
 
   961 - TACAAACGTTATAAGGACGAAGGATTTACCATCATCGGGTTCCCATGCAACCAGTTTGGC -1020  
   321 - Y  K  R  Y  K  D  E  G  F  T  I  I  G  F  P  C  N  Q  F  G   - 340  
 
  1021 - CACCAAGAACCTGGCTCTGATGAAGAAATTGCCCAGTTCTGCCAACTGAACTATGGCGTG -1080  
   341 - H  Q  E  P  G  S  D  E  E  I  A  Q  F  C  Q  L  N  Y  G  V   - 360  
 
  1081 – ACTTTCCCCATTATGAAAAAAATTGACGTTAATGGTGGCAATGAGGACCCTGTTTACAAG -1140  
   361 - T  F  P  I  M  K  K  I  D  V  N  G  G  N  E  D  P  V  Y  K   - 380  
 
  1141 – TTTTTGAAGAGCCAAAAATCCGGTATGTTGGGCTTGAGAGGTATCAAATGGAATTTTGAA -1200  
   381 - F  L  K  S  Q  K  S  G  M  L  G  L  R  G  I  K  W  N  F  E   - 400  
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  1201 – AAATTCTTAGTCGATAAAAAGGGTAAAGTGTACGAAAGATACTCTTCACTAACCAAACCT -1260  
   401 - K  F  L  V  D  K  K  G  K  V  Y  E  R  Y  S  S  L  T  K  P   - 420  
 
  1261 – TCTTCGTTGTCCGAAACCATCGAAGAACTTTTGAAAGAGGTGGAATAA    -1308  
   421 - S  S  L  S  E  T  I  E  E  L  L  K  E  V  E  *   - 440  
 
 
HyPer/SypHer 
           
     1 - GAGATGGCAAGCCAGCAGGGCGAGACGATGTCCGGACCGCTGCACATTGGTTTGATTCCC - 60  
     1 - E  M  A  S  Q  Q  G  E  T  M  S  G  P  L  H  I  G  L  I  P   - 20  
 
    61 - ACAGTTGGACCGTACCTGCTACCGCATATTATCCCTATGCTGCACCAGACCTTTCCAAAG - 120  
    21 - T  V  G  P  Y  L  L  P  H  I  I  P  M  L  H  Q  T  F  P  K   - 40  
 
   121 - CTGGAAATGTATCTGCATGAAGCACAGACCCACCAGTTACTGGCGCAACTGGACAGCGGC - 180  
    41 - L  E  M  Y  L  H  E  A  Q  T  H  Q  L  L  A  Q  L  D  S  G   - 60  
 
   181 - AAACTCGATTGCGTGATCCTCGCGCTGGTGAAAGAGAGCGAAGCATTCATTGAAGTGCCG - 240  
    61 - K  L  D  C  V  I  L  A  L  V  K  E  S  E  A  F  I  E  V  P   - 80  
 
   241 - TTGTTTGATGAGCCAATGTTGCTGGCTATCTATGAAGATCACCCGTGGGCGAACCGCGAA - 300  
    81 - L  F  D  E  P  M  L  L  A  I  Y  E  D  H  P  W  A  N  R  E   - 100  
 
   301 - TGCGTACCGATGGCCGATCTGGCAGGGGAAAAACTGCTGATGCTGGAAGATGGTCACTGT - 360  
   101 - C  V  P  M  A  D  L  A  G  E  K  L  L  M  L  E  D  G  H  C   - 120  
 
   361 - TTGCGCGATCAGGCAATGTCCGCCGGCTACAACAGCGACAACGTCTATATCATGGCCGAC - 420  
   121 - L  R  D  Q  A  M  S  A  G  Y  N  S  D  N  V  Y  I  M  A  D   - 140  
 
   421 - AAGCAGAAGAACGGCATCAAGGCCAACTTCAAGATCCGCCACAACGTCGAGGACGGCAGC - 480  
   141 - K  Q  K  N  G  I  K  A  N  F  K  I  R  H  N  V  E  D  G  S   - 160  
 
   481 - GTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTG - 540  
   161 - V  Q  L  A  D  H  Y  Q  Q  N  T  P  I  G  D  G  P  V  L  L   - 180  
 
   541 - CCCGACAACCACTACCTGAGCTTCCAGTCCGTCCTGAGCAAAGACCCCAACGAGAAGCGC - 600  
   181 - P  D  N  H  Y  L  S  F  Q  S  V  L  S  K  D  P  N  E  K  R   - 200  
 
   601 - GATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAG - 660  
   201 - D  H  M  V  L  L  E  F  V  T  A  A  G  I  T  L  G  M  D  E   - 220  
 
   661 - CTGTACAACGTGGATGGCGGTAGCGGTGGCACCGGCAGCAAGGGCGAGGAGCTGTTCACC - 720  
   221 - L  Y  N  V  D  G  G  S  G  G  T  G  S  K  G  E  E  L  F  T   - 240  
 
   721 - GGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTG - 780  
   241 - G  V  V  P  I  L  V  E  L  D  G  D  V  N  G  H  K  F  S  V   - 260  
 
   781 - TCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGCTGATCTGCACC - 840  
   261 - S  G  E  G  E  G  D  A  T  Y  G  K  L  T  L  K  L  I  C  T   - 280  
 
   841 - ACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTCGGCTACGGCCTGAAG - 900  
   281 - T  G  K  L  P  V  P  W  P  T  L  V  T  T  L  G  Y  G  L  K   - 300  
 
   901 - TGCTTCGCCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCC - 960  
   301 - C  F  A  R  Y  P  D  H  M  K  Q  H  D  F  F  K  S  A  M  P   - 320  
 
   961 – GAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGC -1020  
   321 - E  G  Y  V  Q  E  R  T  I  F  F  K  D  D  G  N  Y  K  T  R   - 340  
 
  1021 – GCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGGC -1080  
   341 - A  E  V  K  F  E  G  D  T  L  V  N  R  I  E  L  K  G  I  G   - 360  
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  1081 – TTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACGGCACCGGTTTCTGT -1140  
   361 - F  K  E  D  G  N  I  L  G  H  K  L  E  Y  N  G  T  G  F  C   - 380  
 
  1141 – TTTGAAGCCGGGGCGGATGAAGATACACACTTCCGCGCGACCAGCCTGGAAACTCTGCGC -1200  
   381 - F  E  A  G  A  D  E  D  T  H  F  R  A  T  S  L  E  T  L  R   - 400  
 
  1201 – AACATGGTGGCGGCAGGTAGCGGGATCACTTTACTGCCAGCGCTGGCTGTGCCGCCGGAG -1260  
   401 - N  M  V  A  A  G  S  G  I  T  L  L  P  A  L  A  V  P  P  E   - 420  
 
  1261 – CGCAAACGCGATGGGGTTGTTTATCTGCCGTGCATTAAGCCGGAACCACGCCGCACTATT -1320  
   421 - R  K  R  D  G  V  V  Y  L  P  C  I  K  P  E  P  R  R  T  I   - 440  
 
  1321 – GGCCTGGTTTATCGTCCTGGCTCACCGCTGCGCAGCCGCTATGAGCAGCTGGCAGAGGCC -1380  
   441 - G  L  V  Y  R  P  G  S  P  L  R  S  R  Y  E  Q  L  A  E  A   - 460  
 
  1381 - ATCCGCGCAAGAATGGATGGCCATTTCGATAAAGTTTTAAAACAGGCGGTTTAA   -1434  
   461 - I  R  A  R  M  D  G  H  F  D  K  V  L  K  Q  A  V  *      - 480  
In HyPer-3: Mutation H34Y (depicted in grey): CAC (H)  TAC (Y) 
In SypHer:  Mutation C199S (depicted in grey): TGT (C)  TCT (S) 
 
hGrx1-roGFP2 
 
     1 - GGTACCATGGCTCAAGAGTTTGTGAACTGCAAAATCCAGCCTGGGAAGGTGGTTGTGTTC - 60  
     1 - G  T  M  A  Q  E  F  V  N  C  K  I  Q  P  G  K  V  V  V  F   - 20  
 
    61 - ATCAAGCCCACCTGCCCGTACTGCAGGAGGGCCCAAGAGATCCTCAGTCAATTGCCCATC - 120  
    21 - I  K  P  T  C  P  Y  C  R  R  A  Q  E  I  L  S  Q  L  P  I   - 40  
 
   121 - AAACAAGGGCTTCTGGAATTTGTCGATATCACAGCCACCAACCACACTAACGAGATTCAA - 180  
    41 - K  Q  G  L  L  E  F  V  D  I  T  A  T  N  H  T  N  E  I  Q   - 60  
 
   181 - GATTATTTGCAACAGCTCACGGGAGCAAGAACGGTGCCTCGAGTCTTTATTGGTAAAGAT - 240  
    61 - D  Y  L  Q  Q  L  T  G  A  R  T  V  P  R  V  F  I  G  K  D   - 80  
 
   241 - TGTATAGGCGGATGCAGTGATCTAGTCTCTTTGCAACAGAGTGGGGAACTGCTGACGCGG - 300  
    81 - C  I  G  G  C  S  D  L  V  S  L  Q  Q  S  G  E  L  L  T  R   - 100  
 
   301 - CTAAAGCAGATTGGAGCTCTGCAGACTAGTGGTGGTTCAGGTGGTGGTGGTTCAGGTGGT - 360  
   101 - L  K  Q  I  G  A  L  Q  T  S  G  G  S  G  G  G  G  S  G  G   - 120  
 
   361 - GGTGGTTCAGGTGGAGGAGGATCAGGAGGAGGAGGATCAGGAGGAGGAGGATCAGGAGGA - 420  
   121 - G  G  S  G  G  G  G  S  G  G  G  G  S  G  G  G  G  S  G  G   - 140  
 
   421 - GAATTCGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTG - 480  
   141 - E  F  V  S  K  G  E  E  L  F  T  G  V  V  P  I  L  V  E  L   - 160  
 
   481 - GACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACC - 540  
   161 - D  G  D  V  N  G  H  K  F  S  V  S  G  E  G  E  G  D  A  T   - 180  
 
   541 - TACGGCAAGCTGACCCTGAAGTTCATCTCCACCACCGGCAAGCTGCCCGTGCCCTGGCCC - 600  
   181 - Y  G  K  L  T  L  K  F  I  S  T  T  G  K  L  P  V  P  W  P   - 200  
 
   601 - ACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATG - 660  
   201 - T  L  V  T  T  L  T  Y  G  V  Q  C  F  S  R  Y  P  D  H  M   - 220  
 
   661 - AAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATC - 720  
   221 - K  Q  H  D  F  F  K  S  A  M  P  E  G  Y  V  Q  E  R  T  I   - 240  
 
   721 - TTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACC - 780  
   241 - F  F  K  D  D  G  N  Y  K  T  R  A  E  V  K  F  E  G  D  T   - 260  
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   781 - CTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGG - 840  
   261 - L  V  N  R  I  E  L  K  G  I  D  F  K  E  D  G  N  I  L  G   - 280  
 
   841 - CACAAGCTGGAGTACAACTACAACTGCCACAACGTCTATATCATGGCCGACAAGCAGAAG - 900  
   281 - H  K  L  E  Y  N  Y  N  C  H  N  V  Y  I  M  A  D  K  Q  K   - 300  
 
   901 - AACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTC - 960  
   301 - N  G  I  K  V  N  F  K  I  R  H  N  I  E  D  G  S  V  Q  L   - 320  
 
   961 - GCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAAC -1020  
   321 - A  D  H  Y  Q  Q  N  T  P  I  G  D  G  P  V  L  L  P  D  N   - 340  
 
  1021 - CACTACCTGAGCACCTGCTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATG -1080  
   341 - H  Y  L  S  T  C  S  A  L  S  K  D  P  N  E  K  R  D  H  M   - 360  
 
  1081 - GTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAG -1140  
   361 - V  L  L  E  F  V  T  A  A  G  I  T  L  G  M  D  E  L  Y  K   - 380  
 
  1141 - ATTGGTACC                                                   - 1149  
   381 - I  G  T                                                     -  383 
 
In pDC2-CAM-[hGrx1-roGFP2]-attP plasmid: T mutated to A. 
 
 
roGFP2-hGrx1 
 
     1 - GGTACCATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAG - 60  
     1 - G  T  M  V  S  K  G  E  E  L  F  T  G  V  V  P  I  L  V   E  - 20  
 
    61 - CTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCC - 120  
    21 - L  D  G  D  V  N  G  H  K  F  S  V  S  G  E  G  E  G  D  A   - 40  
 
   121 - ACCTACGGCAAGCTGACCCTGAAGTTCATCTCCACCACCGGCAAGCTGCCCGTGCCCTGG - 180  
    41 - T  Y  G  K  L  T  L  K  F  I  S  T  T  G  K  L  P  V  P  W   - 60  
 
   181 - CCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCAC - 240  
    61 - P  T  L  V  T  T  L  T  Y  G  V  Q  C  F  S  R  Y  P  D  H   - 80  
 
   241 - ATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACC - 300  
    81 - M  K  Q  H  D  F  F  K  S  A  M  P  E  G  Y  V  Q  E  R  T   - 100  
 
   301 - ATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGAC - 360  
   101 - I  F  F  K  D  D  G  N  Y  K  T  R  A  E  V  K  F  E  G  D   - 120  
 
   361 - ACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTG - 420  
   121 - T  L  V  N  R  I  E  L  K  G  I  D  F  K  E  D  G  N  I  L   - 140  
 
   421 - GGGCACAAGCTGGAGTACAACTACAACTGCCACAACGTCTATATCATGGCCGACAAGCAG - 480  
   141 - G  H  K  L  E  Y  N  Y  N  C  H  N  V  Y  I  M  A  D  K  Q   - 160  
 
   481 - AAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAG - 540  
   161 - K  N  G  I  K  V  N  F  K  I  R  H  N  I  E  D  G  S  V  Q   - 180  
 
   541 - CTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGAC - 600  
   181 - L  A  D  H  Y  Q  Q  N  T  P  I  G  D  G  P  V  L  L  P  D   - 200  
 
   601 - AACCACTACCTGAGCACCTGCTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCAC - 660  
   201 - N  H  Y  L  S  T  C  S  A  L  S  K  D  P  N  E  K  R  D  H   - 220  
 
   661 - ATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTAC - 720  
   221 - M  V  L  L  E  F  V  T  A  A  G  I  T  L  G  M  D  E  L  Y   - 240  
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   721 - AAGACTAGTGGTGGTTCAGGTGGTGGTGGTTCAGGTGGTGGTGGTTCAGGTGGAGGAGGA - 780  
   241 - K  T  S  G  G  S  G  G  G  G  S  G  G  G  G  S  G  G  G  G   - 260  
 
   781 - TCAGGAGGAGGAGGATCAGGAGGAGGAGGATCAGGAGGAGAATTCGCTCAAGAGTTTGTG - 840  
   261 – S  G  G  G  G  S  G  G  G  G  S  G  G  E  F  A  Q  E  F  V   - 280  
 
   841 - AACTGCAAAATCCAGCCTGGGAAGGTGGTTGTGTTCATCAAGCCCACCTGCCCGTACTGC - 900  
   281 – N  C  K  I  Q  P  G  K  V  V  V  F  I  K  P  T  C  P  Y  C   - 300  
 
   901 – AGGAGGGCCCAAGAGATCCTCAGTCAATTGCCCATCAAACAAGGGCTTCTGGAATTTGTC - 960  
   301 – R  R  A  Q  E  I  L  S  Q  L  P  I  K  Q  G  L  L  E  F  V   - 320  
 
   961 - GATATCACAGCCACCAACCACACTAACGAGATTCAAGATTATTTGCAACAGCTCACGGGA -1020  
   321 – D  I  T  A  T  N  H  T  N  E  I  Q  D  Y  L  Q  Q  L  T  G   - 340  
 
  1021 - GCAAGAACGGTGCCTCGAGTCTTTATTGGTAAAGATTGTATAGGCGGATGCAGTGATCTA -1080  
   341 – A  R  T  V  P  R  V  F  I  G  K  D  C  I  G  G  C  S  D  L   - 360  
 
  1081 - GTCTCTTTGCAACAGAGTGGGGAACTGCTGACGCGGCTAAAGCAGATTGGAGCTCTGCAG -1140  
   361 – V  S  L  Q  Q  S  G  E  L  L  T  R  L  K  Q  I  G  A  L  Q   - 380  
 
  1141 - ATTGGTACC                                                    -1149  
   381 – I  G  T                                                      - 383 
         
 
sfroGFP2 
     1 - ATGGTTAGTAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGAT - 60  
     1 - M  V  S  K  G  E  E  L  F  T  G  V  V  P  I  L  V  E  L  D   - 20  
 
    61 - GGTGATGTTAATGGGCACAAATTTTCTGTCAGAGGAGAGGGTGAAGGTGATGCAACAAAT - 120  
    21 - G  D  V  N  G  H  K  F  S  V  R  G  E  G  E  G  D  A  T  N   - 40  
 
   121 - GGAAAACTTACCCTTAAATTTATTAGTACTACTGGAAAACTACCTGTTCCATGGCCAACA - 180  
    41 - G  K  L  T  L  K  F  I  S  T  T  G  K  L  P  V  P  W  P  T   - 60  
 
   181 - CTTGTCACTACTCTTACTTATGGTGTCCAATGCTTTAGTAGATACCCAGATCATATGAAA - 240  
    61 - L  V  T  T  L  T  Y  G  V  Q  C  F  S  R  Y  P  D  H  M  K   - 80  
 
   241 - AGACATGACTTTTTCAAGAGTGCCATGCCCGAAGGTTATGTACAGGAAAGAACTATAAGT - 300  
    81 - R  H  D  F  F  K  S  A  M  P  E  G  Y  V  Q  E  R  T  I  S   - 100  
 
   301 - TTCAAAGATGACGGGACATACAAGACACGTGCTGAAGTCAAGTTTGAAGGTGATACCCTT - 360  
   101 - F  K  D  D  G  T  Y  K  T  R  A  E  V  K  F  E  G  D  T  L   - 120  
 
   361 - GTTAATAGAATCGAGTTAAAAGGTATTGATTTTAAAGAAGATGGAAACATTCTTGGACAC - 420  
   121 - V  N  R  I  E  L  K  G  I  D  F  K  E  D  G  N  I  L  G  H   - 140  
 
   421 - AAATTGGAATACAACTTTAACTGTCACAATGTATACATCACTGCAGACAAACAAAAGAAT - 480  
   141 - K  L  E  Y  N  F  N  C  H  N  V  Y  I  T  A  D  K  Q  K  N   - 160  
 
   481 - GGAATCAAAGCAAACTTCAAAATTAGACACAACGTAGAAGATGGAAGCGTTCAACTAGCA - 540  
   161 - G  I  K  A  N  F  K  I  R  H  N  V  E  D  G  S  V  Q  L  A   - 180  
 
   541 - GACCATTATCAACAAAATACTCCAATTGGCGATGGCCCTGTCCTTTTACCAGACAACCAT - 600  
   181 - D  H  Y  Q  Q  N  T  P  I  G  D  G  P  V  L  L  P  D  N  H   - 200  
 
   601 - TACCTGTCCACATGTTCTGTACTTTCGAAAGATCCCAACGAAAAGAGAGACCACATGGTC - 660  
   201 - Y  L  S  T  C  S  V  L  S  K  D  P  N  E  K  R  D  H  M  V   - 220  
 
   661 - CTTCTTGAGAGAGTAACAGCTGCTGGGATTACACATGGCATGGATGAACTATACAAATAA - 720  
   221 - L  L  E  R  V  T  A  A  G  I  T  H  G  M  D  E  L  Y  K  *   - 240  
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pHluorin 
     1 - ATGAGTAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGGT - 60  
     1 - M  S  K  G  E  E  L  F  T  G  V  V  P  I  L  V  E  L  D  G   - 20  
 
    61 - GATGTTAATGGGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTGATGCAACATACGGA - 120  
    21 - D  V  N  G  H  K  F  S  V  S  G  E  G  E  G  D  A  T  Y  G   - 40  
 
   121 - AAACTTACCCTTAAATTTATTTGCACTACTGGAAAACTACCTGTTCCATGGCCAACACTT - 180  
    41 - K  L  T  L  K  F  I  C  T  T  G  K  L  P  V  P  W  P  T  L   - 60  
 
   181 - GTCACTACTTTCTCTTATGGTGTTCAATGCTTTTCAAGATACCCAGATCATATGAAACGG - 240  
    61 - V  T  T  F  S  Y  G  V  Q  C  F  S  R  Y  P  D  H  M  K  R   - 80  
 
   241 - CATGACTTTTTCAAGAGTGCCATGCCCGAAGGTTATGTACAGGAAAGAACTATATTTTTC - 300  
    81 - H  D  F  F  K  S  A  M  P  E  G  Y  V  Q  E  R  T  I  F  F   - 100  
 
   301 - AAAGATGACGGGAACTACAAGACACGTGCTGAAGTCAAGTTTGAAGGTGATACCCTTGTT - 360  
   101 - K  D  D  G  N  Y  K  T  R  A  E  V  K  F  E  G  D  T  L  V   - 120  
 
   361 - AATAGAATCGAGTTAAAAGGTATTGATTTTAAAGATGATGGAAACATTCTTGGACACAAA - 420  
   121 - N  R  I  E  L  K  G  I  D  F  K  D  D  G  N  I  L  G  H  K   - 140  
 
   421 - TTGGAATACAACTATAACGAGCACTTGGTGTACATCATGGCAGACAAACAAAAGAATGGT - 480  
   141 - L  E  Y  N  Y  N  E  H  L  V  Y  I  M  A  D  K  Q  K  N  G   - 160  
 
   481 - ACCAAAGCTATCTTTCAAGTTCACCACAACATTGAAGATGGAGGCGTTCAACTAGCAGAC - 540  
   161 - T  K  A  I  F  Q  V  H  H  N  I  E  D  G  G  V  Q  L  A  D   - 180  
 
   541 - CATTATCAACAAAATACTCCAATTGGCGATGGCCCTGTCCTTTTACCAGACAACCATTAC - 600  
   181 - H  Y  Q  Q  N  T  P  I  G  D  G  P  V  L  L  P  D  N  H  Y   - 200  
 
   601 - CTGCACACACAATCTGCCCTTTCGAAAGATCCCAACGAAAAGAGAGACCACATGGTCCTT - 660  
   201 - L  H  T  Q  S  A  L  S  K  D  P  N  E  K  R  D  H  M  V  L   - 220  
 
   661 - CTTGAGTTTGTAACAGCTGCTGGGATTACACATGGCATGGATGAACTATACAAATAA    - 720  
   221 - L  E  F  V  T  A  A  G  I  T  H  G  M  D  E  L  Y  K  *      - 240  
 
 
Acyl carrier protein 
     1 – GGTACCATGAAGATCTTATTACTTTGTATAATTTTTCTATATTATGTTAACGCTTTTAAA – 60 
     1 - G  T  M  K  I  L  L  L  C  I  I  F  L  Y  Y  V  N  A  F  K   - 20 
     
    61 – AATACACAAAAAGATGGAGTGTCCTTACAAATATTAAAAAAGAAAAGAAGCAACCAAGTG - 120 
    21 – N  T  Q  K  D  G  V  L  S  Q  I  L  K  K  K  R  S  N  Q  V   - 40 
      
   121 – AATTTTTTAAATAGAAAAAATGATTACAATTTGATAAAAAATAAAAACCCATCTAGCTCT - 180 
    41 – N  F  L  N  R  K  N  D  Y  N  L  I  K  N  K  N  P  S  S  S   - 60 
    
   181 - TTAAAAGGTACC                                                 - 192 
    61 – L  K  G  T                                                   - 64 
 
 
Citrate synthase 
     1 – GGTACCATGGAAGGAATAAGATACCTATCATGCAATAAAATTTTGTATAAAAGAACAGGG - 60      
     1 – G  T  M  E  G  I  R  Y  L  S  C  N  K  I  L  Y  K  R  T  G   - 20 
    
    61 – TCTACAAAAACGCTTATAAATTCATTAAGAAAAAGATATGAGCATAATAATTTTAAAAAG - 120 
    21 - S  T  K  T  L  I  N  S  L  R  K  R  Y  E  H  N  N  F  K  K   - 40 
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   121 – AAAACTTGTGAACAAGTATTAAATACTGTAAATAAATTGCATAATGAAAAGCGATATTTT - 180 
    41 - K  T  C  E  Q  V  L  N  T  V  N  K  L  H  N  E  K  R  Y  F   - 60 
    
   181 – AATTTTTCTTGTTCTTTTACAAAATCCAGTAGATGGAATATTTGTATGAATAGACATAAC – 240 
    61 - N  F  S  C  S  F  T  K  S  S  R  W  N  I  C  M  N  R  H  N   - 80 
   
   241 – AGTCGTTTTTTTTCTAGCAATGAATCTAATAAGAATTTATATCTTGAAAATTATGCTAAT – 300 
    81 - S  R  F  F  S  S  N  E  S  N  K  N  L  Y  L  E  N  Y  A  N   - 100 
    
   301 – ATTAGAAAACATATTAATAGTATAGATAATGAAGAATCTGTTATTATGAATATTTTGAAA – 360 
   101 - I  R  K  H  I  N  S  I  D  N  E  E  S  V  I  M  N  I  L  K   - 120 
   
   361 – GGTACC                                                       - 366 
   121 – G  T                                                         - 140 
 
  
Plasmepsin IV 
           1 – GGTACCATGGCTCTTACCGTTAAAGAAGAAGAATTTTCGAATACATTGATTAAAAATGCT - 60      
     1 – G  T  M  A  L  T  V  K  E  E  E  F  S  N  T  L  I  K  N  A   - 20 
     
    61 – TCAGCATTTGATCGATTGAAATTAGGTAATTTGAAGAACTTGAAAATCCAGAAAAAGCTT - 120 
    21 - S  A  F  D  R  L  K  L  G  N  L  K  N  L  K  I  Q  K  K  L   - 40 
   
   121 – CAGTTTTTATATTTAATATTGTTTGTCCTTATTACGGGTGTGTTTTTCTTTTTTTTGATT - 180 
    41 - Q  F  L  Y  L  I  L  F  V  L  I  T  G  V  F  F  F  F  L  I   - 60 
   
   181 - GGAAATTTTTATTCACATCGCAAGTTGTATCAAGTTGGTACC                   - 223 
    61 - G  N  F  Y  S  H  R  K  L  Y  Q  V  G  T                     - 74 
 
 
STEVOR  
 1 – ATGAAGATGTATAACCTTAAAATGTTATTGTTTAACTTTTTAATAAATGTTTTAGTATTA - 60   
     1 – M  K  M  Y  N  L  K  M  L  L  F  N  F  L  I  N  V  L  V  L   - 20  
   
    61 – CCACATTATGAAAATTATCAAAATAACCAT                               - 90 
    21 - P  H  Y  E  N  Y  Q  N  N  H                                 - 30 
 
  
 
 
 
